Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
42529215	p-fsh	u/l (u/l)	5866	7717	0.00%
42529215	p-fsh	— (—)	1547	1860	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Female infertility

984

1401

4.47

321.24

1.4

1.3

13.31

31.75

u/l

50.57

873

1129

Disorders of other endocrine glands

1023

2844

3.65

303.17

1.6

1.3

16.80

25.96

u/l

18.50

888

2321

Hypopituitarism

302

263

12.66

297.59

1.8

1.3

13.78

22.22

u/l

3.38

247

219

Exclusions for E4_PCOS_BROAD

548

1092

5.31

260.48

1.8

1.3

17.16

24.57

u/l

6.38

467

907

Female infertility, cervical, vaginal, other or unspecified origin

827

1382

4.06

247.29

1.3

14.48

32.05

u/l

42.17

727

1113

Female infertility, associated with anovulation

420

705

6.55

242.91

1.4

1.3

9.16

26.26

u/l

28.82

375

562

General examination and investigation of persons without complaint and reported diagnosis

1068

1735

3.27

222.15

1.4

1.3

25.94

25.65

u/l

0.08

881

1477

Medical observation and evaluation for suspected diseases and conditions

1082

1735

3.24

220.86

1.4

1.3

23.33

25.65

u/l

1.17

846

1477

Irregular menses

1397

4415

2.58

213.62

1.5

1.3

19.69

28.94

u/l

23.09

1191

3614

Examination and observation for other reasons

970

1733

3.29

212.23

1.4

1.3

21.78

25.67

u/l

2.68

778

1475

Depression

1706

5026

2.34

207.38

1.4

1.3

22.34

26.31

u/l

4.97

1328

4240

Mood disorders

1753

5046

2.28

199.62

1.4

1.3

22.28

26.28

u/l

5.20

1367

4255

Mood [affective] disorders

1750

5046

2.28

199.32

1.4

1.3

22.33

26.27

u/l

5.04

1365

4254

Anxiety disorders, excluding more controls

1463

3936

2.46

196.51

1.4

1.3

24.93

27.16

u/l

1.54

1171

3340

L02BG Aromatase inhibitors

547

1388

4.06

190.02

1.4

1.3

38.71

40.23

u/l

0.38

509

1098

Polycystic ovarian syndrome, consortium definition

1697

4517

2.28

186.03

1.5

1.3

20.04

29.23

u/l

24.92

1442

3697

Neurotic, stress-related and somatoform disorders

1619

5093

2.26

183.63

1.4

1.3

24.10

25.92

u/l

1.28

1297

4253

Mood disorders, excluding more controls

1540

3975

2.35

183.15

1.4

1.3

23.11

27.03

u/l

4.29

1202

3369

Anxiety disorders

1623

5095

2.26

183.05

1.4

1.3

24.05

25.97

u/l

1.39

1300

4255

Hypogonadotropic hypogonadism

131

24.19

179.21

1.4

4.39

12.51

u/l

2.80

Amenorrhoea

298

484

6.67

177.59

1.8

1.3

12.55

26.43

u/l

11.71

275

385

Recurrent or chronic depression

810

1859

3.13

173.73

1.4

1.3

24.72

28.68

u/l

2.27

637

1593

Polycystic ovarian syndrome, broad definition

537

1472

3.95

171.19

1.4

1.3

8.87

20.10

u/l

29.00

483

1209

Medicines for HER+ breast cancer

717

2229

3.14

165.92

1.4

1.3

36.36

37.83

u/l

0.45

668

1759

Hypothyroidism (congenital or acquired)

627

1064

3.41

142.68

1.5

1.2

17.21

19.61

u/l

1.10

526

902

Hypothyroidism, other/unspecified

1509

4787

2.10

141.69

1.5

1.3

24.11

25.65

u/l

0.96

1238

3972

Noninflammatory disorders of female genital tract

847

1511

2.88

141.10

1.4

1.3

17.59

30.48

u/l

20.86

745

1222

Disorders of the thyroid gland

1540

4903

2.07

139.11

1.4

1.3

23.68

25.26

u/l

1.04

1248

4063

Hypothyroidism and >3 levothyroxin purchases

620

1064

3.38

139.01

1.5

1.2

17.48

19.61

u/l

0.91

519

902

Hypothyroidism, levothyroxine purchases

620

1064

3.38

139.01

1.5

1.2

17.48

19.61

u/l

0.91

519

902

Endocrine, nutritional and metabolic diseases

1410

3287

2.20

138.64

1.4

1.3

19.07

26.34

u/l

13.51

1187

2731

Hypothyreosis and Thyroxine purchase for inclusion criteria

1548

5008

2.06

137.00

1.5

1.3

24.34

25.88

u/l

0.98

1271

4149

Excessive, frequent and irregular menstruation

774

1488

2.91

135.99

1.3

20.14

30.88

u/l

12.96

639

1201

Ovarian dysfunction

370

932

4.33

133.28

1.6

1.3

13.98

19.27

u/l

3.47

339

786

Non-small cell lung cancer, including Hilmo

175

197

8.55

131.74

1.3

26.63

36.88

u/l

2.42

170

134

Lung cancer and mesothelioma

205

247

7.24

128.95

1.3

26.67

35.79

u/l

2.53

197

190

Anxiety (asthma-related co-morbidities)

1180

4282

2.17

123.92

1.4

1.3

20.29

26.32

u/l

8.52

940

3621

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

285

607

4.73

121.90

1.6

1.3

33.44

33.42

u/l

0.00

271

435

Oxycodone

465

1271

3.36

121.14

1.5

1.3

28.88

31.96

u/l

1.06

410

1022

Pain in joint

911

2431

2.42

118.84

1.4

1.3

25.52

25.46

u/l

0.01

715

2053

Polycystic ovarian syndrome

292

686

4.68

115.77

1.5

1.3

7.36

17.87

u/l

16.61

263

584

Hypothyroidism, strict autoimmune

1232

3914

2.10

115.42

1.4

1.3

24.50

25.97

u/l

0.78

1006

3253

Other special examinations and investigations of persons without complaint or reported diagnosis

858

1736

2.53

114.66

1.4

1.3

23.15

25.65

u/l

1.25

702

1477

Malignant neoplasm of bronchus and lung, including Hilmo

194

243

6.79

114.35

1.3

27.65

36.34

u/l

2.08

187

164

Malignant neoplasm of respiratory system and intrathoracic organs

193

256

6.38

107.12

1.4

1.3

24.45

34.48

u/l

2.74

185

169

All anxiety disorders

1198

4730

2.03

107.03

1.4

1.3

20.05

25.05

u/l

6.39

957

3948

Behavioural syndromes associated with physiological disturbances and physical factors

1420

5294

1.92

106.69

1.4

1.3

22.56

25.91

u/l

3.39

1160

4392

Headache

1104

4301

2.08

105.26

1.4

1.3

23.44

24.81

u/l

0.68

902

3532

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

622

2428

2.62

105.24

1.7

1.3

21.99

29.30

u/l

6.26

516

1976

Depression or dysthymia

858

2007

2.39

104.40

1.4

1.3

25.33

28.01

u/l

1.28

672

1721

Special screening examination for infectious and parasitic diseases

527

1342

2.96

104.23

1.3

16.74

22.73

u/l

3.73

376

1143

Benzodiazepine use

1471

5418

1.89

104.07

1.4

1.3

24.53

25.44

u/l

0.45

1140

4546

Exclusions for E4_PCOS_CONSORTIUM

1431

4731

1.92

103.95

1.5

1.3

22.74

26.83

u/l

4.87

1207

3858

Sleep disorders

1380

5254

1.92

103.48

1.4

1.3

23.18

26.03

u/l

2.45

1123

4358

Other nutritional deficiencies

1150

5465

2.01

103.14

1.4

1.3

17.41

26.91

u/l

27.73

938

4527

Other antidepressants

1372

3605

1.97

102.19

1.4

1.3

23.06

25.77

u/l

2.14

1090

3051

Pain and other conditions associated with female genital organs and menstrual cycle

456

1406

3.07

101.14

1.3

19.03

30.01

u/l

8.88

376

1129

Malignant neoplasm of bronchus and lung

169

208

6.86

100.16

1.3

25.61

37.66

u/l

3.14

163

140

Follow-up examination after treatment for conditions other than malignant neoplasms

636

1635

2.61

97.86

1.3

28.77

26.77

u/l

0.69

519

1388

Male infertility

13.79

95.96

1.4

1.3

11.82

9.05

u/l

0.65

Insomnia

1372

5399

1.87

95.61

1.4

1.3

22.92

25.69

u/l

2.36

1121

4480

Obesity and other hyperalimentation

1096

5409

1.98

94.67

1.4

1.3

17.27

26.96

u/l

28.57

893

4476

Obesity

1093

5402

1.98

94.44

1.4

1.3

17.27

26.95

u/l

28.44

891

4470

GASTRO-related operations

1252

3227

1.97

92.41

1.4

1.3

22.61

22.82

u/l

0.08

1064

2628

Any gastric operation

1252

3227

1.97

92.41

1.4

1.3

22.61

22.82

u/l

0.08

1064

2628

Any event in cancer register

1421

4581

1.85

90.61

1.4

1.3

32.92

23.77

u/l

17.19

1259

3653

Other specific joint derangements/joint disorders

1248

4273

1.91

90.07

1.4

1.3

25.29

22.89

u/l

1.58

993

3581

Malignant neoplasm of breast, HER-positive

578

1784

2.58

89.95

1.4

1.3

42.51

37.59

u/l

2.24

543

1351

Malignant neoplasm

1258

3956

1.90

87.98

1.4

1.3

35.88

26.82

u/l

14.44

1141

3102

Obesity due to excess calories

852

4111

2.11

87.79

1.4

1.3

17.73

26.92

u/l

19.82

682

3376

Malignant neoplasm of breast, ER-positive, including Hilmo

587

1825

2.54

87.77

1.4

1.3

42.45

37.40

u/l

2.38

551

1383

Ovarian cyst

625

1443

2.55

87.48

1.4

1.3

23.93

31.56

u/l

6.00

535

1162

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

194

405

4.90

86.91

1.5

1.4

35.19

29.17

u/l

1.34

182

294

Any mental disorder

1443

3986

1.83

86.04

1.4

1.3

25.29

26.99

u/l

1.02

1141

3377

Other soft tissue disorders, not elsewhere classified

1347

4319

1.85

85.92

1.4

1.3

22.75

23.56

u/l

0.40

1082

3618

Solid cancers, helper endpoint

1232

3900

1.89

83.92

1.4

1.3

35.50

27.14

u/l

12.31

1119

3055

General symptoms and signs

1547

4405

1.78

83.80

1.4

1.3

25.74

24.46

u/l

0.74

1280

3619

Testicular dysfunction

17.07

83.54

1.4

1.2

18.47

9.89

u/l

1.90

Malignant neoplasm, wide definition for exclusion

1299

4159

1.85

83.49

1.4

1.3

35.01

25.87

u/l

15.33

1176

3270

Depression medications

558

1098

2.60

78.12

1.4

1.2

19.40

19.31

u/l

0.02

462

932

Neoplasms

1225

3532

1.86

77.69

1.4

1.3

19.91

19.04

u/l

0.45

1053

2844

Dermatitis and eczema

1497

5440

1.72

76.58

1.4

1.3

24.06

25.28

u/l

0.71

1224

4507

Used for control exclusion in common control thyroid runs

1421

4096

1.77

76.17

1.4

1.3

20.56

24.75

u/l

5.16

1169

3420

Testicular hypofunction

18.06

76.05

1.4

1.2

20.13

7.89

u/l

3.59

Persons encountering health services for examination and investigation

757

1736

2.21

75.48

1.4

1.3

22.76

25.65

u/l

1.46

615

1477

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

193

450

4.37

75.32

1.5

1.3

34.59

33.58

u/l

0.14

184

315

Anaemias

422

991

2.83

75.26

1.4

1.2

23.67

20.47

u/l

1.06

351

836

Hypothyroidism, strict autoimmune, 3 medication purchases required

1280

4911

1.78

74.66

1.4

1.3

25.64

26.22

u/l

0.24

1038

4061

Genitourinary diseases

602

1262

2.41

73.32

1.4

1.3

17.81

24.27

u/l

5.04

512

1027

Low back pain

1096

4306

1.85

73.19

1.4

1.3

24.41

24.63

u/l

0.08

865

3598

Neurological diseases

1269

3582

1.80

71.64

1.4

1.3

21.04

24.07

u/l

2.68

1050

3004

Migraine

979

4284

1.88

70.41

1.4

1.3

21.24

25.91

u/l

4.70

813

3563

Other anxiety disorders

883

4012

1.94

70.23

1.4

1.3

19.09

22.96

u/l

3.41

717

3347

Lower back pain or/and sciatica

1426

5538

1.70

70.10

1.4

1.3

25.22

25.02

u/l

0.08

1150

4602

Parasetamol

1054

2851

1.89

69.97

1.4

1.3

21.17

22.77

u/l

0.85

888

2366

Selective serotonin reuptake inhibitors

1231

3612

1.79

69.97

1.4

1.3

22.64

25.73

u/l

2.47

988

3057

Procreative management

579

2165

2.27

69.48

1.4

19.34

28.65

u/l

10.29

502

1712

Psychiatric diseases

1205

3381

1.80

68.49

1.4

1.3

25.16

27.21

u/l

1.19

961

2870

Dysplasia of cervi uteri

459

1352

2.51

66.46

1.3

24.25

32.23

u/l

5.02

357

1090

Dorsalgia

1387

4409

1.70

65.83

1.4

1.3

23.44

24.20

u/l

0.37

1123

3689

Caries of dentine

306

1024

2.96

65.65

1.4

1.3

20.64

26.45

u/l

2.56

249

876

Continuous positive airway pressure

220

507

3.71

65.61

1.2

1.4

23.87

33.98

u/l

3.92

175

417

Thyrotropin deficiency

11.22

64.47

1.8

1.4

16.96

25.30

u/l

1.24

Malignant neoplasm of breast

756

2484

2.02

63.86

1.4

1.3

40.74

35.03

u/l

3.70

708

1900

Malignant neoplasm of breast, HER2-negative

738

2417

2.03

63.48

1.4

1.3

41.01

35.39

u/l

3.51

691

1843

Menorrhagia

545

1326

2.32

62.31

1.3

24.97

33.75

u/l

6.23

452

1073

Nerve, nerve root and plexus disorders

1371

5088

1.66

62.05

1.4

1.3

26.51

26.23

u/l

0.11

1101

4213

Sleep disorders (combined)

1437

4591

1.66

61.68

1.4

1.3

21.70

25.94

u/l

5.26

1148

3828

Symptoms and signs involving the circulatory and respiratory systems

1467

4515

1.64

60.21

1.4

1.3

23.30

24.18

u/l

0.45

1207

3742

Malignant neoplasm of breast, HER2-negative, including Hilmo

768

2572

1.97

60.13

1.4

1.3

40.51

34.71

u/l

3.92

720

1967

Malignant neoplasm of breast, including Hilmo

768

2572

1.97

60.12

1.4

1.3

40.51

34.71

u/l

3.92

720

1967

Chronic laryngitis and laryngotracheitis

228

702

3.33

59.83

1.4

1.3

31.74

31.20

u/l

0.07

176

592

Dental caries

328

1186

2.70

59.33

1.4

1.3

21.34

25.98

u/l

1.83

269

1004

Opioids

1391

4405

1.65

59.31

1.4

1.3

22.64

23.64

u/l

0.53

1148

3654

Endometriosis

533

1403

2.26

58.64

1.3

24.99

32.31

u/l

4.62

458

1131

Soft tissue disorders

1382

4347

1.65

58.31

1.4

1.3

21.82

23.43

u/l

1.07

1136

3644

Myalgia

420

1816

2.36

57.17

1.5

1.3

23.66

27.36

u/l

1.48

334

1496

Episodal and paroxysmal disorders

1463

4640

1.62

56.89

1.4

1.3

21.31

25.32

u/l

4.84

1192

3865

Benign neoplasm: Pituitary gland, craniopharyngeal duct

129

279

4.86

56.09

2.2

1.4

16.42

23.91

u/l

2.20

120

230

Other dorsopathies, not elsewhere classified

1369

4419

1.63

55.90

1.4

1.3

22.69

24.16

u/l

0.91

1112

3697

Neurological diseases, wide definition

539

1228

2.23

55.25

1.4

1.3

19.29

22.75

u/l

1.57

447

1035

Hyperfunction of pituitary gland

151

376

4.25

55.01

1.9

1.4

13.52

24.51

u/l

5.73

138

317

Acute upper respiratory infections

1331

5101

1.62

54.41

1.4

1.3

25.25

26.21

u/l

0.47

1068

4232

Other problems related to primary support group, including family circumstances

301

1113

2.73

54.29

1.5

1.4

20.25

20.71

u/l

0.09

263

942

Persons encountering health services in other circumstances

573

2841

2.03

54.09

1.4

1.3

22.32

25.39

u/l

1.49

499

2311

Chronic diseases of tonsils and adenoids

1112

4220

1.68

52.67

1.4

1.3

25.10

25.28

u/l

0.06

902

3533

Caries of enamel

1232

5517

1.62

52.55

1.4

1.3

23.06

25.97

u/l

2.46

999

4584

Other reaction to severe stress, and adjustment disorders

673

3585

1.91

52.53

1.4

1.3

24.33

24.44

u/l

0.03

550

2978

Abnormal findings on diagnostic imaging of lung

370

1517

2.36

50.80

1.4

1.3

29.84

33.55

u/l

1.31

325

1212

Liquid cancers, helper endpoint

299

1005

2.62

50.34

1.5

1.3

34.52

29.33

u/l

1.60

263

760

Smoking dependency

160

441

3.75

50.09

1.4

25.66

26.21

u/l

0.07

121

361

Carpal tunnel syndrome

788

3911

1.79

50.05

1.4

1.3

29.06

31.32

u/l

1.08

647

3215

Hyperprolactinaemia

129

308

4.50

50.01

1.8

1.4

13.63

25.57

u/l

5.54

117

256

Mental and behavioural disorders due to tobacco

160

443

3.73

49.76

1.4

25.66

26.11

u/l

0.05

121

365

Other symptoms and signs involving the digestive system and abdomen

269

1011

2.72

49.46

1.4

1.3

30.25

33.15

u/l

0.63

214

833

Dorsopathies

1369

4426

1.58

49.02

1.4

1.3

21.96

24.12

u/l

1.68

1126

3704

Oligomenorrhoea

102

207

5.21

47.94

1.3

9.35

26.19

u/l

9.71

168

Pain, not elsewhere classified

411

1919

2.17

46.40

1.6

1.3

25.46

25.65

u/l

0.04

353

1564

Codeine

1255

4336

1.58

45.78

1.4

1.3

22.85

23.89

u/l

0.53

1023

3596

Triptan medication for migraine, single purchase ok

1165

4996

1.59

45.42

1.4

1.3

24.58

26.21

u/l

0.89

966

4112

Migraine, single triptan purchase ok & required. ICD-code if available is included

1165

4996

1.59

45.42

1.4

1.3

24.58

26.21

u/l

0.89

966

4112

Personality disorders, excluding more controls

444

2162

2.09

44.99

1.5

1.3

20.93

23.35

u/l

0.89

348

1836

Substance abuse, excluding more controls

611

2799

1.88

44.89

1.4

1.3

22.48

25.50

u/l

1.42

467

2363

Other menopausal disorders

440

1151

2.19

44.49

1.5

1.3

34.37

37.22

u/l

0.78

354

940

Persons encountering health services in other circumstances, wide

1392

4687

1.54

44.29

1.3

23.88

26.73

u/l

2.47

1166

3833

Abnormalities of breathing

1214

4505

1.58

44.10

1.4

1.3

25.62

24.22

u/l

0.72

1003

3732

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1325

4686

1.55

43.67

1.3

23.76

26.73

u/l

2.55

1115

3832

Sciatica+with lumbago

666

3428

1.81

43.64

1.4

1.3

27.35

29.07

u/l

0.65

553

2832

Pain in limb

1018

4213

1.63

43.49

1.4

1.3

24.44

23.98

u/l

0.17

817

3525

Dental pulpitis, including avohilmo

1293

5504

1.54

42.80

1.4

1.3

22.78

25.09

u/l

1.80

1060

4556

Dermatitis

745

4337

1.73

42.46

1.4

1.3

25.27

27.64

u/l

1.19

615

3570

Sleep apnoea, including avohilmo

1188

4732

1.57

42.45

1.4

1.3

25.79

29.02

u/l

2.70

963

3882

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

600

2934

1.84

42.14

1.4

1.3

27.93

31.35

u/l

1.70

511

2376

Other diseases of intestines

1421

5395

1.51

42.10

1.4

1.3

25.63

23.87

u/l

1.15

1155

4481

Unspecified urinary incontinence

132

360

3.76

41.94

1.5

1.3

30.88

32.53

u/l

0.18

300

Hypertrichosis

105

248

4.68

41.75

1.5

1.4

7.41

20.10

u/l

8.12

208

Substance use, excluding alcohol

303

1306

2.36

41.70

1.4

22.19

22.30

u/l

0.02

234

1090

Malignant melanoma

143

414

3.51

41.36

1.5

1.3

32.75

32.82

u/l

0.01

132

298

Other and unspecified disorders of skin and subcutaneous tissue

111

271

4.23

41.26

1.4

30.30

28.82

u/l

0.14

220

Other joint disorders

1251

4303

1.54

40.70

1.4

1.3

21.74

22.80

u/l

0.53

1005

3606

Fever of other and unknown origin

645

3242

1.79

40.70

1.5

1.3

28.20

24.74

u/l

1.83

566

2656

Abnormalities of heart beat

446

2214

2.00

40.29

1.4

1.3

22.55

27.08

u/l

2.12

365

1824

Malignant melanoma of skin

119

310

3.91

40.26

1.6

1.4

31.70

31.91

u/l

0.02

111

223

Hirsutism in women

218

4.89

40.20

1.6

1.4

6.84

19.51

u/l

8.07

184

First line medication for Crohn's disease

1397

5075

1.50

39.62

1.5

1.3

25.41

23.74

u/l

1.08

1164

4170

Malignant melanoma, including Hilmo

161

517

3.16

39.40

1.5

1.3

32.80

32.00

u/l

0.10

150

374

Unknown and unspecified causes of morbidity

123

335

3.77

39.21

1.3

26.36

25.68

u/l

0.07

118

277

Other and unspecified dermatitis

639

3663

1.76

39.12

1.5

1.3

24.90

28.13

u/l

1.73

526

3004

Malignant melanoma of skin, including Hilmo

142

426

3.39

38.88

1.5

1.3

32.45

31.58

u/l

0.10

134

308

Fibromyalgia

221

864

2.65

38.05

1.4

26.60

30.13

u/l

0.75

175

721

Somatoform disorder

269

1153

2.38

37.64

1.5

1.3

28.27

26.85

u/l

0.26

218

954

Any reimbursement code in KELA

952

2968

1.62

37.58

1.4

1.3

23.07

20.75

u/l

1.34

804

2397

Symptoms and signs involving the skin and subcutaneous tissue

875

5384

1.60

37.38

1.4

1.3

25.28

26.92

u/l

0.78

726

4419

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

471

2493

1.91

37.19

1.4

1.3

18.82

23.84

u/l

3.27

361

2110

Non-selective monoamine reuptake inhibitors

371

1747

2.07

36.91

1.4

1.3

31.45

35.98

u/l

1.56

285

1436

Malignant neoplasm of urinary organs

127

5.59

36.87

1.3

37.83

30.77

u/l

0.70

Codeine or tramadol medication

1409

5275

1.47

36.74

1.4

1.3

23.66

25.21

u/l

1.01

1151

4369

Other intervertebral disc disorders

992

3819

1.57

36.27

1.4

1.3

27.71

27.07

u/l

0.23

793

3161

Diarrhoea and gastroenteritis of presumed infectious origin

1232

5482

1.49

35.68

1.4

1.3

22.34

25.86

u/l

3.32

1007

4536

Generalized anxiety disorder

323

1534

2.15

35.32

1.4

1.3

19.77

18.34

u/l

0.37

254

1286

Acute upper respiratory infections of multiple and unspecified sites

1009

4879

1.54

35.16

1.4

1.3

21.96

25.47

u/l

2.94

816

4050

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

144

5.14

35.07

1.3

35.11

31.83

u/l

0.26

101

Cervicobrachial syndrome

317

1502

2.14

34.68

1.5

1.3

30.94

32.54

u/l

0.34

263

1208

Autoimmune diseases

1336

4646

1.47

34.45

1.4

1.3

22.48

24.28

u/l

1.23

1085

3869

Certain infectious and parasitic diseases

1274

4326

1.48

34.19

1.4

1.3

25.86

25.50

u/l

0.14

1037

3589

Panic disorder

299

1398

2.19

34.07

1.5

1.3

18.88

19.10

u/l

0.04

232

1171

Benign neoplasm of other and unspecified endocrine glands

174

636

2.79

33.97

2.0

1.4

19.63

29.81

u/l

4.26

158

519

Gastro-oesophageal reflux disease

759

4055

1.63

33.94

1.4

1.3

27.49

29.57

u/l

0.90

582

3351

Bronchitis

1308

5674

1.46

33.94

1.4

1.3

22.58

25.53

u/l

2.70

1070

4699

Complications of procedures, not elsewhere classified

970

5253

1.54

33.93

1.4

1.3

27.45

26.32

u/l

0.47

827

4288

Other disorders of skin and subcutaneous tissue, not elsewhere classified

166

594

2.84

33.67

1.5

1.4

28.07

28.53

u/l

0.06

142

490

Benign neoplasms

1241

4650

1.48

33.58

1.4

1.3

22.18

22.67

u/l

0.21

1038

3835

Endometriosis of pelvic peritoneum

281

1224

2.23

33.53

1.3

28.53

33.69

u/l

1.51

242

986

Substance abuse

611

3387

1.71

33.43

1.4

1.3

22.48

23.83

u/l

0.47

467

2799

Malignant neoplasm of kidney, except renal pelvis

119

5.46

32.86

1.3

37.22

29.64

u/l

0.73

Complications of surgical and medical care, not elsewhere classified

1164

5426

1.48

32.63

1.4

1.3

28.31

25.70

u/l

1.75

993

4433

Fentanyl

228

4.04

32.43

1.5

1.3

39.38

34.05

u/l

0.55

180

Missing teeth due to accident, extraction or parodontitis

500

2650

1.79

32.37

1.4

1.3

29.94

32.02

u/l

0.67

387

2168

Mental and behavioural disorders due to psychoactive substance use

627

3491

1.68

31.97

1.4

1.3

22.63

23.87

u/l

0.42

480

2893

Use of hypnotics and sedatives

1264

5010

1.46

31.88

1.4

1.3

27.09

26.57

u/l

0.20

998

4151

Follow-up care involving plastic surgery

250

3.94

31.35

1.2

1.3

34.37

30.02

u/l

0.47

201

Polyp of the female genital tract

414

1241

1.94

30.97

1.4

1.3

29.82

35.38

u/l

2.43

341

1006

Other headache syndromes

608

3669

1.67

30.91

1.4

1.3

25.74

28.36

u/l

1.14

488

3040

Excluding asthma or asthma-COPD overlap

969

3177

1.54

30.82

1.4

1.3

24.54

26.66

u/l

1.15

781

2664

Other diseases of upper respiratory tract

1205

4307

1.47

30.82

1.4

1.3

25.88

25.12

u/l

0.31

974

3601

Irritable bowel syndrome

408

2204

1.88

30.74

1.4

1.3

25.22

26.93

u/l

0.47

336

1826

Inflammatory diseases of female pelvic organs

1035

5148

1.49

30.60

1.4

1.3

25.13

27.19

u/l

1.12

831

4277

Medical treatment for female infertility

589

3539

1.69

30.47

1.3

1.4

15.16

24.50

u/l

16.27

514

2902

Sleep apnoea

1028

4473

1.50

30.43

1.4

1.3

25.45

30.71

u/l

5.73

830

3663

Symptoms and signs involving the digestive system and abdomen

1102

3735

1.49

29.98

1.4

1.3

24.00

25.26

u/l

0.60

908

3115

Disorders of thyroid, IBD co-morbidities

296

993

2.12

29.68

1.4

1.3

29.82

26.38

u/l

0.83

240

833

Arthropathies

1225

4304

1.45

29.51

1.4

1.3

20.67

22.79

u/l

1.55

1004

3607

Antihypertensive medication - note that there are other indications

1023

3639

1.50

29.49

1.4

1.3

18.91

21.90

u/l

2.43

850

3046

Oedema, not elsewhere classified

308

1514

2.03

29.30

1.5

1.3

26.63

29.05

u/l

0.65

256

1234

1336

4874

1.42

29.25

1.4

1.3

26.17

26.14

u/l

0.01

1075

4045

Diseases of the skin and subcutaneous tissue

1194

4138

1.45

29.22

1.4

1.3

24.06

25.09

u/l

0.49

974

3421

Other pulmonary diagnosis

959

3177

1.52

29.13

1.4

1.3

24.41

26.66

u/l

1.26

771

2664

ILD medications: prednisolone, methylprednisolone, prednisone

1311

5182

1.42

29.07

1.4

1.3

25.56

24.52

u/l

0.53

1089

4275

Vasomotor and allergic rhinitis

568

3372

1.67

28.72

1.4

1.3

23.75

24.59

u/l

0.24

443

2816

Gastrointestinal diseases

851

2756

1.56

28.72

1.4

1.3

21.77

22.85

u/l

0.44

711

2315

Migraine without aura

432

2450

1.80

28.00

1.5

1.3

21.11

24.77

u/l

1.73

358

2029

ILD differential diagnosis

957

3202

1.51

27.77

1.4

1.3

24.70

26.57

u/l

0.95

773

2684

COPD differential diagnosis

957

3203

1.51

27.74

1.4

1.3

24.70

26.57

u/l

0.95

773

2684

ILD medications

1357

5271

1.40

27.68

1.4

1.3

25.33

24.19

u/l

0.61

1124

4352

L01XE Protein kinase inhibitors

151

4.56

27.67

1.5

1.4

35.33

33.52

u/l

0.14

119

Contraceptive management

552

2315

1.69

27.55

1.3

1.4

30.39

29.91

u/l

0.11

446

1836

Impingement syndrome of shoulder

233

1072

2.20

27.52

1.4

1.3

35.84

35.94

u/l

0.01

178

870

Obesity, other/unspecified

548

3332

1.67

27.35

1.5

1.3

15.45

28.87

u/l

31.61

459

2718

Diseases of male genital organs

221

467

2.40

27.26

1.4

1.3

10.79

9.97

u/l

0.33

176

394

Unspecified/other endometriosis

185

779

2.43

27.23

1.3

19.36

29.69

u/l

4.40

165

630

Hyperhidrosis

197

4.09

27.14

1.7

1.3

28.36

21.39

u/l

0.93

168

Shoulder lesions

795

3136

1.54

27.05

1.4

1.3

30.89

29.96

u/l

0.29

630

2596

Bipolar affective disorders

309

1594

1.97

26.96

1.5

1.3

17.82

23.31

u/l

3.10

247

1336

Diseases of the ear and mastoid process

1456

5311

1.38

26.92

1.4

1.3

24.54

25.00

u/l

0.20

1177

4414

Other/unspecified dorsalgia

437

2486

1.76

26.85

1.4

1.3

22.85

28.40

u/l

3.16

351

2036

Abdominal and pelvic pain

1078

3735

1.46

26.67

1.4

1.3

23.86

25.26

u/l

0.70

889

3115

Persistent mood disorders

246

1175

2.12

26.50

1.4

1.3

24.59

27.09

u/l

0.57

189

981

Complications of medical and surgical care

831

5126

1.50

26.40

1.4

1.3

27.11

27.72

u/l

0.20

689

4200

Diseases of oesophagus, stomach and duodenum

1238

5287

1.41

26.28

1.4

1.3

26.56

26.03

u/l

0.21

973

4404

Oxicams

224

556

2.31

26.25

1.4

22.25

26.48

u/l

1.09

182

455

Triptan medication for migraine, min. 3 purchases

1004

5320

1.45

26.25

1.4

1.3

21.94

26.23

u/l

4.33

849

4367

Tramadol

895

3708

1.49

25.94

1.4

1.3

28.58

26.96

u/l

0.68

734

3040

Cervicalgia

242

1163

2.11

25.64

1.4

1.3

27.48

31.60

u/l

1.08

198

954

Disorders of skin appendages

645

4135

1.57

25.63

1.4

1.3

20.22

24.76

u/l

3.57

540

3404

Intestinal infectious diseases

1307

5406

1.39

25.35

1.4

1.3

24.12

25.96

u/l

1.16

1072

4477

Personality disorders

444

2609

1.72

25.31

1.5

1.3

20.93

22.41

u/l

0.47

348

2172

Dentofacial anomalies [including malocclusion]

999

5608

1.44

25.29

1.4

1.3

23.37

25.72

u/l

1.51

819

4635

Hypothyroidism, drug reimbursement

223

723

2.21

24.77

1.5

1.2

30.46

26.17

u/l

0.97

179

592

Other maternal disorders predominantly related to pregnancy

1005

4403

1.45

24.64

1.4

1.3

25.20

29.06

u/l

3.24

851

3610

COPD/asthma/ILD related infections

1243

4474

1.40

24.57

1.3

26.47

26.17

u/l

0.11

1012

3711

COPD/asthma related infections

1243

4474

1.40

24.57

1.3

26.47

26.17

u/l

0.11

1012

3711

L02BA Anti-estrogens

259

1301

2.03

24.50

1.5

1.4

36.09

37.22

u/l

0.20

244

1036

Disorders of adult personality and behaviour

468

2818

1.68

24.36

1.5

1.3

20.78

22.36

u/l

0.53

368

2355

Lumbar disc prolapse

713

3598

1.53

24.26

1.4

1.3

27.48

28.27

u/l

0.25

574

2967

Bacterial infection, other or unspecified

404

2017

1.75

24.04

1.4

1.3

29.00

28.67

u/l

0.07

346

1659

KRA_PSY_EATING, excluding more controls

198

906

2.23

23.81

1.5

1.3

13.24

15.95

u/l

0.95

173

784

Tonsillectomy and adenotomy

999

4911

1.43

23.49

1.4

20.31

23.49

u/l

2.66

836

4061

Postpartum care and examination

402

1460

1.79

23.42

1.4

21.68

24.98

u/l

1.15

339

1160

Hernia of abdominal wall, postoperative

159

667

2.41

23.42

1.3

27.23

30.02

u/l

0.44

127

540

Persons encountering health services in circumstances related to reproduction

606

2600

1.58

23.32

1.4

25.23

28.62

u/l

1.67

510

2080

Supervision of high-risk pregnancy

504

1847

1.67

23.24

1.3

1.4

23.11

30.40

u/l

4.95

432

1450

Disease of hard tissues of teeth, NOS

528

1680

1.65

23.21

1.4

1.3

25.67

27.39

u/l

0.51

403

1424

Poisoning by drugs, medicaments and biological substances

369

2118

1.77

22.94

1.4

20.15

23.35

u/l

1.21

280

1756

Diseases of the respiratory system

769

2564

1.51

22.87

1.4

1.3

25.47

26.61

u/l

0.39

620

2147

Endometriosis of ovary

242

1186

2.02

22.77

1.3

23.40

34.33

u/l

5.43

214

959

Bacterial infection, other or unspecified

455

2320

1.67

22.72

1.4

1.3

28.36

28.18

u/l

0.04

391

1905

Malaise and fatigue

471

2303

1.66

22.70

1.4

1.3

26.77

26.93

u/l

0.04

398

1884

Convalescence

293

3.20

22.58

1.4

24.81

28.46

u/l

0.46

240

Nonorganic sleeping disorders, excluding more controls

282

1499

1.91

22.55

1.5

1.3

19.72

24.58

u/l

1.87

234

1256

Chronic apical periodontitis

1307

5498

1.36

22.49

1.4

1.3

25.01

24.84

u/l

0.06

1041

4582

Tobacco use

284

3.23

22.43

1.4

14.20

19.33

u/l

1.16

235

Problems related to lifestyle

147

610

2.45

22.34

1.4

1.3

14.05

21.30

u/l

3.24

126

512

Disorders of synovium and tendon

624

3581

1.54

22.19

1.3

27.63

26.98

u/l

0.17

495

2980

Complications of labour and delivery

950

3713

1.43

22.06

1.3

1.4

26.96

28.53

u/l

0.70

801

3030

Adenomyosis (Endometriosis of uterus)

169

750

2.29

22.01

1.4

1.3

20.50

37.46

u/l

9.72

149

605

Asthma (only as main-diagnosis)

799

3149

1.48

21.92

1.4

1.3

23.84

26.59

u/l

1.57

660

2640

Melanocytic naevi, other sites/unspecified

128

504

2.60

21.84

1.5

1.4

26.42

25.68

u/l

0.09

108

422

Other medical care

367

1912

1.74

21.53

1.5

1.3

28.27

27.90

u/l

0.07

326

1534

Asthma (mode)

864

3202

1.45

21.47

1.4

1.3

23.20

26.57

u/l

2.37

716

2684

Asthma, excluding more controls

863

3114

1.45

21.36

1.4

1.3

23.19

26.51

u/l

2.30

712

2610

Symptoms and signs concerning food and fluid intake

108

393

2.78

21.34

1.5

1.3

21.57

25.00

u/l

0.52

339

Specific personality disorders

389

2318

1.70

21.18

1.5

1.3

20.36

21.97

u/l

0.48

306

1924

Diseases of the musculoskeletal system and connective tissue

715

2393

1.51

21.04

1.4

1.3

19.46

22.48

u/l

1.77

594

2025

Asthma

864

3149

1.45

20.89

1.4

1.3

23.19

26.59

u/l

2.39

712

2640

Asthma (only as main-diagnosis), excluding more controls

793

3114

1.46

20.82

1.4

1.3

23.80

26.51

u/l

1.54

656

2610

Infections with a predominantly sexual mode of transmission

678

4284

1.49

20.78

1.4

19.83

20.92

u/l

0.44

544

3574

Pain (limb, back, neck, head abdominally)

725

2438

1.50

20.71

1.4

1.3

22.28

25.35

u/l

1.67

600

2060

Other functional intestinal disorders

444

2542

1.63

20.66

1.5

1.3

23.20

28.34

u/l

2.82

367

2101

Dysphagia

209

1032

2.04

20.64

1.4

1.3

30.53

30.45

u/l

0.01

169

846

Spinal instabilities

140

4.16

20.42

1.5

1.4

30.00

30.80

u/l

0.05

112

Artrosis, including avohilmo

980

3842

1.40

20.29

1.4

1.3

27.31

27.48

u/l

0.05

776

3190

Rotator cuff syndrome

553

2564

1.56

20.27

1.4

1.3

31.76

33.28

u/l

0.45

445

2102

Acute sinusitis

699

4437

1.47

20.16

1.3

23.39

25.24

u/l

0.82

561

3670

Symptoms and signs involving the urinary system

654

3352

1.49

20.05

1.4

1.3

26.43

28.27

u/l

0.71

527

2757

Pain associated with micturition

139

591

2.39

20.05

1.4

25.14

27.88

u/l

0.43

110

499

Other disorders of adrenal gland

197

3.55

20.01

1.8

1.3

28.78

27.48

u/l

0.10

159

Functional dyspepsia

315

1798

1.77

19.98

1.4

24.41

29.90

u/l

2.16

239

1496

Trochanteric bursitis

161

730

2.24

19.95

1.4

31.38

35.80

u/l

0.87

128

595

Schizophrenia or delusion, excluding more controls

333

1911

1.74

19.92

1.5

1.3

21.20

25.51

u/l

1.76

259

1604

Soft tissue disorders related to use, overuse and pressure

251

1339

1.89

19.82

1.4

30.00

32.49

u/l

0.53

203

1106

Disturbances of skin sensation

405

2482

1.65

19.79

1.4

1.3

22.26

26.03

u/l

1.63

327

2030

Poisoning by medicine

329

1909

1.75

19.78

1.4

19.67

23.26

u/l

1.33

256

1584

Oral corticosteroids

1206

5334

1.35

19.78

1.4

1.3

25.98

25.37

u/l

0.26

1011

4377

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

446

1357

1.66

19.73

1.4

1.3

22.09

23.24

u/l

0.31

374

1142

Factors influencing health status and contact with health services

209

496

2.12

19.72

1.4

21.24

28.41

u/l

2.41

166

417

Pain in thoracic spine

201

998

2.04

19.69

1.4

1.3

23.81

29.54

u/l

1.77

170

822

Other enthesopathies

343

2018

1.72

19.52

1.4

1.3

26.96

32.83

u/l

2.55

272

1663

Diseases of pulp and periapical tissues, including avohilmo

1168

4480

1.36

19.50

1.4

1.3

22.92

24.46

u/l

0.90

943

3762

Diseases of external ear

337

1974

1.72

19.46

1.4

22.35

26.55

u/l

1.49

247

1636

Chronic periodontitis, complicated

444

2764

1.60

19.41

1.3

1.4

28.33

32.36

u/l

1.85

341

2261

Infections with a predominantly sexual mode of transmission

526

3441

1.54

19.35

1.3

1.4

21.15

21.93

u/l

0.23

414

2872

Inflammatory bowel disease treatment related agents

1313

5554

1.33

19.33

1.4

1.3

25.35

24.58

u/l

0.37

1106

4568

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

535

3415

1.53

19.15

1.4

1.3

24.89

27.31

u/l

0.91

431

2830

Persons encountering health services for specific procedures and health care

1246

5626

1.33

19.14

1.4

1.3

27.88

24.37

u/l

3.16

1052

4619

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

267

1475

1.84

19.06

1.4

20.54

22.79

u/l

0.56

200

1228

Primary ovarian failure

182

3.69

18.94

2.1

1.3

40.44

24.81

u/l

3.09

153

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

324

1901

1.73

18.87

1.4

1.3

17.79

22.90

u/l

2.58

248

1589

Phobic anxiety disorders

228

1201

1.93

18.83

1.5

1.4

18.46

18.33

u/l

0.02

183

1010

Haemorrhoids and perianal venous thrombosis

253

1373

1.85

18.78

1.4

1.3

27.63

29.16

u/l

0.30

207

1146

Allergic rhinitis

493

3168

1.55

18.76

1.4

22.65

23.37

u/l

0.19

388

2627

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

117

475

2.51

18.74

1.4

27.50

26.60

u/l

0.10

394

Family history of malignant neoplasm

205

1051

1.99

18.52

1.4

30.40

27.71

u/l

0.46

185

866

Gastroduodenal ulcer

144

641

2.25

18.43

1.4

1.3

27.59

30.53

u/l

0.54

120

529

Migraine without aura and triptan purchases

356

2157

1.68

18.42

1.5

1.4

21.80

23.70

u/l

0.57

291

1784

Visual disturbances and blindness

513

3376

1.53

18.30

1.5

1.3

25.99

27.18

u/l

0.34

424

2767

Postmenopausal bleeding

281

819

1.85

18.23

1.4

1.3

43.35

46.37

u/l

0.69

235

669

Any operation in hilmo

5.28

18.20

1.5

1.3

17.64

24.89

u/l

0.59

Adrenocortical insufficiency

157

3.74

18.14

1.8

1.3

29.80

29.27

u/l

0.04

127

Localized swelling, mass and lump of skin and subcutaneous tissue

324

1920

1.70

17.99

1.4

1.3

25.52

28.99

u/l

1.13

270

1574

Atopic dermatitis

845

5003

1.39

17.98

1.4

1.3

21.10

25.14

u/l

3.32

684

4138

Endometriosis of intestine

146

3.93

17.89

1.4

1.2

26.82

26.57

u/l

0.02

126

Autoimmune diseases related-to ILD

937

5899

1.36

17.79

1.4

1.3

25.06

25.45

u/l

0.14

763

4875

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

471

3072

1.55

17.73

1.4

18.82

22.53

u/l

2.06

361

2555

Seborrhoeic dermatitis

376

2.65

17.63

1.5

1.4

20.71

25.72

u/l

0.96

313

Coxibs

259

732

1.88

17.62

1.3

1.4

17.28

21.28

u/l

1.35

215

613

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

619

4214

1.46

17.51

1.4

1.3

26.89

28.53

u/l

0.58

509

3443

Other shoulder lesions

132

584

2.30

17.47

1.5

1.4

25.30

29.60

u/l

0.81

106

487

Obesity related asthma

378

2350

1.62

17.43

1.4

1.3

20.02

31.07

u/l

11.50

303

1915

Pleural effusion

321

2.76

17.40

1.4

23.90

28.62

u/l

0.79

263

Visual disturbances

485

3192

1.53

17.38

1.5

1.3

25.89

27.04

u/l

0.32

402

2611

Arthrosis

781

3036

1.42

17.34

1.4

1.3

29.31

29.52

u/l

0.06

619

2510

Cystitis

1070

4760

1.34

17.26

1.4

1.3

26.56

25.78

u/l

0.32

879

3957

Gastric ulcer

106

428

2.49

17.09

1.4

28.46

31.06

u/l

0.36

355

Suicide or other Intentional self-harm

336

2042

1.66

17.05

1.4

21.02

25.11

u/l

1.61

246

1689

Other predominantly sexually transmitted diseases, not elsewhere classified

313

1871

1.70

17.04

1.3

1.4

20.76

20.72

u/l

0.01

246

1567

Failed induction of labour

163

799

2.11

16.94

1.3

1.4

12.71

18.96

u/l

2.44

136

662

Lateral epicondylitis

180

909

2.01

16.92

1.4

26.20

34.91

u/l

2.90

142

741

Cough

408

2457

1.58

16.86

1.4

1.3

27.85

29.17

u/l

0.33

336

2017

Pain in throat and chest

960

4259

1.36

16.86

1.4

1.3

26.35

25.33

u/l

0.42

783

3520

Other disorders of lacrimal gland

377

2367

1.61

16.72

1.5

1.3

30.08

30.87

u/l

0.16

304

1936

Otitis externa

258

1467

1.78

16.70

1.4

1.3

22.71

25.61

u/l

0.68

193

1229

Other abnormal uterine and vaginal bleeding

230

889

1.87

16.61

1.4

1.3

26.43

37.03

u/l

4.94

196

709

Disorders of lacrimal system

443

2882

1.54

16.59

1.5

1.3

28.71

31.15

u/l

0.76

358

2358

Other diseases of urinary system

1154

4937

1.32

16.37

1.4

1.3

25.60

25.19

u/l

0.15

932

4102

Polyuria

168

837

2.02

16.32

1.4

1.3

23.11

26.77

u/l

0.76

129

695

Cervical disc disorders

311

1874

1.67

16.23

1.5

1.3

32.27

34.29

u/l

0.45

246

1525

Hyperkinetic disorders, excluding more controls

199

1008

1.92

16.23

1.4

1.3

12.88

14.22

u/l

0.31

148

880

Other and unspecified polyneuropathies, also in other diseases

122

538

2.29

16.19

1.5

1.4

35.86

28.60

u/l

1.17

446

Benign neoplasm: Colon

317

1831

1.66

16.12

1.4

1.3

32.84

34.16

u/l

0.26

252

1484

Other and unspecified drugs and medicaments

106

442

2.44

16.10

1.4

28.66

26.31

u/l

0.28

367

Other diseases of hard tissues of teeth

496

1683

1.53

16.06

1.4

1.3

27.68

27.46

u/l

0.04

397

1427

Other disorders of skin and subcutaneous tissue

621

3865

1.43

15.96

1.4

1.3

27.14

29.65

u/l

1.11

518

3146

Deforming dorsopathies

285

1689

1.70

15.89

1.4

1.3

28.20

28.81

u/l

0.11

226

1389

Cardiovascular diseases (excluding rheumatic etc)

1020

4414

1.34

15.86

1.4

1.3

23.68

22.74

u/l

0.42

847

3681

Spondylolisthesis/Spondylolysis

172

875

1.99

15.80

1.4

1.3

32.20

35.05

u/l

0.49

138

711

Alcohol use disorder, ICD-based

343

2138

1.61

15.66

1.4

22.22

24.67

u/l

0.72

262

1771

Any death

319

1380

1.66

15.56

1.4

1.3

29.10

33.44

u/l

1.51

284

1103

Nausea and vomiting

251

1415

1.75

15.51

1.5

1.4

21.77

24.72

u/l

0.82

215

1185

Cardiovascular diseases

973

3915

1.34

15.48

1.4

1.3

21.37

21.21

u/l

0.06

817

3265

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

569

3961

1.44

15.33

1.4

1.3

26.20

28.82

u/l

1.09

464

3229

Other otitis externa (chronic)

310

2.70

15.30

1.5

1.4

24.84

26.02

u/l

0.10

255

Complications associated with artificial fertilization

153

3.58

15.20

1.4

1.3

8.68

25.49

u/l

6.84

130

Concussion

548

3084

1.46

15.19

1.4

1.3

22.11

24.99

u/l

1.33

442

2594

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

873

5165

1.35

15.06

1.4

1.3

25.10

26.95

u/l

0.90

724

4244

Emotionally unstable personality disorder

237

1363

1.77

14.96

1.5

1.3

19.37

20.34

u/l

0.20

182

1142

Polyneuropathies and other disorders of the peripheral nervous system

142

688

2.08

14.92

1.4

35.91

28.25

u/l

1.44

115

561

Chronic rhinitis, nasopharyngitis and pharyngitis

372

2393

1.57

14.92

1.4

1.3

24.50

28.87

u/l

1.87

294

1973

Preterm labour and delivery

409

2691

1.54

14.92

1.4

29.42

32.07

u/l

0.80

337

2164

Certain infectious and parasitic diseases

826

3030

1.37

14.87

1.3

26.02

26.27

u/l

0.07

689

2548

Kela-code for severe mental illness

415

2739

1.53

14.81

1.5

1.3

20.34

24.71

u/l

2.29

321

2259

Assault

178

941

1.92

14.70

1.5

1.4

19.65

20.14

u/l

0.08

137

797

Dyshidrosis [pompholyx]

114

3.98

14.65

1.3

1.4

26.04

18.83

u/l

0.67

Temporomandibular joint disorders, including avohilmo

691

4960

1.38

14.58

1.5

1.3

24.56

24.08

u/l

0.15

576

4092

Cerebral cysts

336

2.59

14.55

1.4

21.58

21.22

u/l

0.03

285

Malignant neoplasm of breast, HER-negative

167

849

1.95

14.55

1.3

36.69

37.29

u/l

0.07

154

641

Premenstrual syndrome

4.64

14.51

1.4

1.3

7.02

28.42

u/l

6.53

COPD (mode)

128

466

2.17

14.38

1.3

25.69

32.69

u/l

1.55

102

382

Mental and behavioural disorders due to alcohol, excluding acute intoxication

357

2283

1.56

14.34

1.4

22.48

24.57

u/l

0.57

269

1885

Finngen Rheumatological endpoints

1166

5153

1.29

14.33

1.4

1.3

24.99

24.28

u/l

0.31

946

4289

Migraine with aura

406

2693

1.52

14.26

1.5

1.3

18.99

24.80

u/l

3.76

337

2233

False labour

704

3189

1.39

14.25

1.4

22.83

26.99

u/l

2.69

586

2630

Assault by bodily force

111

500

2.26

14.19

1.5

1.4

19.25

20.23

u/l

0.13

424

Hypo-osmolality and hyponatraemia

105

459

2.29

14.09

1.6

1.4

39.91

33.54

u/l

0.84

379

Candidiasis

346

2223

1.57

14.03

1.4

23.05

23.71

u/l

0.14

267

1855

FESS (DNB20)

150

761

2.00

14.02

1.4

24.22

26.56

u/l

0.37

121

628

Mouth breathing

343

2199

1.57

13.90

1.3

1.4

23.39

28.44

u/l

2.21

289

1806

Other disorders of fluid, electrolyte and acid-base balance

195

1030

1.81

13.64

1.6

1.4

31.24

29.91

u/l

0.18

156

839

Excessive attrition of teeth

698

5147

1.36

13.61

1.4

1.3

22.86

25.67

u/l

1.50

550

4265

Disorders of mineral metabolism

318

2.55

13.50

1.3

1.4

32.70

29.12

u/l

0.31

262

Pollen allergy

315

1977

1.59

13.45

1.4

18.31

20.00

u/l

0.46

245

1659

Other pleural conditions

200

2.98

13.45

1.5

1.4

22.47

29.11

u/l

1.02

159

Eating disorder

198

1120

1.80

13.29

1.5

1.4

13.24

16.04

u/l

1.01

173

965

Other complications of surgical and medical care, not elsewhere classified

118

560

2.14

13.25

1.4

33.65

27.22

u/l

1.09

103

464

Weight loss

352

2.44

13.15

1.6

1.4

24.47

24.83

u/l

0.03

293

Other predominantly sexually transmitted diseases, not elsewhere classified

354

2324

1.54

13.14

1.3

1.4

19.62

18.92

u/l

0.18

281

1957

Urticaria and erythema

468

3246

1.45

13.11

1.4

23.25

26.25

u/l

1.16

383

2671

Mental and behavioural disorders due to sedatives or hypnotics

378

2.40

13.08

1.3

1.4

23.23

21.56

u/l

0.18

315

Other diseases of the digestive system

188

1048

1.80

13.06

1.4

1.3

21.47

26.30

u/l

1.41

155

858

Viral hepatitis, IBD co-morbidity

260

2.70

13.00

1.4

1.3

16.34

28.17

u/l

2.15

220

Spontaneous abortion

737

3696

1.35

12.93

1.3

25.14

27.32

u/l

0.96

608

3063

Allergic contact dermatitis

204

1173

1.76

12.92

1.4

1.3

27.21

28.45

u/l

0.20

165

975

Endometriosis diagnosis and infertility diagnosis occurring together

229

1364

1.71

12.89

1.4

18.23

26.34

u/l

4.37

203

1122

Other skin changes

149

776

1.94

12.88

1.5

1.3

29.82

29.48

u/l

0.04

133

637

Vocal cord dysfunction

161

768

1.90

12.86

1.5

1.3

27.62

32.35

u/l

0.94

129

641

Wide developmental disorders, excluding more controls

172

3.11

12.76

1.4

11.67

13.10

u/l

0.13

155

Mycoses

910

6101

1.30

12.75

1.4

1.3

23.06

24.91

u/l

0.99

711

5079

Early lumbar disc prolapse, operated

165

897

1.87

12.63

1.6

1.4

17.32

24.27

u/l

2.59

137

748

Ethmoidectomy

151

797

1.92

12.61

1.4

24.06

26.29

u/l

0.35

122

653

Post-traumatic stress disorder

164

892

1.87

12.58

1.5

1.3

17.20

18.44

u/l

0.25

141

761

Autism spe, excluding more controls

141

3.36

12.56

1.4

13.48

12.62

u/l

0.06

128

Glucagon-like peptide-1 (GLP-1) analogues

286

1806

1.60

12.54

1.4

21.93

34.01

u/l

10.39

220

1455

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

286

1806

1.60

12.54

1.4

21.93

34.01

u/l

10.39

220

1455

Implicit viral Sepsis

218

1285

1.71

12.49

1.4

1.3

25.13

25.64

u/l

0.08

177

1065

Obsessive-compulsive disorder

115

556

2.11

12.39

1.4

1.3

12.61

16.08

u/l

0.80

487

All influenza

208

1215

1.72

12.34

1.3

25.58

23.88

u/l

0.31

179

1007

Postpartum haemorrhage due to anatomy

262

1636

1.64

12.32

1.3

1.4

16.64

19.20

u/l

0.80

216

1375

Other symptoms and signs involving cognitive functions and awareness

297

1723

1.58

12.29

1.4

1.3

24.17

30.93

u/l

3.08

228

1419

Inflammatory disease of uterus

261

1629

1.63

12.19

1.4

1.3

21.79

24.51

u/l

0.71

207

1358

Single delivery by caesarean section

395

1521

1.51

12.18

1.3

1.4

20.50

23.10

u/l

0.92

344

1246

Alcohol use disorder, Swedish definition

439

2789

1.45

12.17

1.4

21.90

25.07

u/l

1.29

335

2294

Misadventures to patients during surgical and medical care

144

757

1.92

12.17

1.4

26.62

28.44

u/l

0.28

127

616

Otitis externa, unspecified

140

730

1.94

12.16

1.4

20.17

24.08

u/l

0.81

114

614

Malignant neoplasm of breast, ER-negative, including Hilmo

190

1034

1.76

12.14

1.3

36.13

36.51

u/l

0.05

177

784

Unspecified mental disorder

462

3243

1.43

12.14

1.5

1.3

21.30

24.27

u/l

1.26

356

2669

Mental and behavioural disorders due to alcohol

417

2757

1.46

12.11

1.4

22.10

24.03

u/l

0.59

316

2282

Other postsurgical states

282

2.56

12.07

1.4

23.48

27.10

u/l

0.45

234

Exposure to other specified factors

822

5791

1.31

12.04

1.3

1.4

21.87

25.10

u/l

2.40

650

4814

Disorders of calcium metabolism

236

2.71

12.04

1.3

1.4

31.42

28.96

u/l

0.17

196

Follow-up examination after treatment for malignant neoplasms

219

2.76

11.99

1.4

1.3

32.37

35.66

u/l

0.25

194

Migraine with aura and triptan purchases

301

1950

1.57

11.98

1.4

19.06

22.82

u/l

1.40

243

1614

Dyspnoea

890

5084

1.30

11.96

1.4

1.3

27.90

26.87

u/l

0.39

731

4179

Sacroiliitis, not elsewhere classified

382

2.33

11.96

1.3

1.4

18.31

22.62

u/l

0.71

324

Covid-19 suspected case

313

2045

1.55

11.90

1.3

1.4

25.04

22.20

u/l

0.82

259

1697

Alcohol dependence

190

1094

1.75

11.89

1.4

22.83

24.86

u/l

0.39

147

907

Dental operations

461

1632

1.46

11.89

1.4

1.3

26.30

27.81

u/l

0.42

378

1366

Benign neoplasm of colon, rectum, anus and anal canal

376

2202

1.49

11.88

1.5

1.3

33.60

34.19

u/l

0.11

300

1790

Other and unspecified urticaria

266

1676

1.60

11.87

1.4

22.83

25.24

u/l

0.58

216

1394

Urticaria

401

2759

1.47

11.81

1.4

22.40

25.48

u/l

1.11

325

2269

Chronic sinusitis

459

3237

1.42

11.72

1.4

1.3

27.38

28.15

u/l

0.18

370

2674

Hypertrophic disorders of skin

411

2.26

11.69

1.5

1.4

20.80

23.04

u/l

0.33

348

Nonorganic sleeping disorders

282

1810

1.57

11.63

1.5

1.4

19.72

23.05

u/l

1.08

234

1498

Eating disorders

204

1211

1.71

11.57

1.5

1.4

13.05

16.51

u/l

1.48

178

1042

Elevated blood glucose level

355

2.34

11.56

1.4

17.00

23.69

u/l

1.24

292

Anorexia (incl.atypical)

111

545

2.08

11.52

1.6

1.4

8.91

17.27

u/l

5.60

470

Use of pramipexole

163

907

1.81

11.50

1.3

28.51

32.34

u/l

0.76

133

731

Dissociative [conversion] disorders

290

2.51

11.49

1.3

20.97

17.79

u/l

0.33

251

Use of disulfiram, acamprosate or naltrexone

388

2.27

11.45

1.4

23.57

25.50

u/l

0.22

310

Other disorders of optic [2nd] nerve and visual pathways

308

2.44

11.43

1.8

1.3

17.05

23.36

u/l

1.21

252

Osteopathies and chondropathies

472

3126

1.41

11.43

1.5

1.3

29.83

29.24

u/l

0.13

388

2554

Perineal laceration during delivery

369

2100

1.49

11.38

1.3

1.4

15.39

18.69

u/l

1.59

316

1733

Other disorders of the genitourinary system

107

519

2.08

11.38

1.5

1.4

34.21

37.12

u/l

0.33

419

Infections of the skin and subcutaneous tissue

586

4291

1.36

11.28

1.5

1.3

23.50

24.08

u/l

0.17

490

3539

Other noninflammatory disorders of uterus, except cervix

184

705

1.77

11.26

1.4

1.3

32.17

43.02

u/l

3.79

155

575

Endometriosis of rectovaginal septum and vagina

417

2.22

11.24

1.5

1.3

32.88

33.90

u/l

0.09

339

Lesion of ulnar nerve

126

651

1.95

11.24

1.5

1.3

26.79

30.98

u/l

0.76

103

531

Maternal care related to the fetus and amniotic cavity and possible delivery problems

781

3502

1.32

11.23

1.4

1.3

26.40

28.97

u/l

1.24

644

2889

Diseases of the digestive system

331

2202

1.50

11.20

1.4

23.62

26.70

u/l

0.94

273

1811

Corns and callosities

251

2.59

11.19

1.3

22.91

29.23

u/l

0.74

204

Other diseases of anus and rectum

222

1353

1.65

11.17

1.4

1.3

27.70

28.93

u/l

0.21

177

1124

Hypertrophic scar

388

2.27

11.11

1.5

1.4

19.52

22.82

u/l

0.54

329

Other specified/unspecified soft tissue disorders

173

2.94

11.11

1.6

1.4

24.57

32.22

u/l

0.83

147

Haemorrhage in early pregnancy

495

3485

1.40

11.09

1.4

1.3

23.38

27.84

u/l

2.61

423

2847

Deviated nasal septum

236

1469

1.61

10.97

1.3

22.68

26.85

u/l

1.22

195

1212

Diaphragmatic hernia

245

1543

1.60

10.90

1.4

1.3

33.95

33.84

u/l

0.02

200

1267

Other follicular disorders

105

516

2.07

10.88

1.4

21.85

23.01

u/l

0.15

442

Inflammatory disease of cervix uteri

353

2.31

10.87

1.3

1.4

28.12

34.29

u/l

0.87

296

Other sexually transmitted chlamydial diseases

128

676

1.93

10.85

1.3

1.4

11.96

13.91

u/l

0.46

587

Mental and behavioural disorders due to opioids

245

2.59

10.76

1.5

1.4

15.76

14.59

u/l

0.13

208

Anomalies of dental arch relationship, including avohilmo

270

1571

1.56

10.74

1.5

1.4

19.38

21.18

u/l

0.47

214

1329

Fitting and adjustment of other devices

188

999

1.71

10.72

1.3

27.73

31.01

u/l

0.69

164

797

Atypical facial pain

307

2.39

10.61

1.5

1.4

26.69

30.71

u/l

0.50

261

Brachial plexus disorders

148

824

1.83

10.59

1.5

1.4

23.36

28.85

u/l

1.25

125

679

Rheumatism, unspecified

143

787

1.84

10.55

1.4

27.16

36.62

u/l

2.68

112

642

Other eating disorders

106

530

2.05

10.54

1.6

1.4

13.09

15.54

u/l

0.50

464

Abnormal findings in secretions and smears from cervix uteri vagina vulva

843

4988

1.29

10.51

1.4

1.3

25.23

27.43

u/l

1.14

702

4101

Hypertrophy of breast in women and men

303

2023

1.51

10.51

1.3

1.4

27.92

32.27

u/l

1.46

247

1637

Subjective visual disturbances

252

1616

1.57

10.45

1.5

1.4

27.04

26.44

u/l

0.10

204

1330

Other noninflammatory disorders of vulva and perineum

110

558

2.00

10.42

1.4

1.3

27.76

35.32

u/l

1.74

453

Type 2 diabetes

1075

5037

1.25

10.39

1.4

1.3

21.24

28.45

u/l

12.28

867

4162

Diseases of oral cavity, salivary glands and jaws

462

1684

1.42

10.35

1.4

1.3

26.40

27.45

u/l

0.26

377

1428

Ovarian hyperstimulation (induction)

188

2.85

10.32

1.4

1.5

8.82

22.76

u/l

5.28

159

Dermatitis due to substances taken internally

274

2.45

10.30

1.4

27.45

25.76

u/l

0.14

224

Epilepsy

260

1679

1.55

10.27

1.4

1.3

23.06

27.43

u/l

1.52

213

1393

Spondylopathies

691

3138

1.32

10.25

1.4

1.3

29.36

30.86

u/l

0.54

559

2586

Superficial injury of head

207

1273

1.64

10.21

1.4

21.96

25.11

u/l

0.84

165

1051

Propionic acid derivatives

244

761

1.62

10.19

1.4

16.87

20.76

u/l

1.40

213

641

Other disorders of patella

234

1486

1.59

10.18

1.4

1.3

28.89

28.06

u/l

0.12

182

1227

Abnormal weight loss

312

2.33

10.17

1.6

1.4

26.98

24.61

u/l

0.24

258

Other diseases of lip and oral mucosa

378

2648

1.44

10.16

1.4

31.23

28.83

u/l

0.66

300

2176

Disorders of vestibular function (Vertigo)

374

2570

1.44

10.14

1.4

1.3

30.47

32.49

u/l

0.53

308

2083

Thyroiditis, ILD-related definition

160

923

1.76

10.14

1.5

1.4

27.65

24.91

u/l

0.45

130

763

Other disorders of urethra and urinary system

807

4550

1.29

10.11

1.4

1.3

26.58

26.64

u/l

0.01

648

3782

Social phobias

133

727

1.86

10.10

1.4

1.3

18.46

16.99

u/l

0.22

100

631

Monoamine oxidase A inhibitors

106

537

1.99

10.06

1.4

1.3

25.18

31.98

u/l

1.24

432

Codes for special purposes

554

4133

1.34

10.04

1.4

25.72

23.70

u/l

0.73

469

3412

Intracranial trauma

600

3166

1.34

10.03

1.4

1.3

21.75

24.71

u/l

1.48

484

2663

Later onset COPD, excluding more controls

120

2.97

9.97

1.2

26.82

35.95

u/l

1.00

Early onset COPD, excluding more controls

114

593

1.93

9.96

1.3

24.86

32.71

u/l

1.69

493

Provisional assignment of new diseases of uncertain etiology

553

4130

1.34

9.95

1.4

25.72

23.71

u/l

0.73

469

3410

Schizophrenia, schizotypal and delusional disorders

334

2297

1.46

9.93

1.5

1.4

21.17

24.23

u/l

1.06

258

1899

Vitamin D deficiency

3.55

9.85

1.7

1.4

26.45

24.05

u/l

0.15

Spondylosis

403

2328

1.42

9.84

1.4

1.3

33.30

35.27

u/l

0.54

315

1894

Other diseases of pleura

212

1154

1.62

9.83

1.4

1.3

23.37

29.50

u/l

2.30

174

930

Other and unspecified nerve root and plexus disorders, also in other diseases

192

1172

1.65

9.81

1.4

1.3

26.30

30.57

u/l

1.03

149

971

Hypertensive diseases (excluding secondary)

733

3286

1.30

9.79

1.4

1.3

28.04

28.33

u/l

0.08

570

2705

Schizophrenia or delusion

333

2296

1.46

9.78

1.5

1.4

21.20

24.03

u/l

0.96

259

1897

GI-bleeding

172

1020

1.69

9.75

1.4

1.3

20.88

26.39

u/l

1.79

141

839

Autism

170

2.84

9.75

1.4

13.22

12.61

u/l

0.04

151

Spinal stenosis

267

1324

1.54

9.74

1.4

1.3

32.56

38.03

u/l

1.82

218

1059

Acute suppurative otitis media

377

2482

1.43

9.72

1.4

14.28

16.55

u/l

1.15

306

2095

Implicit Sepsis

573

3243

1.34

9.69

1.3

24.88

27.47

u/l

1.05

463

2661

Flat foot [pes planus] (acquired)

100

504

2.01

9.67

1.5

1.3

32.34

37.11

u/l

0.64

421

Postpartum haemorrhage

513

3210

1.36

9.61

1.3

1.4

21.06

26.53

u/l

3.62

427

2605

Infections, IBD-co-morbidities

147

592

1.79

9.46

1.4

1.3

29.91

31.17

u/l

0.15

124

493

Postprocedural disorders of nervous system

132

737

1.83

9.45

1.4

18.88

23.35

u/l

1.06

112

620

Other and unspecified local infections of skin and subcutaneous tissue

475

2.02

9.41

1.3

1.4

21.19

24.32

u/l

0.51

395

Disturbance of activity and attention

197

1201

1.63

9.40

1.4

12.90

14.39

u/l

0.35

146

1049

Hypercalcemia

124

3.11

9.39

1.5

1.3

27.78

31.26

u/l

0.21

Diseases of the eye and adnexa

1050

4247

1.24

9.36

1.4

1.3

23.03

23.52

u/l

0.19

866

3553

Other peripheral vertigo

376

2.15

9.34

1.4

33.70

32.54

u/l

0.09

314

Special screening examination for other diseases and disorders

402

2.10

9.31

1.4

1.3

20.11

26.52

u/l

1.21

350

Asthma, including avohilmo

1242

5746

1.22

9.30

1.4

1.3

22.37

25.27

u/l

2.74

1018

4760

Diabetes mellitus

1124

5364

1.23

9.28

1.4

1.3

21.41

27.08

u/l

8.25

910

4450

Deep endometriosis

150

874

1.74

9.26

1.4

26.68

23.90

u/l

0.44

126

742

Benign neoplasm: Sigmoid colon

104

539

1.94

9.25

1.5

1.4

28.06

33.88

u/l

1.11

434

Other local infections of skin and subcutaneous tissue

499

1.99

9.23

1.3

1.4

22.15

24.24

u/l

0.29

414

Mycoses

238

1552

1.54

9.21

1.4

23.64

25.35

u/l

0.36

185

1288

Abnormal results of function studies

412

2.09

9.17

1.4

20.10

26.61

u/l

1.07

336

Injuries to the ankle and foot

839

5947

1.26

9.17

1.3

1.4

22.57

24.44

u/l

0.93

682

4930

Internal derangement of knee

355

2495

1.42

9.16

1.4

1.3

28.74

27.66

u/l

0.23

284

2062

Disorders of puberty, all

101

3.38

9.14

2.3

1.4

8.71

11.02

u/l

0.37

Fibroblastic disorders

156

923

1.70

8.99

1.4

30.49

32.60

u/l

0.31

121

758

Wide developmental disorders

212

2.55

8.99

1.4

11.67

11.65

u/l

0.00

186

Convulsions, not elsewhere classified

202

1260

1.59

8.97

1.4

1.3

19.79

19.87

u/l

0.01

160

1046

Other noninfective gastroenteritis and colitis

228

1482

1.55

8.94

1.5

1.4

26.88

25.19

u/l

0.33

186

1224

Hyperkinetic disorders

200

1238

1.60

8.94

1.4

12.83

14.28

u/l

0.35

149

1080

Intracranial injury

497

3517

1.34

8.91

1.4

18.89

23.87

u/l

3.75

398

2909

Injuries to the wrist and hand

1058

5990

1.23

8.90

1.4

1.3

23.41

25.07

u/l

0.91

862

4964

Congenital malformations, deformations and chromosomal abnormalities

794

5825

1.26

8.86

1.4

1.3

22.12

24.29

u/l

1.26

661

4809

Acetic acid derivatives and related substances

218

712

1.60

8.75

1.3

1.4

16.70

21.77

u/l

1.87

177

594

Benign neoplasm: Caecum

257

2.35

8.75

1.3

1.4

29.20

33.73

u/l

0.48

208

Non-invasive ventilation

1216

0.47

8.74

1.2

1.3

29.42

29.46

u/l

0.00

1017

Ganglion

252

1685

1.51

8.73

1.3

1.4

26.69

29.19

u/l

0.57

202

1394

Impotence

3.88

8.69

1.2

11.45

12.33

u/l

0.08

Fenamates

147

577

1.74

8.64

1.4

1.3

25.35

25.16

u/l

0.02

117

474

Postmenopausal atrophic vaginitis

252

912

1.53

8.62

1.4

1.3

44.70

43.40

u/l

0.19

209

746

Other abnormal products of conception

671

3466

1.29

8.60

1.4

1.3

22.41

26.25

u/l

2.33

572

2859

Iron deficiency anaemia

355

2499

1.41

8.59

1.3

26.19

27.42

u/l

0.25

291

2054

492

3252

1.34

8.58

1.4

1.3

21.89

24.21

u/l

0.91

378

2685

Other systemic involvement of connective tissue (FG)

240

1574

1.51

8.53

1.4

26.44

29.94

u/l

0.87

208

1308

Autism spe

177

2.67

8.52

1.4

13.48

11.48

u/l

0.16

156

Unspecified misadventure during surgical and medical care

236

2.41

8.52

1.5

1.4

25.51

27.38

u/l

0.16

193

Psychotic depression

299

2.24

8.49

1.5

1.3

17.78

26.17

u/l

1.50

252

Caries of dentine, including avohilmo

680

2698

1.29

8.47

1.3

25.38

27.21

u/l

0.73

555

2275

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

319

1994

1.44

8.47

1.4

12.73

13.93

u/l

0.39

248

1725

Chronic periodontitis, including avohilmo

913

4951

1.24

8.44

1.3

29.81

28.21

u/l

0.71

704

4091

Symptoms and signs involving cognition, perception, emotional state and behaviour

984

5475

1.23

8.40

1.4

1.3

25.34

26.56

u/l

0.55

803

4519

Thyrotoxicosis, other and/or unspecified

219

1434

1.54

8.40

1.4

1.3

31.22

30.13

u/l

0.18

180

1172

Maltreatment syndromes

421

2.03

8.38

1.6

1.4

14.70

19.73

u/l

1.09

361

Dental caries, including avohilmo

607

2379

1.31

8.37

1.3

25.68

27.97

u/l

0.90

495

2016

Periodontitis

916

4964

1.24

8.35

1.3

29.71

28.16

u/l

0.68

707

4102

Maternal care for other known or suspected fetal problems

578

2812

1.32

8.35

1.4

18.50

24.47

u/l

5.17

475

2337

All influenza (not pneumonia)

124

704

1.77

8.33

1.3

1.4

23.03

21.66

u/l

0.19

109

589

Early lumbar disc prolapse operation

167

1032

1.64

8.28

1.6

1.4

17.38

22.72

u/l

1.79

138

860

Radiculopathy

113

627

1.81

8.20

1.6

1.3

34.25

33.13

u/l

0.14

517

Type 2 diabetes, definitions combined, including avohilmo

992

4720

1.23

8.20

1.4

1.3

22.25

29.64

u/l

11.55

802

3900

Care involving use of rehabilitation procedures

589

4201

1.29

8.17

1.5

1.3

27.91

28.41

u/l

0.13

491

3392

449

3035

1.34

8.07

1.4

1.3

22.00

24.04

u/l

0.70

345

2505

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

495

3751

1.32

8.04

1.4

22.31

22.98

u/l

0.18

400

3114

Gonarthrosis

576

2521

1.31

7.99

1.4

1.3

34.06

33.04

u/l

0.27

454

2068

Small fibre neuropathy

3.40

7.97

1.5

1.4

41.62

25.57

u/l

1.16

Fissure and fistula of anal and rectal regions

209

1370

1.53

7.97

1.4

26.90

28.27

u/l

0.22

169

1144

Other specified/unspecified dorsopathies

148

2.75

7.97

1.4

34.41

31.47

u/l

0.17

128

Agranulocytosis

533

1.88

7.96

1.4

33.17

29.15

u/l

0.57

434

Dislocation, sprain and strain of joints and ligaments at neck level

200

1302

1.55

7.94

1.4

1.3

19.86

21.66

u/l

0.41

167

1077

Torsion of ovary, ovarian pedicle and fallopian tube

155

2.72

7.89

1.6

1.3

24.24

28.08

u/l

0.30

133

Lesion of lateral popliteal nerve

172

2.59

7.86

1.3

1.4

22.30

27.28

u/l

0.44

141

Injuries to the neck

251

1715

1.47

7.86

1.4

20.07

21.97

u/l

0.50

211

1424

Female genital prolapse

284

1103

1.46

7.84

1.4

1.3

35.25

38.38

u/l

0.69

218

896

Diseases of middle ear and mastoid

688

4469

1.26

7.81

1.4

1.3

15.79

20.63

u/l

5.59

564

3735

Focal epilepsy, strict definition

159

983

1.63

7.81

1.4

22.34

25.29

u/l

0.64

134

821

Diseases of inner ear

416

2996

1.35

7.80

1.4

1.3

30.14

32.23

u/l

0.62

344

2433

Superficial injury of wrist and hand

230

1549

1.50

7.76

1.3

1.4

22.66

22.29

u/l

0.06

185

1289

Hernia of abdominal wall

337

2432

1.39

7.76

1.3

1.4

23.25

27.77

u/l

1.93

268

2006

Gingivitis and periodontal diseases

1001

4241

1.22

7.74

1.4

1.3

26.66

25.93

u/l

0.28

794

3542

Nutritional anaemias

385

2736

1.36

7.71

1.3

26.15

27.74

u/l

0.37

315

2242

Car occupant injured in other and unspecified transport accidents

222

1487

1.51

7.70

1.4

18.17

22.11

u/l

1.37

174

1243

Other septicaemia

202

1273

1.53

7.65

1.5

1.4

34.40

26.92

u/l

1.95

162

1044

External causes of morbidity and mortality

784

3146

1.25

7.64

1.3

22.97

24.67

u/l

0.76

635

2669

Asthma-related infections

555

4229

1.29

7.61

1.4

21.75

26.00

u/l

2.90

456

3479

Asthma, hospital admission 2, infections

555

4229

1.29

7.61

1.4

21.75

26.00

u/l

2.90

456

3479

Diabetes, varying definitions

1099

5362

1.20

7.59

1.4

1.3

21.47

27.16

u/l

8.17

895

4441

Disorders of psychological development

142

796

1.67

7.59

1.5

1.4

11.60

12.81

u/l

0.24

115

701

Open wound of wrist and hand

414

3026

1.34

7.59

1.4

22.52

22.22

u/l

0.07

341

2505

Focal epilepsy

179

1147

1.57

7.57

1.4

1.3

22.08

25.13

u/l

0.74

150

956

Systemic connective tissue disorders

306

2184

1.41

7.55

1.4

27.25

29.77

u/l

0.63

256

1795

Ovarian dysfunction, other/unspecified

4.30

7.53

1.9

1.4

30.12

21.93

u/l

0.54

Implicit viral Sepsis

133

794

1.68

7.50

1.4

24.05

24.41

u/l

0.04

111

659

Uterine polyps

106

595

1.80

7.49

1.4

1.3

34.52

40.94

u/l

1.14

481

Unspecified haematuria

213

1171

1.51

7.48

1.4

1.3

27.42

26.84

u/l

0.09

182

962

Vitamin deficiency

201

2.42

7.45

1.6

1.3

25.39

25.89

u/l

0.04

163

Vitamin deficiency, wide

201

2.42

7.45

1.6

1.3

25.39

25.89

u/l

0.04

163

Dizziness and giddiness

692

4381

1.26

7.45

1.4

1.3

25.69

28.57

u/l

1.50

572

3602

Focal epilepsy, mode (most common among epilepsy diagnosis)

153

950

1.62

7.41

1.4

23.17

25.04

u/l

0.34

129

792

Additional codes for the location of defect, injury or illness

271

2.21

7.40

1.3

1.4

28.70

24.52

u/l

0.38

220

463

3506

1.32

7.39

1.4

21.78

25.22

u/l

1.75

384

2893

Plantar fascial fibromatosis

108

613

1.78

7.36

1.4

33.26

34.22

u/l

0.10

505

Diseases of pulp and periapical tissues and dental caries

531

2087

1.31

7.33

1.4

1.3

26.40

27.50

u/l

0.30

437

1785

Viral Sepsis

133

800

1.67

7.31

1.4

24.05

24.30

u/l

0.03

111

665

Other diseases of blood and blood-forming organs, wide

170

1087

1.57

7.30

1.4

1.3

29.38

28.27

u/l

0.17

146

883

Diseases of salivary glands

317

2292

1.39

7.28

1.4

26.91

28.70

u/l

0.42

255

1880

Syncope and collapse

304

1860

1.40

7.28

1.3

23.55

24.92

u/l

0.30

247

1537

Osteoporosis

118

641

1.73

7.26

1.6

1.3

45.06

37.29

u/l

1.03

516

Injury, poisoning and certain other consequences of external causes

644

2544

1.27

7.23

1.3

23.82

24.23

u/l

0.11

526

2134

Premature rupture of membranes

467

2555

1.32

7.20

1.4

15.80

24.38

u/l

9.57

373

2127

Candidiasis

143

882

1.64

7.17

1.3

1.4

26.40

25.47

u/l

0.11

109

740

Congenital malformations, deformations and chromosomal abnormalities

725

5585

1.24

7.17

1.4

1.3

22.83

23.64

u/l

0.31

608

4602

Algoneurodystrophy

237

2.29

7.16

1.8

1.4

29.69

24.81

u/l

0.49

193

Diplopia

106

603

1.77

7.16

1.4

25.93

27.06

u/l

0.13

491

Enthesopathies of lower limb, excluding foot

212

1429

1.49

7.15

1.5

1.3

29.18

31.95

u/l

0.53

174

1155

Paracetamol or NSAID medication

147

445

1.67

7.12

1.5

1.4

15.37

19.92

u/l

1.25

129

372

Sequelae of injuries of head

231

2.28

7.08

1.2

1.4

19.44

22.59

u/l

0.35

187

Other arthrosis

427

2230

1.33

7.08

1.4

1.3

31.17

33.96

u/l

0.87

333

1827

Pediculosis, acariasis and other infestations

296

2.12

7.08

1.5

1.3

17.46

21.05

u/l

0.60

243

Suppurative and unspecified otitis media

460

3125

1.31

7.06

1.4

14.43

17.97

u/l

2.68

374

2624

Other disorders of breast

179

1170

1.55

7.05

1.5

1.4

27.38

28.91

u/l

0.24

150

968

Acute generalized exanthematous pustulosis

213

2.34

7.03

1.5

1.4

23.52

25.43

u/l

0.16

175

Other systemic involvement of connective tissue

243

1688

1.45

7.02

1.4

26.22

29.11

u/l

0.68

210

1390

Other sexually transmitted chlamydial diseases

165

1062

1.57

6.98

1.3

1.4

11.47

13.19

u/l

0.47

128

923

Hidradenitis suppurativa

292

2.13

6.98

1.3

1.4

23.26

21.75

u/l

0.17

247

Transport accidents

524

3520

1.29

6.94

1.3

1.4

18.13

24.42

u/l

5.91

420

2980

Intestinal infectious diseases

941

5934

1.21

6.90

1.4

1.3

21.18

24.76

u/l

3.03

791

4896

Nontoxic single thyroid nodule

368

1.98

6.84

1.2

1.4

24.30

31.17

u/l

0.81

307

Cervicocranial syndrome

106

612

1.75

6.83

1.6

1.3

24.69

31.97

u/l

1.45

505

Disorders of continuity of bone

102

583

1.77

6.82

1.5

1.3

25.43

26.77

u/l

0.14

476

Other epidermal thickening

185

2.41

6.81

1.5

1.4

26.05

23.79

u/l

0.16

150

Other and unspecified mononeuropathies, also in other diseases

3.06

6.80

1.3

46.37

29.41

u/l

0.74

Salpingitis and oophoritis

208

1414

1.48

6.78

1.5

1.3

35.51

35.87

u/l

0.05

160

1155

Schizoaffective disorder

504

1.83

6.78

1.4

19.66

23.97

u/l

0.70

418

Pulmonary heart disease

161

1034

1.56

6.78

1.5

1.4

28.33

31.12

u/l

0.56

145

832

Acne

153

973

1.59

6.78

1.4

10.08

14.64

u/l

2.38

135

846

Pulmonary embolism

161

1035

1.56

6.76

1.5

1.4

28.33

31.12

u/l

0.56

145

832

Other and unspecified iron deficiency

278

1996

1.40

6.66

1.3

1.4

25.94

26.54

u/l

0.10

230

1649

Hypermobility syndrome

102

591

1.76

6.61

1.5

1.4

26.71

22.49

u/l

0.54

507

Radial styloid tenosynovitis [de Quervain]

430

1.89

6.59

1.3

1.4

24.56

28.93

u/l

0.54

360

Other symptoms and signs involving the urinary system

352

1.98

6.58

1.4

1.3

22.68

23.68

u/l

0.09

291

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

437

1.88

6.57

1.4

14.22

17.38

u/l

0.67

374

Disorders of optic nerve and visual pathways

112

665

1.70

6.57

1.6

1.4

19.48

24.36

u/l

1.13

552

Asthma, unspecified (mode)

496

2912

1.29

6.56

1.4

1.3

24.07

28.16

u/l

2.15

395

2439

Cellulitis

176

1164

1.52

6.54

1.5

1.3

24.35

25.46

u/l

0.19

143

962

Septicaemia

225

1458

1.45

6.53

1.5

1.3

32.39

26.71

u/l

1.45

182

1198

Scabies

253

2.17

6.51

1.6

1.3

17.39

19.13

u/l

0.23

208

Primary_lymphoid and hematopoietic malignant neoplasms

119

718

1.66

6.51

1.5

1.4

31.10

28.00

u/l

0.44

102

590

Type 2 diabetes, strict (exclude DM1)

957

4689

1.20

6.50

1.4

1.3

21.70

30.03

u/l

14.31

778

3866

Asthma, unspecified (mode), excluding more controls

494

2883

1.29

6.50

1.4

1.3

24.11

28.07

u/l

2.03

393

2413

Type 2 diabetes, definitions combined

955

4678

1.20

6.50

1.4

1.3

21.68

30.03

u/l

14.33

776

3855

Impacted teeth

286

1843

1.39

6.49

1.4

12.21

12.67

u/l

0.16

257

1589

Other CVD

459

1.84

6.49

1.5

1.4

34.02

30.33

u/l

0.35

373

Cholecystectomy

679

4753

1.24

6.48

1.4

1.3

27.27

30.67

u/l

1.97

552

3884

Diabetes mellitus in pregnancy

734

3838

1.23

6.45

1.4

17.33

26.06

u/l

15.43

624

3149

Sequelae of external causes of morbidity and mortality

191

1291

1.49

6.40

1.5

1.3

29.51

27.68

u/l

0.31

171

1063

Non-Hodgkin lymphoma, all, including Hilmo

254

2.14

6.39

1.4

1.3

31.32

31.45

u/l

0.01

177

Pruritus

114

685

1.68

6.39

1.5

1.4

21.13

26.91

u/l

1.45

579

Alcohol abuse, main dg, excluding more controls

115

692

1.67

6.38

1.3

20.41

21.49

u/l

0.13

584

Acne vulgaris

122

748

1.65

6.36

1.5

1.4

10.17

13.89

u/l

1.34

108

649

Other sleep disorders

537

1.76

6.31

1.4

18.81

26.07

u/l

1.80

461

Spontaneous rupture of synovium and tendon

289

2.06

6.31

1.3

1.4

29.95

35.71

u/l

0.65

240

Other and unspecified tonsillitis

414

2677

1.31

6.22

1.4

15.55

17.13

u/l

0.62

342

2258

Other disorders of amniotic fluid and membranes

291

2088

1.38

6.21

1.3

1.4

20.78

23.63

u/l

0.93

240

1740

Other disorders of penis

126

2.63

6.21

1.4

1.3

7.66

10.92

u/l

0.74

100

Acute bronchitis

317

2307

1.35

6.20

1.4

23.19

25.00

u/l

0.50

270

1898

Extrapyramidal and movement disorders

236

1671

1.42

6.18

1.3

1.4

31.97

29.93

u/l

0.37

190

1363

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

320

2385

1.35

6.16

1.4

23.16

24.85

u/l

0.43

263

1976

Hypertrophy of breast

272

1980

1.39

6.15

1.3

1.4

29.12

32.66

u/l

0.98

225

1605

Volume depletion

219

2.20

6.15

1.5

1.4

26.27

25.19

u/l

0.06

184

Bell's palsy

101

594

1.71

6.14

1.5

1.4

28.36

28.77

u/l

0.04

494

Spondylopathies (FG)

151

982

1.55

6.12

1.3

1.4

21.23

24.18

u/l

0.62

127

818

Examination and encounter for administrative purposes

110

2.75

6.12

1.4

1.2

30.53

21.08

u/l

0.59

101

Ventral hernia

171

1141

1.51

6.12

1.3

1.4

27.60

30.24

u/l

0.47

137

942

Noninfective enteritis and colitis

440

3424

1.29

6.11

1.4

1.3

25.18

25.57

u/l

0.09

364

2814

Drug-induced neutropenia

300

2.02

6.10

1.4

40.86

30.62

u/l

1.36

246

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

314

1.99

6.07

1.2

1.4

32.60

32.64

u/l

0.00

254

Implicit bacterial Sepsis

208

1242

1.45

6.07

1.4

1.3

27.81

27.67

u/l

0.02

165

1022

Ocular pain

582

1.72

6.06

1.3

1.4

21.48

24.13

u/l

0.33

496

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

714

5112

1.22

6.03

1.3

1.4

22.57

27.96

u/l

5.04

610

4195

Iron deficiency anaemia secondary to blood loss (chronic)

110

665

1.66

6.02

1.4

25.55

28.98

u/l

0.44

548

Other noninflammatory disorders of vagina

450

1.82

6.01

1.3

25.66

36.84

u/l

2.22

368

Bruxism

172

2.40

6.01

1.6

1.4

21.62

21.40

u/l

0.01

142

Implicit bacterial Sepsis

184

1104

1.48

6.01

1.4

1.3

27.73

27.84

u/l

0.01

143

897

Colonic or urogenital fistula

223

1573

1.42

6.00

1.4

27.67

27.70

u/l

0.00

181

1296

Nontoxic multinodular goitre

139

891

1.57

5.99

1.3

29.63

34.56

u/l

0.86

102

735

Congenital malformations and deformations of the musculoskeletal system

137

872

1.58

5.98

1.3

1.4

19.75

20.43

u/l

0.09

107

746

Mixed and other personality disorders

106

638

1.68

5.96

1.3

23.13

23.61

u/l

0.05

537

Hypertension

886

4180

1.20

5.94

1.4

1.3

29.32

30.05

u/l

0.24

693

3441

Hypertensive diseases

887

4186

1.20

5.94

1.4

1.3

29.32

30.00

u/l

0.23

693

3447

Benign neoplasm of mouth and pharynx

437

1.82

5.94

1.3

1.4

25.14

29.31

u/l

0.57

354

Papilloedema, unspecified

142

2.53

5.93

1.8

1.4

10.17

19.78

u/l

2.24

122

Meralgia paraesthetica

148

2.47

5.90

1.8

1.3

18.52

28.58

u/l

1.32

119

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

436

3374

1.29

5.89

1.4

21.28

21.51

u/l

0.06

379

2802

Dermatophytosis

545

4375

1.25

5.86

1.4

1.3

24.52

25.83

u/l

0.42

429

3601

Constipation

784

4503

1.21

5.86

1.5

1.3

27.59

29.68

u/l

0.94

612

3716

Disorders of breast

658

4896

1.23

5.84

1.4

1.3

27.88

29.25

u/l

0.49

557

4010

Other bacterial diseases

796

4446

1.21

5.84

1.4

1.3

28.61

28.29

u/l

0.10

658

3628

Diabetes medication

1075

5432

1.18

5.81

1.4

1.3

20.76

27.18

u/l

10.76

871

4508

Familial hypercholesterolemia

319

1.95

5.80

1.4

30.07

29.07

u/l

0.07

268

Disturbances of smell and taste

187

2.28

5.77

1.3

1.4

38.43

31.51

u/l

0.48

159

Postpartum hemorraghe, all women as controls

513

4047

1.26

5.76

1.3

1.4

21.06

23.94

u/l

1.33

427

3336

Autoimmune diseases excluding thyroid diseases

994

4592

1.18

5.73

1.4

1.3

24.68

24.33

u/l

0.12

820

3823

Symptoms and signs involving the nervous and musculoskeletal systems

504

4025

1.26

5.72

1.4

1.3

27.09

27.35

u/l

0.06

429

3290

Vulvovaginal ulceration/inflammation in other diseases

111

686

1.65

5.70

1.3

1.4

20.75

21.98

u/l

0.15

592

Benign neoplasm: Rectum, anus and anal canal

592

1.68

5.67

1.5

1.4

35.81

33.35

u/l

0.26

481

Malignant neoplasm of tongue, including Hilmo

3.74

5.66

1.6

1.3

41.14

37.02

u/l

0.15

Pulmonary heart disease, diseases of pulmonary circulation

164

1105

1.49

5.61

1.5

1.3

28.47

30.97

u/l

0.49

147

891

Umbilical hernia

204

1436

1.43

5.59

1.3

20.20

23.94

u/l

1.21

159

1203

Abnormal findings on examination of urine, without diagnosis

177

2.29

5.58

1.4

32.64

22.23

u/l

0.83

145

Enlarged lymph nodes

127

812

1.57

5.57

1.4

1.3

23.47

24.93

u/l

0.22

112

668

Anti-inflammatory and antirheumatic products, non-steroids

217

761

1.44

5.54

1.4

16.68

20.76

u/l

1.46

188

641

Other enthesopathy of foot (+metatarsalgia)

102

621

1.66

5.50

1.5

1.4

26.61

32.00

u/l

0.87

517

Sequelae of other external causes

257

2.05

5.50

1.6

1.3

26.64

25.93

u/l

0.05

208

Other chronic obstructive pulmonary disease, including avohilmo

225

1329

1.40

5.48

1.3

1.4

28.24

32.90

u/l

1.31

180

1073

Toxic effects of substances chiefly nonmedicinal as to source

107

661

1.63

5.45

1.5

1.4

21.15

21.54

u/l

0.05

556

Pregnancy with abortive outcome

885

3890

1.19

5.44

1.4

1.3

24.88

26.62

u/l

0.82

731

3229

Thyrotoxicosis

257

1891

1.37

5.44

1.4

1.3

32.11

30.22

u/l

0.36

212

1539

Trigger finger

126

810

1.57

5.42

1.4

33.93

33.91

u/l

0.00

664

Other and unspecified follicular disorders

212

2.16

5.42

1.5

1.3

19.46

20.76

u/l

0.09

174

Chronic lower respiratory diseases

1250

5765

1.16

5.41

1.4

1.3

22.35

25.13

u/l

2.56

1031

4773

Metatarsalgia

563

1.68

5.41

1.5

1.4

27.29

32.54

u/l

0.78

471

Collagenous colitis

444

1.77

5.38

1.4

23.60

27.99

u/l

0.64

369

Other chronic obstructive pulmonary disease

161

894

1.49

5.38

1.3

25.54

31.84

u/l

1.70

128

722

Cutaneous abscess, furuncle and carbuncle

240

1750

1.38

5.38

1.5

1.4

22.33

23.70

u/l

0.31

213

1448

Other extrapyramidal and movement disorders in other diseases

169

1158

1.47

5.37

1.3

30.57

29.15

u/l

0.18

130

946

Speech and linguistic disorders, excluding more controls

438

1.75

5.35

1.7

1.3

11.95

13.26

u/l

0.21

389

Abnormal findings on diagnostic imaging of other body structures

107

664

1.62

5.35

1.5

1.3

26.17

31.90

u/l

0.98

529

Otalgia

485

1.73

5.25

1.4

23.57

24.97

u/l

0.14

406

Scabies

175

1215

1.45

5.24

1.4

19.02

20.42

u/l

0.29

145

1022

Female infertility, tubal origin

412

1.80

5.24

1.4

1.3

20.31

37.89

u/l

4.41

335

Implicit Sepsis

647

3902

1.21

5.23

1.3

1.4

25.24

27.45

u/l

0.92

521

3207

Open wound of head

348

2590

1.30

5.22

1.3

1.4

26.05

25.38

u/l

0.14

273

2133

Bulimia nervosa (incl. atypical)

421

1.80

5.22

1.4

14.19

16.51

u/l

0.41

367

Bacterial Sepsis

224

1381

1.39

5.22

1.4

1.3

26.88

27.27

u/l

0.06

178

1135

Heartburn

607

1.64

5.21

1.3

1.4

27.21

27.40

u/l

0.02

496

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

3.66

5.20

1.3

19.31

36.32

u/l

1.06

Abrasion of teeth

342

2641

1.30

5.20

1.5

1.3

34.03

31.11

u/l

0.73

277

2149

Viral hepatitis

427

1.77

5.20

1.4

1.3

19.24

20.82

u/l

0.14

352

Falls/tendency to fall

1215

5274

1.16

5.18

1.4

1.3

24.17

24.52

u/l

0.13

957

4431

Benign neoplasm: Stomach

326

1.88

5.16

1.4

32.88

34.03

u/l

0.10

263

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

384

1.81

5.16

1.4

25.81

27.74

u/l

0.20

316

Abnormal findings on examination of blood, without diagnosis

268

1834

1.35

5.14

1.4

23.49

25.24

u/l

0.37

225

1508

Stomatitis and related lesions

184

1293

1.43

5.14

1.4

1.3

24.37

24.79

u/l

0.06

152

1075

Benign neoplasm: Rectum

517

1.69

5.14

1.5

1.4

35.70

33.25

u/l

0.24

418

Diseases of the myoneural junction and muscle

413

1.78

5.14

1.4

1.3

22.76

26.15

u/l

0.41

335

Disorders of parathyroid gland

107

662

1.60

5.14

1.6

1.3

33.74

36.61

u/l

0.33

521

Other female pelvic inflammatory diseases

184

1295

1.43

5.12

1.5

1.3

29.77

30.10

u/l

0.04

145

1077

Agoraphobia

265

2.00

5.12

1.5

1.3

19.26

17.77

u/l

0.14

227

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

437

1.76

5.10

1.4

19.05

20.50

u/l

0.15

371

Embedded and impacted teeth

369

2375

1.29

5.09

1.4

12.70

14.67

u/l

1.16

329

2004

Trigeminal neuralgia

307

1.91

5.08

1.4

23.11

30.54

u/l

0.86

255

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

364

1.83

5.08

1.1

1.4

30.96

32.33

u/l

0.12

296

Pediculosis, acariasis and other infestations

189

1339

1.42

5.07

1.4

18.68

21.07

u/l

0.62

156

1120

Other (not insulin) diabetes medications

949

4809

1.17

5.06

1.4

1.3

20.78

29.72

u/l

17.94

766

3968

Recurrent dislocation of patella

545

1.68

5.04

1.3

19.60

20.05

u/l

0.05

471

Noninfectious colitis NAS

123

801

1.55

5.04

1.6

1.4

27.52

25.23

u/l

0.30

671

Other contact dermatitis

514

1.69

5.02

1.3

1.4

27.79

26.76

u/l

0.10

435

Spondyloarthritis

162

1117

1.46

5.02

1.3

1.4

23.17

24.42

u/l

0.20

136

926

Retention of urine

151

838

1.48

4.99

1.4

1.3

24.19

24.94

u/l

0.11

119

695

Gluteal tendinitis

206

2.12

4.99

1.5

1.4

28.64

35.49

u/l

0.58

171

COPD related to multimorbidity

124

680

1.54

4.98

1.3

25.39

32.44

u/l

1.70

544

LSIL lesion of the cervix uteri, vagina or vulva

256

1917

1.35

4.95

1.4

27.79

25.37

u/l

0.59

211

1588

Erysipelas

318

2162

1.30

4.92

1.4

1.3

26.53

29.79

u/l

1.10

256

1759

Benign neoplasm: Transverse colon

261

1.97

4.91

1.2

1.3

34.89

32.20

u/l

0.21

212

Diseases of liver

244

1811

1.35

4.91

1.3

1.4

26.13

30.60

u/l

1.20

184

1480

Other disorders of conjunctiva

509

1.68

4.91

1.3

1.4

32.07

31.58

u/l

0.04

418

Other specified and unspecified personality disorders

111

712

1.57

4.90

1.5

1.3

20.99

23.00

u/l

0.28

597

Implicit fungal Sepsis

255

1.98

4.88

1.3

29.74

26.34

u/l

0.26

215

Melanocytic naevi

312

2403

1.30

4.88

1.4

23.97

26.19

u/l

0.62

265

1990

Asthma, hospital admissions , main diagnosis only

815

6113

1.18

4.87

1.4

1.3

23.56

25.30

u/l

0.88

671

5057

Other acute lower respiratory infections

424

3227

1.26

4.87

1.4

21.69

23.26

u/l

0.52

359

2666

Heart failure, not strict

442

2396

1.26

4.86

1.5

1.3

28.57

33.60

u/l

2.32

362

1946

Haemorrhage from respiratory passages

171

1077

1.44

4.86

1.5

1.3

26.43

27.56

u/l

0.18

150

892

Mixed hyperlipidaemia

2.72

4.85

1.1

1.2

15.36

29.24

u/l

1.45

COPD, early/later onset

161

936

1.45

4.84

1.3

25.54

31.88

u/l

1.72

128

745

Transplanted organ and tissue status

377

1.79

4.83

1.4

33.52

25.39

u/l

1.07

313

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

3.00

4.82

1.3

19.08

32.47

u/l

1.02

Congenital iodine-deficiency syndrome/hypothyroidism

119

2.47

4.82

1.6

1.3

23.95

23.23

u/l

0.05

Other benign neoplasms of skin

273

2067

1.33

4.81

1.4

31.06

31.18

u/l

0.02

214

1700

Dermatophytosis

482

1.69

4.80

1.5

1.4

22.82

26.62

u/l

0.56

397

Sequelae of injuries, of poisoning and of other consequences of external causes

198

1428

1.39

4.79

1.3

1.4

23.76

26.98

u/l

0.72

157

1182

Abnormalities of forces of labour

196

1416

1.40

4.79

1.3

1.4

29.83

32.76

u/l

0.62

161

1126

Autoimmune diseases excluding thyroid diseases, strict definition

935

4385

1.17

4.79

1.4

1.3

24.70

24.37

u/l

0.11

767

3644

Benign neoplasm: Descending colon

176

2.18

4.78

1.5

1.3

30.43

33.05

u/l

0.16

139

Benign neoplasm of other and ill-defined parts of digestive system

115

747

1.55

4.77

1.5

1.3

31.53

32.91

u/l

0.16

597

Dependent personality disorder

108

2.55

4.76

1.4

21.31

26.34

u/l

0.37

Other and unspecified myopathies

223

2.03

4.75

1.4

1.3

21.50

24.64

u/l

0.27

181

Viral infections characterized by skin and mucous membrane lesions

847

6188

1.17

4.75

1.4

1.3

24.88

24.82

u/l

0.02

690

5125

Other and unspecified visual disturbances

515

1.66

4.73

1.4

27.27

26.80

u/l

0.05

426

Acute alcohol intoxication

168

1180

1.43

4.73

1.4

1.3

21.38

22.00

u/l

0.09

125

988

Oter anti-inflammatory and antirheumatic agents, non-steroids

120

425

1.56

4.73

1.5

1.4

31.41

32.24

u/l

0.09

347

Fistulae involving female genital tract

3.08

4.71

1.5

1.2

33.92

35.40

u/l

0.07

COPD

165

940

1.44

4.69

1.3

25.48

32.23

u/l

1.90

130

758

Gestational diabetes (for exclusion)

777

4591

1.18

4.69

1.3

1.4

16.02

25.59

u/l

22.09

654

3778

Fracture of skull and facial bones

160

1116

1.44

4.69

1.5

1.4

24.13

24.27

u/l

0.02

138

920

Medical abortion

836

3858

1.18

4.69

1.3

27.63

26.80

u/l

0.28

661

3200

Thyroiditis

479

1.69

4.68

1.6

1.4

30.85

27.95

u/l

0.29

400

Diarrhoea and gastroenteritis of presumed infectious origin

693

5257

1.19

4.68

1.5

1.3

21.03

23.52

u/l

1.38

586

4337

Other symptoms and signs involving the nervous and musculoskeletal systems

392

3123

1.26

4.67

1.4

1.3

27.48

26.77

u/l

0.15

337

2548

Early onset COPD

114

743

1.54

4.66

1.3

24.86

32.04

u/l

1.51

588

Other bacterial diseases

954

5214

1.16

4.65

1.4

1.3

29.06

26.80

u/l

1.22

784

4284

SLE (Finngen)

192

2.12

4.64

1.3

23.64

22.55

u/l

0.06

159

Benign neoplasm of other and unspecified female genital organs

226

2.02

4.63

1.4

1.3

28.57

30.63

u/l

0.15

189

COPD, hospital admission 2, with asthma infections

107

587

1.57

4.63

1.2

1.3

26.49

31.60

u/l

0.95

471

Viral and other specified intestinal infections

314

2351

1.29

4.62

1.5

1.3

15.68

17.59

u/l

0.68

270

1970

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

289

1.89

4.62

1.2

1.4

31.13

31.49

u/l

0.03

237

Complications of internal orthopaedic prosthetic devices, implants and grafts

611

1.59

4.60

1.3

34.13

34.73

u/l

0.05

486

Asthma-related pneumonia

237

1767

1.34

4.59

1.4

1.3

22.96

27.86

u/l

1.73

193

1457

Family history of certain disabilities and chronic diseases leading to disablement

437

1.72

4.59

1.4

11.41

20.34

u/l

4.51

380

Vasomotor rhinitis (mode)

384

1.76

4.59

1.5

1.4

29.12

28.11

u/l

0.07

317

Contusion of ankle

234

1.99

4.57

1.6

1.4

24.20

19.41

u/l

0.45

203

Accidents

917

3941

1.17

4.55

1.3

1.4

23.22

25.37

u/l

1.23

743

3343

Inflammatory diseases of prostate (prostatitis)

160

2.19

4.54

1.3

1.2

11.25

12.85

u/l

0.27

127

Endometriosis ASRM stages 3,4

307

2386

1.30

4.54

1.4

24.80

27.57

u/l

0.78

265

1964

Malignant neoplasm of skin

228

1153

1.36

4.54

1.5

1.3

35.77

35.06

u/l

0.11

202

851

Anankastic personality disorder

306

1.86

4.52

1.5

1.3

24.21

21.74

u/l

0.19

260

Overjet

154

2.24

4.51

1.5

21.16

17.56

u/l

0.25

133

Unspecified event, undetermined intent

136

2.32

4.49

1.3

1.4

17.20

19.44

u/l

0.20

116

Asthma, hospital admissions 3, pneumonia

237

1774

1.34

4.48

1.4

1.3

22.96

27.78

u/l

1.69

193

1464

Asthma-related pneumonia or sepsis

237

1774

1.34

4.48

1.4

1.3

22.96

27.78

u/l

1.69

193

1464

malignant neoplasm of male genital organs

159

1.96

4.47

1.4

1.3

11.78

11.28

u/l

0.08

104

Scoliosis

508

1.65

4.47

1.4

19.05

20.14

u/l

0.12

440

Acute and transient psychotic disorders

115

760

1.52

4.46

1.5

1.4

24.83

26.35

u/l

0.20

621

Other other unspecified disorders of the circulatory system

130

2.34

4.45

1.4

37.20

32.33

u/l

0.28

104

Other external causes of accidental injury

915

3941

1.17

4.43

1.3

1.4

23.55

25.37

u/l

0.96

744

3343

Benign neoplasm: Lip

3.05

4.42

1.6

1.5

13.91

29.21

u/l

1.27

Injuries to the thorax

283

2181

1.30

4.40

1.3

1.4

22.79

26.32

u/l

1.10

213

1809

Nontoxic goitre/thyroid nodule

224

1673

1.34

4.39

1.3

29.57

34.52

u/l

1.23

177

1370

Supplementary factors related to causes of morbidity and mortality classified elsewhere

267

2045

1.31

4.39

1.4

22.60

24.20

u/l

0.31

212

1695

Emotional disorders starting during childhood or adolecense, excluding more controls

315

1.82

4.38

1.5

1.4

5.69

9.92

u/l

4.41

285

Use of interferon beta-1a

225

2.01

4.38

1.3

1.4

26.62

24.76

u/l

0.14

187

Benign lipomatous neoplasm

218

1623

1.35

4.36

1.3

1.4

30.58

31.57

u/l

0.17

180

1324

Undetermined asthma

107

699

1.54

4.36

1.4

1.3

27.35

28.05

u/l

0.08

589

Undetermined asthma, excluding more controls

107

699

1.54

4.36

1.4

1.3

27.35

27.65

u/l

0.03

587

Cardiac murmurs and other cardiac sounds

544

1.61

4.35

1.3

1.4

21.51

20.49

u/l

0.12

464

Superficial injury of ankle and foot

136

936

1.46

4.34

1.5

1.4

16.55

20.99

u/l

1.28

116

795

Leisure time condition

147

1026

1.44

4.34

1.3

1.4

21.56

23.48

u/l

0.25

108

860

Benign neoplasm: Ascending colon

353

1.76

4.33

1.5

1.4

35.63

34.35

u/l

0.09

288

Hypertension, essential

831

4031

1.17

4.31

1.4

1.3

29.03

30.73

u/l

0.70

647

3314

Abnormal involuntary movements

102

663

1.55

4.28

1.3

1.4

26.17

26.31

u/l

0.01

550

Chronic viral hepatitis

326

1.80

4.28

1.4

11.01

19.67

u/l

3.24

269

Ménière disease

370

1.74

4.26

1.5

1.4

31.30

32.93

u/l

0.13

307

Sicca syndrome [Sjögren]

461

1.66

4.26

1.5

1.4

27.04

32.06

u/l

0.69

382

DVT of lower extremities and pulmonary embolism

228

1708

1.33

4.25

1.5

1.4

27.25

30.78

u/l

0.99

199

1385

LSIL lesion of the cervix uteri

212

1584

1.35

4.24

1.3

1.4

26.13

23.41

u/l

0.63

178

1316

Schizophrenia

140

974

1.45

4.22

1.4

20.86

24.59

u/l

0.76

112

800

Cerebral palsy and other paralytic syndromes

579

1.58

4.20

1.7

1.4

24.72

26.49

u/l

0.20

478

Abnormal findings on diagnostic imaging of central nervous system

270

1.87

4.20

1.4

25.15

25.88

u/l

0.05

220

Assault by unspecified means

115

2.39

4.19

1.4

1.5

22.57

19.94

u/l

0.16

Alcoholic liver disease

241

1.92

4.19

1.3

26.86

26.65

u/l

0.01

195

Event of undetermined intent

350

1.76

4.19

1.3

1.4

23.82

19.31

u/l

0.49

294

Familial hypercholesterolemia, with ischemic heart disease

127

2.29

4.19

1.1

1.3

23.59

26.23

u/l

0.16

100

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

463

1.65

4.19

1.6

1.4

31.54

26.17

u/l

0.66

384

Endometriosis ASRM stages 1,2

283

2204

1.29

4.18

1.3

1.4

28.60

27.02

u/l

0.32

244

1820

COPD, hospital admissions

156

932

1.42

4.18

1.3

25.27

31.92

u/l

1.84

126

741

Other viral hepatitis

388

1.72

4.17

1.5

1.3

15.88

19.43

u/l

0.38

321

Secondary malignant neoplasm of other and unspecified sites

4.40

4.14

1.6

1.2

41.80

32.09

u/l

0.38

Atopic dermatitis, strict definition with reimbursement

408

3200

1.24

4.14

1.4

1.3

20.65

22.38

u/l

0.55

329

2665

In situ neoplasms

294

2301

1.28

4.12

1.4

1.3

26.92

28.43

u/l

0.35

242

1887

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

4.05

4.11

1.6

1.4

45.04

33.18

u/l

0.46

Explicit Sepsis

271

1957

1.30

4.11

1.5

1.4

28.34

25.41

u/l

0.69

221

1611

Ectopic pregnancy

241

1841

1.32

4.11

1.4

1.3

27.60

31.70

u/l

1.21

203

1500

Anogenital herpesviral [herpes simplex] infection

169

1224

1.39

4.11

1.5

1.4

19.82

18.65

u/l

0.21

144

1026

Polyhydramnios

633

1.56

4.10

1.4

22.36

21.61

u/l

0.07

530

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

265

1.87

4.10

1.2

1.4

22.78

26.36

u/l

0.29

224

Other and unspecified nonorganic psychotic disorders

206

1538

1.35

4.10

1.5

1.4

18.85

21.65

u/l

0.75

163

1275

Superficial injury of shoulder and upper arm

599

1.56

4.08

1.2

1.4

20.01

24.13

u/l

0.69

502

Other disorders starting during childhood or adolecense, excluding more controls

281

1.82

4.08

1.4

9.24

10.33

u/l

0.21

251

Xerosis cutis

3.39

4.06

1.5

30.64

25.75

u/l

—

Erosion of teeth , including avohilmo

290

2272

1.28

4.06

1.5

1.3

23.37

22.24

u/l

0.24

228

1891

Specific development disorders of scholastic skills

298

1.81

4.06

1.7

1.4

10.88

12.29

u/l

0.19

265

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

111

746

1.50

4.04

1.2

1.4

21.59

28.83

u/l

1.73

616

Disorders of eyelid, lacrimal system and orbit

789

5159

1.16

4.04

1.4

1.3

28.12

28.05

u/l

0.02

641

4241

Hypoglycaemia, other or unspecified

317

1.78

4.04

1.5

1.4

16.88

21.58

u/l

0.64

263

Unspecified kidney failure

182

2.04

4.03

1.9

1.3

22.74

25.62

u/l

0.20

148

Injury of muscle and tendon at wrist and hand level

577

1.57

4.03

1.3

1.4

26.22

25.22

u/l

0.10

476

Other and unspecified nail disorders

111

2.39

4.03

1.3

24.69

24.74

u/l

0.00

Vestibular neuronitis

362

1.73

4.01

1.4

33.46

29.02

u/l

0.48

302

Other symptoms and signs involving the circulatory and respiratory systems

281

1.83

4.01

1.2

1.4

35.55

24.38

u/l

1.22

229

Oral leukoplakia, including avohilmo

2.70

4.01

1.3

31.39

32.97

u/l

0.06

Foreign body in alimentary tract

218

1.94

3.97

1.4

1.3

28.21

20.56

u/l

0.71

177

Restless leg syndrome

109

732

1.50

3.96

1.2

1.4

30.76

29.45

u/l

0.12

593

Hyperparathyroidism

549

1.57

3.96

1.6

1.3

34.39

37.32

u/l

0.30

430

Other diseases of peritoneum

205

1.97

3.93

1.3

1.4

28.06

30.75

u/l

0.15

169

Androgenic alopecia

2.87

3.92

1.7

1.6

29.51

23.05

u/l

0.37

Acute alcohol intoxication, ICD10

150

1072

1.41

3.92

1.3

1.4

20.79

21.48

u/l

0.10

108

900

Persistent delusional disorders

298

1.79

3.91

1.5

1.4

29.92

27.83

u/l

0.14

238

Benign neoplasm: Colon, unspecified

102

677

1.51

3.90

1.4

1.3

28.93

33.19

u/l

0.60

545

Necrosis of pulp, including avohilmo

615

5211

1.18

3.90

1.4

1.3

23.43

26.76

u/l

2.03

492

4295

Disorders of conjunctiva

865

6043

1.15

3.88

1.4

1.3

24.40

25.15

u/l

0.29

703

5007

Impacted cerumen

277

1.81

3.87

1.5

1.4

24.99

25.90

u/l

0.07

230

All dysplastic lesions of the cervix uteri, vagina or vulva

528

4370

1.20

3.87

1.4

24.92

25.18

u/l

0.07

416

3599

Puerperal sepsis

132

927

1.43

3.84

1.4

30.67

33.55

u/l

0.47

107

765

Diabetic retinopathy

122

1091

0.69

3.81

1.4

24.02

21.02

u/l

0.39

901

Lesion of radial nerve

133

2.20

3.81

1.4

1.3

38.85

27.95

u/l

0.88

108

Status post-ami

352

1.63

3.80

1.2

1.3

35.85

27.65

u/l

0.97

284

Burn and corrosion of wrist and hand

208

1.95

3.79

1.3

1.4

13.87

17.80

u/l

0.45

173

Sudden idiopathic hearing loss

376

1.69

3.78

1.5

1.4

22.30

28.19

u/l

0.66

314

Congenital malformations and deformations of the musculoskeletal system

102

680

1.50

3.77

1.3

1.4

23.14

19.51

u/l

0.50

592

Dystonia

280

1.80

3.77

1.3

1.4

34.95

25.82

u/l

0.97

230

Polyarthrosis

103

640

1.50

3.77

1.4

1.3

39.62

43.12

u/l

0.43

529

Moderate visual impairment, binocular

2.75

3.76

1.9

1.5

12.73

23.07

u/l

1.02

Duodenal ulcer

194

1.97

3.76

1.3

1.4

24.87

30.20

u/l

0.57

154

Disorders of ocular muscles, binocular movement, accommodation and refraction

500

4152

1.20

3.75

1.4

1.3

23.94

24.92

u/l

0.26

406

3415

Other/unspecified synovitis and tenosynovitis

636

1.52

3.75

1.4

24.92

29.97

u/l

0.67

530

Neuralgia and neuritis, unspecified

259

1.83

3.73

1.5

1.4

38.16

30.72

u/l

0.60

215

Raynaud syndrome

100

671

1.50

3.70

1.4

18.83

24.55

u/l

1.05

570

Nonalcoholic fatty liver disease

535

1.56

3.68

1.3

1.4

25.89

29.16

u/l

0.35

432

Dipeptidyl peptidase 4 (DPP-4) inhibitors

250

1553

1.29

3.68

1.3

24.83

35.84

u/l

6.33

191

1254

Other and unspecified rosacea

570

1.54

3.60

1.4

31.65

29.90

u/l

0.17

469

Malignant neoplasm of tongue

3.76

3.60

1.5

1.4

44.55

33.91

u/l

0.38

Hypoparathyroidism

117

2.25

3.59

1.8

1.3

34.43

30.56

u/l

0.18

Seborrhoeic keratosis

110

756

1.46

3.58

1.4

1.3

35.38

35.20

u/l

0.02

101

601

Other and unspecified effects of external causes

303

2428

1.25

3.57

1.4

19.90

23.57

u/l

1.36

256

2020

Disorders of tooth development and eruption

161

955

1.37

3.56

1.3

20.31

21.92

u/l

0.27

134

815

Other abnormal findings in urine

3.09

3.55

1.6

1.5

38.34

24.53

u/l

—

Personal history of malignant neoplasm

415

1.63

3.53

1.8

1.4

30.90

33.88

u/l

0.31

348

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

846

4472

1.15

3.53

1.3

25.91

26.18

u/l

0.09

694

3710

846

4472

1.15

3.53

1.3

25.91

26.18

u/l

0.09

694

3710

Postpartum hemorraghe, parous women as controls

513

3691

1.19

3.51

1.3

21.06

25.79

u/l

2.91

427

3040

Episcleritis

347

1.69

3.51

1.4

22.87

27.66

u/l

0.52

288

Labour and delivery complicated by umbilical cord complications

536

1.55

3.48

1.4

23.58

27.64

u/l

0.57

441

Primary hyperparathyroidism

393

1.64

3.48

1.6

1.4

33.27

37.58

u/l

0.39

311

All dysplastic lesions of the cervix uteri

479

4001

1.19

3.47

1.3

1.4

23.23

24.18

u/l

0.28

376

3316

Maternal care for known or suspected malpresentation of fetus

418

2512

1.21

3.47

1.3

1.4

21.83

24.57

u/l

1.09

350

2084

Neuromuscular dysfunction of bladder

386

1.64

3.46

1.4

24.12

28.07

u/l

0.46

317

Gonarthrosis [arthrosis of knee](FG)

619

3075

1.17

3.44

1.4

1.3

34.57

34.23

u/l

0.08

485

2509

Other disorders of eye and adnexa

138

998

1.39

3.43

1.4

1.3

21.30

25.88

u/l

0.95

114

827

Mental retardation, excluding more controls

155

2.03

3.42

1.6

1.3

13.55

19.13

u/l

0.78

136

Nail disorders

403

1.62

3.42

1.2

1.4

22.33

24.76

u/l

0.26

334

Effects of foreign body entering through natural orifice

169

1262

1.34

3.42

1.4

1.3

22.17

21.43

u/l

0.12

137

1058

Other and unspecified mood [affective] disorders

594

1.51

3.41

1.4

15.76

19.81

u/l

0.73

510

Hypokalaemia

450

1.59

3.40

1.5

1.4

21.34

30.78

u/l

1.45

368

Conductive hearing loss, unspecified

404

1.62

3.39

1.4

32.83

25.51

u/l

0.96

336

Asthma and allergy, excluding more controls

164

1206

1.35

3.38

1.5

1.3

18.87

22.40

u/l

0.86

141

1031

Biguanides

869

4651

1.14

3.36

1.4

1.3

19.84

30.40

u/l

24.97

702

3821

Osteoporosis with pathological fracture (FG)

127

2.14

3.35

1.6

1.3

63.02

47.63

u/l

0.65

103

Hypermetropia

351

1.66

3.35

1.5

1.4

16.10

21.02

u/l

0.86

289

Disorder of lipoprotein metabolism, unspecified

298

1.72

3.34

1.4

22.04

32.45

u/l

1.60

247

Type of accident

237

1861

1.28

3.33

1.4

21.04

24.25

u/l

0.75

187

1544

Nummular dermatitis

269

1.76

3.32

1.6

1.4

25.30

26.96

u/l

0.12

218

Cardiac arrhythmias

710

4003

1.16

3.32

1.4

1.3

26.90

27.15

u/l

0.07

586

3318

Other peripheral vascular diseases

446

1.58

3.30

1.4

17.44

25.93

u/l

1.68

373

Invasive ventilation

237

0.34

3.30

1.5

1.3

35.58

22.88

u/l

—

195

Spirochaetal infections, other/unspecified

376

1.63

3.29

1.4

28.93

30.71

u/l

0.13

313

Benign paroxysmal vertigo

199

1530

1.31

3.29

1.3

1.4

28.66

31.70

u/l

0.67

160

1255

Disorders of sclera, cornea, iris and ciliary body

475

4015

1.19

3.28

1.4

1.3

27.50

26.95

u/l

0.14

402

3268

Other bursopathies

494

1.55

3.28

1.4

34.73

32.90

u/l

0.16

410

Injuries to the abdomen, lower back, lumbar spine and pelvis

274

2169

1.25

3.27

1.4

22.02

23.93

u/l

0.47

222

1798

Presence of other devices

117

826

1.41

3.26

1.3

31.43

29.31

u/l

0.27

102

681

Diabetic retinopathy, excluding more controls

116

914

0.71

3.26

1.4

24.27

20.44

u/l

0.53

754

Condition for Implicit Sepsis (Organ dysfunction codes)

673

4113

1.16

3.26

1.3

1.4

25.19

27.61

u/l

1.09

541

3388

Burns and corrosions of external body surface, specified by site

584

1.50

3.24

1.4

19.81

21.11

u/l

0.16

493

Melanocytic naevi of trunk

109

765

1.43

3.24

1.4

21.67

25.17

u/l

0.60

640

Presbyopia

465

1.56

3.23

1.3

1.4

42.03

33.45

u/l

0.69

364

Tinnitus

165

1240

1.34

3.22

1.3

25.82

29.92

u/l

0.83

130

1010

Allergic urticaria

610

1.49

3.22

1.5

1.4

21.28

23.70

u/l

0.26

522

Chronic gastritis

123

882

1.40

3.21

1.6

1.4

33.64

33.04

u/l

0.06

100

733

Systemic lupus erythematosus

221

1.83

3.21

1.3

1.4

23.64

25.35

u/l

0.10

186

Pregnancy, childbirth and the puerperium

281

1169

1.26

3.20

1.4

20.29

20.43

u/l

0.02

242

958

Viral infections of the central nervous system

450

1.57

3.20

1.5

1.4

18.15

24.15

u/l

1.17

374

Zoster [herpes zoster]

327

2634

1.22

3.18

1.4

1.3

32.54

30.12

u/l

0.55

267

2150

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

106

743

1.43

3.18

1.4

33.18

30.64

u/l

0.33

601

Other and unspecified anaemias

196

1439

1.30

3.18

1.4

1.3

29.05

28.97

u/l

0.01

163

1180

Alcohol abuse, main dg

115

818

1.41

3.17

1.3

1.4

20.41

21.73

u/l

0.17

683

Ascites

207

1.85

3.17

1.3

1.4

30.71

36.49

u/l

0.53

169

Other anaemias

198

1453

1.30

3.16

1.4

1.3

28.78

29.20

u/l

0.06

165

1192

Obstructed labour due to maternal pelvic abnormality

167

1263

1.33

3.16

1.3

1.4

32.69

38.56

u/l

1.29

138

997

Asthma and allergy

164

1220

1.33

3.16

1.5

1.4

18.87

22.48

u/l

0.89

141

1042

Malignant neoplasm of corpus uteri, including Hilmo

229

1.80

3.15

1.4

1.3

37.08

43.98

u/l

0.61

160

Crohn disease

127

921

1.39

3.14

1.3

22.42

23.35

u/l

0.14

110

769

Injuries to the knee and lower leg

1175

5854

1.12

3.13

1.4

1.3

25.53

24.60

u/l

0.44

964

4850

Conjunctivitis (acute, non atopic)

278

2235

1.24

3.13

1.4

1.3

24.24

24.96

u/l

0.14

230

1856

Maternal care for known or suspected fetal abnormality and damage

205

2249

0.78

3.12

1.4

16.48

23.83

u/l

3.88

162

1868

Viral and other specified intestinal infections

214

1635

1.28

3.11

1.5

1.4

13.85

14.97

u/l

0.30

188

1390

Enterocolitis due to Clostridium difficile

328

1.65

3.10

1.5

1.3

39.00

25.82

u/l

1.60

269

Other mental disorders due to brain damage and dysfunction and to physical disease

260

1.74

3.09

1.4

1.3

32.48

30.46

u/l

0.14

211

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

231

1.79

3.08

1.4

24.81

29.03

u/l

0.35

186

Ankylosing spondylitis

454

1.55

3.08

1.3

22.89

26.53

u/l

0.50

382

Bacterial intestinal infections, IBD co-morbidities

111

789

1.41

3.08

1.4

32.46

27.76

u/l

0.66

651

Other disorders of central nervous system

2.56

3.07

1.2

1.4

34.96

25.96

u/l

0.57

Hyperlipidaemia, other/unspecified

142

966

1.36

3.07

1.3

1.4

30.33

31.64

u/l

0.18

105

795

Pneumothorax

195

1.86

3.06

1.5

1.4

26.85

22.03

u/l

0.39

157

Tooth agenesis EXCLUDE clefts and syndromes

315

1.67

3.05

1.5

1.4

17.39

15.23

u/l

0.23

274

SLE, strict definition

225

1.80

3.05

1.3

23.64

26.59

u/l

0.19

188

SLE, ICD10

225

1.80

3.05

1.3

23.64

26.59

u/l

0.19

188

Paralytic strabismus

254

1.74

3.05

1.3

17.99

25.49

u/l

1.43

203

Congenital malformations of uterus and cervix

241

1.78

3.03

1.3

1.4

14.37

19.10

u/l

0.71

207

Other disorders of glucose regulation and pancreatic internal secretion

393

1.59

3.02

1.5

1.4

16.64

23.21

u/l

1.14

330

Peritonsillar abscess

215

1693

1.28

3.01

1.4

20.58

22.37

u/l

0.40

185

1416

Speech therapy

1384

0.71

3.00

1.4

1.3

35.98

30.34

u/l

0.82

1127

Aplastic and other anaemias

220

1617

1.27

2.99

1.4

1.3

29.41

28.86

u/l

0.08

184

1327

Other neurological diseases

474

3167

1.18

2.99

1.4

1.3

26.98

29.65

u/l

0.97

395

2581

Postprocedural musculoskeletal disorders, not elsewhere classified

204

1.82

2.99

1.5

1.3

38.14

34.66

u/l

0.22

162

Superficial injury of forearm

637

1.45

2.98

1.3

1.4

19.13

20.84

u/l

0.22

541

Other noninflammatory disorders of cervix uteri

190

1.86

2.97

1.4

1.3

43.54

42.90

u/l

0.03

163

Appendectomy

690

5783

1.14

2.97

1.4

1.3

27.62

25.55

u/l

0.91

574

4761

Other CVD (FINNGEN)

255

1.65

2.96

1.5

1.3

31.63

25.94

u/l

0.44

210

Acute laryngitis and tracheitis

132

958

1.36

2.95

1.4

13.29

18.11

u/l

1.60

117

823

Other infectious diseases

356

1.61

2.95

1.5

1.4

28.49

23.43

u/l

0.48

293

Malignant neoplasm of vulva, including Hilmo

3.30

2.95

1.7

1.4

41.90

39.51

u/l

0.08

Allergic asthma (mode), excluding more controls

259

2044

1.24

2.95

1.4

1.3

19.28

24.31

u/l

2.20

222

1711

Conduction disorders

130

772

1.37

2.94

1.3

21.03

27.30

u/l

1.42

100

626

Pregnancy examination and test

318

1621

1.23

2.93

1.5

1.4

21.20

26.98

u/l

2.60

270

1279

Thyrotoxicosis with diffuse goitre

152

1148

1.33

2.93

1.3

27.91

29.41

u/l

0.21

124

951

Allergic asthma (mode)

259

2046

1.24

2.93

1.4

1.3

19.28

24.38

u/l

2.24

222

1713

Redundant prepuce, phimosis and paraphimosis

322

1.63

2.93

1.4

1.3

6.79

9.53

u/l

2.05

270

Crohn's disease of large intestine

311

1.66

2.92

1.4

27.55

22.87

u/l

0.54

260

Sequelae with surgical and medical care as external cause

124

908

1.37

2.91

1.4

1.3

32.62

28.44

u/l

0.66

112

743

Inflammatory disorders of breast

658

1.44

2.90

1.6

1.4

17.31

21.93

u/l

0.94

558

Venous thromboembolism

317

2525

1.21

2.89

1.5

1.3

28.87

31.40

u/l

0.69

275

2048

Malignant neoplasm of other and unspecified parts of tongue

3.76

2.89

1.5

1.4

51.04

30.41

u/l

—

Secondary malignant neoplasm of respiratory and digestive organs

4.14

2.89

1.4

1.3

41.89

36.41

u/l

—

Excessive vomiting in pregnancy

129

955

1.36

2.88

1.4

18.19

23.52

u/l

1.37

111

789

Scleritis and episcleritis

415

1.56

2.86

1.5

1.4

21.35

28.35

u/l

1.01

340

Arthropathies in other diseases classified elsewhere

143

1.98

2.86

1.3

1.4

20.75

27.50

u/l

0.66

123

Speech and linguistic disorders

537

1.47

2.85

1.7

1.4

11.89

11.97

u/l

0.01

472

Lichen sclerosus et atrophicus

479

1.51

2.85

1.3

1.4

30.99

35.55

u/l

0.59

388

Early complications of trauma

179

1.86

2.83

1.7

1.4

12.18

21.70

u/l

1.74

146

!Aliquae complicationes praecoces traumatis

179

1.86

2.83

1.7

1.4

12.18

21.70

u/l

1.74

146

Superficial injury of abdomen, lower back and pelvis

131

973

1.35

2.83

1.3

17.59

21.15

u/l

0.87

109

817

Palmar fascial fibromatosis [Dupuytren]

275

1.68

2.82

1.5

1.3

23.94

31.19

u/l

0.72

233

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

595

1.46

2.82

1.4

1.3

19.40

26.16

u/l

1.70

500

Deep bite

107

673

1.40

2.82

1.3

1.4

16.95

20.47

u/l

0.73

578

Other gastritis (incl. Duodenitis)

115

837

1.38

2.81

1.4

29.25

29.54

u/l

0.03

695

Extreme obesity with alveolar hypoventilation

144

1.96

2.81

1.2

1.3

23.49

32.34

u/l

0.81

113

Disorders of optic nerve, not elsewhere classified

2.57

2.80

2.1

1.3

31.76

30.22

u/l

—

Pregnancy hypertension

647

5085

1.14

2.79

1.3

1.4

22.49

27.55

u/l

4.17

547

4179

Other conjunctival vascular disorders and cysts

2.29

2.78

1.3

1.4

32.06

29.60

u/l

0.11

Other disorders of Eustachian tube

166

1.89

2.78

1.4

18.13

24.31

u/l

0.66

139

Presence of other functional implants

175

1561

0.78

2.78

1.3

32.71

34.91

u/l

0.31

134

1263

Foreign body on external eye

556

1.46

2.75

1.4

19.62

18.22

u/l

0.17

459

Malignant cancer of tonsil and base of tongue

3.27

2.73

1.4

1.3

27.47

42.24

u/l

0.93

Recurrent dislocation and subluxation of joint

525

1.48

2.73

1.3

18.65

24.86

u/l

1.42

444

Crohn disease (strict definition, require KELA)

420

1.54

2.73

1.4

21.08

20.18

u/l

0.09

359

Other inflammation of eyelid

699

1.41

2.72

1.4

1.3

22.45

29.10

u/l

1.35

575

Other nonscarring hair loss

2.34

2.72

1.3

1.5

37.36

20.76

u/l

0.58

Pustulosis palmaris et plantaris

211

1.77

2.72

1.2

1.4

28.32

30.57

u/l

0.17

176

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

421

1.53

2.71

1.4

12.51

14.61

u/l

0.33

376

Outcome of delivery

218

1681

0.80

2.70

1.4

33.94

28.62

u/l

1.39

200

1325

Monoarthritis, not elsewhere classified

204

1.78

2.70

1.2

1.4

26.41

27.08

u/l

0.04

178

Crohn disease (strict definition, require KELA, min 2 HDR)

413

1.54

2.70

1.4

21.00

20.21

u/l

0.08

353

Cholelithiasis

784

4797

1.13

2.70

1.4

1.3

27.31

29.47

u/l

1.09

632

3930

Calcific tendinitis of shoulder

326

1.61

2.70

1.3

1.4

41.02

36.57

u/l

0.32

266

Hypotension

341

1.59

2.69

1.5

1.3

31.63

28.06

u/l

0.25

277

Benign neoplasm: Skin of other and unspecified parts of face

413

1.53

2.68

1.4

28.09

29.46

u/l

0.11

340

Stenosis and insufficiency of lacrimal passages

406

1.54

2.66

1.5

1.4

22.70

29.90

u/l

1.04

342

Later onset COPD

227

1.65

2.66

1.2

1.3

26.97

32.52

u/l

0.60

182

Conjunctivitis

802

5969

1.12

2.65

1.4

1.3

23.71

25.33

u/l

0.76

657

4942

Contact with machinery

288

1.64

2.65

1.3

1.4

24.06

18.00

u/l

0.73

234

Other disorders of pigmentation

176

1.83

2.65

1.3

1.4

31.94

28.00

u/l

0.22

142

Viral infections of the central nervous system

407

1.53

2.64

1.5

1.4

18.36

23.78

u/l

0.93

338

Crossbite

420

1.51

2.64

1.6

1.5

15.01

17.06

u/l

0.30

364

Disorders of refraction and accommodation

285

2344

1.22

2.64

1.4

25.42

25.02

u/l

0.06

228

1944

Diseases of peritoneum

423

1.52

2.64

1.3

1.4

27.77

29.58

u/l

0.14

351

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

375

1.55

2.63

1.3

1.4

25.99

28.51

u/l

0.19

303

Disorders of muscles

513

1.47

2.62

1.4

28.30

27.26

u/l

0.09

429

Nasal polyp

109

797

1.37

2.62

1.5

1.4

23.14

27.92

u/l

0.88

675

ILD medications: immunosuppressive drugs

582

4731

1.14

2.61

1.3

27.79

26.03

u/l

0.63

487

3885

Alzheimer disease, including avohilmo

294

0.50

2.60

1.2

1.3

56.50

36.87

u/l

0.92

236

Open bite

466

1.50

2.60

1.5

1.4

17.72

17.23

u/l

0.05

404

Congenital malformations of genital organs

137

1035

1.33

2.59

1.5

1.4

23.16

22.22

u/l

0.14

118

868

Systemic lupus erythematosus, unspecified

200

1.77

2.58

1.3

1.4

26.64

27.04

u/l

0.02

170

Viral infections characterized by skin and mucous membrane lesions

337

2831

1.19

2.57

1.5

1.3

20.49

25.50

u/l

2.43

279

2334

Erysipelas

472

3105

1.16

2.56

1.4

1.3

28.06

30.22

u/l

0.70

374

2521

Periapical abscess

370

3138

1.18

2.56

1.3

1.4

24.88

29.41

u/l

2.14

295

2559

Orchitis and epididymitis

114

2.02

2.55

1.3

1.2

14.34

11.87

u/l

0.34

Other specified disorders of external ear

2.14

2.55

1.5

1.4

17.41

24.28

u/l

0.29

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

207

1660

1.25

2.54

1.3

1.4

25.06

25.25

u/l

0.03

171

1381

Other bacterial intestinal infections

159

1235

1.29

2.54

1.3

30.11

26.54

u/l

0.60

126

1019

Injuries to the head

1075

5988

1.10

2.53

1.4

1.3

23.09

25.07

u/l

1.26

871

4967

Carcinoma in situ of breast, intraductal

444

1.50

2.52

1.3

1.4

35.76

40.33

u/l

0.47

360

Recurrent aphthous stomatitis , including avohilmo

109

803

1.36

2.52

1.5

1.4

25.49

24.65

u/l

0.09

675

Emotional disorders and disorders of social functioning with onset specific to childhood

413

1.51

2.52

1.5

1.4

5.63

9.83

u/l

4.60

372

Rosacea

112

830

1.36

2.51

1.4

28.83

29.34

u/l

0.05

680

Fracture of rib(s), sternum and thoracic spine

143

1097

1.31

2.50

1.3

26.77

27.54

u/l

0.09

104

891

Lichen planus

469

1.48

2.50

1.4

1.3

40.48

34.44

u/l

0.66

376

Procedures for purposes other than remedying health state

158

1.86

2.50

1.1

1.3

36.67

28.25

u/l

0.59

130

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

224

1.70

2.50

1.4

1.3

24.63

30.06

u/l

0.49

183

Acute nasopharyngitis (common cold)

474

1.47

2.49

1.4

1.3

21.67

18.11

u/l

0.43

393

Disorders of gallbladder, biliary tract and pancreas

901

5106

1.11

2.49

1.4

1.3

27.31

28.08

u/l

0.29

726

4195

Artificial joint operation, meniscal resection

483

3615

0.87

2.48

1.3

34.69

32.60

u/l

0.65

389

2924

Chronic suppurative otitis media, including avohilmo

373

1.54

2.48

1.3

1.4

22.58

20.77

u/l

0.17

314

Pyoderma

2.16

2.46

1.5

37.56

24.80

u/l

0.60

Burns and corrosions

110

815

1.36

2.46

1.5

1.4

20.03

21.72

u/l

0.25

686

Disorders of choroid and retina

374

3119

0.85

2.46

1.4

1.3

30.91

30.51

u/l

0.07

287

2543

Malignant cancer of tonsil and base of tongue, including Hilmo

2.69

2.46

1.5

1.2

25.78

37.22

u/l

0.77

Acute pharyngitis

149

1144

1.30

2.45

1.4

14.95

16.91

u/l

0.42

123

977

Carcinoma in situ of other and unspecified sites

2.68

2.45

1.4

1.3

21.40

23.49

u/l

0.10

Retained placenta and membranes, without haemorrhage

143

1103

1.30

2.44

1.5

1.4

30.24

31.39

u/l

0.16

125

899

Other disorders of bone

181

1437

1.26

2.44

1.4

1.3

24.75

25.46

u/l

0.11

151

1180

Pustular psoriasis

226

1.70

2.44

1.2

1.4

27.74

29.70

u/l

0.15

187

Other diseases of liver

133

1015

1.32

2.44

1.3

23.79

31.12

u/l

1.62

101

823

Injury of muscle and tendon at shoulder and upper arm level

165

1296

1.28

2.42

1.3

1.4

29.83

29.94

u/l

0.01

135

1050

Hordeolum and other deep inflammation of eyelid

328

1.57

2.41

1.5

1.4

28.83

22.71

u/l

0.65

274

Crohn's disease of small intestine

449

1.48

2.41

1.3

1.4

15.33

21.92

u/l

1.72

380

Diseases of appendix

728

5857

1.12

2.41

1.3

27.74

25.53

u/l

1.03

602

4819

Keratitis

292

2441

1.20

2.41

1.4

28.15

25.87

u/l

0.56

245

2008

Cholecystitis

465

1.47

2.40

1.2

1.3

25.83

31.21

u/l

0.70

380

Juvenile cataract

3.78

2.40

2.1

1.3

17.19

35.66

u/l

—

Visual impairment including blindness (binocular or monocular)

227

1.68

2.40

1.7

1.3

24.85

27.37

u/l

0.16

184

Achilles tendinitis

482

1.46

2.39

1.3

1.4

25.16

34.14

u/l

1.29

394

Cholelithiasis, broad definition with cholecystitis

803

4843

1.12

2.39

1.4

1.3

27.28

29.26

u/l

0.98

649

3969

Prolonged pregnancy

207

2227

0.81

2.38

1.3

1.4

20.57

22.70

u/l

0.48

173

1863

Non-allergic asthma (mode), excluding more controls

124

931

1.32

2.38

1.4

1.3

25.76

26.96

u/l

0.17

105

787

conjunctival haemorrhage

228

1.68

2.36

1.4

1.3

36.70

29.98

u/l

0.52

186

Hydrocele

132

1.90

2.35

1.1

1.3

5.52

12.23

u/l

4.32

108

Malignant neoplasm, without specification of site

2.84

2.34

1.7

1.2

43.54

37.87

u/l

0.17

Insulin, intermediate and long-acting

319

2617

1.19

2.34

1.3

1.4

21.95

25.58

u/l

1.41

251

2148

Crohn's disease NAS

395

1.50

2.34

1.3

1.4

26.66

21.61

u/l

0.59

333

Benign leiomyoma with endometriosis

127

971

1.31

2.32

1.3

1.4

30.88

35.79

u/l

0.86

103

791

Lichen planus, including avohilmo

109

815

1.34

2.32

1.4

36.41

32.89

u/l

0.47

649

Lichen ruber planus, wide definition including periferal and oral lichen planus

132

1015

1.30

2.31

1.4

36.24

33.26

u/l

0.41

114

824

Graves disease, strict definition

120

912

1.32

2.31

1.3

1.4

28.18

27.18

u/l

0.11

754

Exposure to other and unspecified inanimate mechanical forces

372

1.51

2.30

1.4

29.37

19.54

u/l

1.29

306

Late syphilis

2.49

2.29

1.3

1.4

14.93

27.17

u/l

—

Asthma (diagnoses ohter than nonallergic)

820

6128

1.11

2.29

1.4

1.3

22.45

25.45

u/l

2.15

670

5073

Diagnoses used for exclusion with ILD

134

1034

1.30

2.28

1.4

1.3

31.96

29.60

u/l

0.29

117

836

Striking against or struck by other objects

271

2261

1.20

2.28

1.3

1.4

21.25

20.93

u/l

0.06

219

1876

Atopic dermatitis, strict definition

392

3308

1.16

2.28

1.4

20.30

21.36

u/l

0.29

317

2767

Inflammatory diseases of the central nervous system

430

1.47

2.27

1.5

1.4

22.51

24.97

u/l

0.28

350

Superficial injury of hip and thigh

562

1.41

2.27

1.3

1.4

18.85

24.27

u/l

0.87

475

Benign neoplasm: Cerebral meninges

357

1.52

2.27

1.6

1.4

32.46

36.74

u/l

0.39

290

Osteomyelitis

178

1.75

2.26

1.6

1.3

15.58

23.85

u/l

0.83

141

Perforation of tympanic membrane

480

1.44

2.26

1.4

19.76

24.47

u/l

0.61

406

Left ventricular outflow tract obstruction (LVOTO), broad definition

447

1.46

2.26

1.3

1.4

29.39

26.28

u/l

0.34

365

Non-allergic asthma (mode)

124

940

1.31

2.24

1.4

1.3

25.76

27.19

u/l

0.20

105

794

Superficial injury of thorax

709

1.36

2.23

1.3

1.4

17.29

24.84

u/l

2.22

590

Other specified/unspecified systemic involvement of connective tissue

343

1.53

2.22

1.5

1.4

13.74

27.95

u/l

5.06

285

Postpartum haemorrhage due to retained placenta

240

1991

1.21

2.22

1.3

22.93

25.39

u/l

0.58

195

1648

Mucosal proctocolitis

891

0.69

2.21

1.4

24.65

22.79

u/l

0.18

750

Benign neoplasm of ovary

130

1005

1.30

2.21

1.3

1.4

38.65

35.99

u/l

0.39

118

816

Bitten or struck by other mammals

131

1015

1.30

2.20

1.4

23.70

23.64

u/l

0.01

105

850

Other bacterial intestinal infections

108

814

1.33

2.19

1.4

1.3

33.04

27.90

u/l

0.72

673

Benign neoplasm of urinary organs

143

1.83

2.19

1.2

1.4

31.89

29.53

u/l

0.09

116

Congenital deformities of hip

151

1.81

2.18

1.3

1.5

25.86

17.36

u/l

0.49

132

Nonsuppurative otitis media

232

1658

1.21

2.18

1.4

14.58

14.54

u/l

0.01

188

1419

HSIL lesion of the cervix uteri

330

2821

1.18

2.18

1.4

20.77

24.07

u/l

1.21

248

2348

Carcinoma in situ of other and unspecified genital organs

108

1.97

2.17

1.8

1.4

25.40

31.41

u/l

0.44

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

585

1.39

2.16

1.4

12.98

15.84

u/l

0.64

508

Panniculitis affecting regions of neck and back

166

1.76

2.16

1.7

1.4

26.80

32.23

u/l

0.31

136

Astigmatism

337

1.52

2.15

1.4

17.09

19.85

u/l

0.27

281

Acute gastritis

258

1.60

2.15

1.3

25.63

30.50

u/l

0.37

213

Bacterial, viral and other infectious agents

494

1.42

2.14

1.3

1.4

24.93

21.13

u/l

0.41

407

Other obstetric trauma

699

1.36

2.14

1.4

23.79

24.87

u/l

0.12

572

Acute and subacute iridocyclitis

144

1133

1.28

2.14

1.4

1.3

27.45

26.86

u/l

0.08

124

930

Blood alcohol or alcohol intoxication level

130

1.87

2.14

1.4

32.72

19.21

u/l

0.70

109

Congenital malformations of the nervous system

167

1.76

2.13

1.4

16.47

19.69

u/l

0.24

145

Lichen simplex chronicus and prurigo

243

1.61

2.13

1.3

35.34

29.99

u/l

0.42

198

Pedal cyclist injured in other and unspecified transport accidents

596

1.38

2.12

1.5

1.4

17.83

23.81

u/l

1.39

497

Carrier of infectious disease

145

1.82

2.12

1.4

17.93

19.14

u/l

0.07

123

Benign neoplasm: Skin of eyelid, including canthus

647

1.36

2.12

1.4

1.3

32.44

33.33

u/l

0.08

526

Chalazion

656

1.36

2.11

1.4

1.3

26.49

25.88

u/l

0.06

547

Superficial injury of lower leg

220

1817

1.21

2.11

1.4

23.84

24.37

u/l

0.08

172

1501

Arthropod-borne viral fevers and viral haemorrhagic fevers

396

1.47

2.11

1.4

28.12

26.02

u/l

0.19

321

Papulosquamous disorders

276

2328

1.19

2.11

1.3

1.4

29.12

30.28

u/l

0.24

229

1896

Other complications of labour and delivery, not elsewhere classified

205

1544

1.23

2.11

1.4

12.90

16.07

u/l

1.52

186

1292

Degenerative diseases of the nervous system

340

0.58

2.10

1.4

1.3

54.19

34.76

u/l

0.83

274

Mental retardation

189

1.70

2.09

1.6

1.4

13.55

20.12

u/l

1.00

163

Atopic conjunctivitis

308

1.54

2.09

1.4

1.3

20.99

22.84

u/l

0.16

261

Covid-19 confirmed case

246

2055

1.20

2.09

1.4

27.10

23.65

u/l

0.87

216

1695

Zoster [herpes zoster]

717

1.34

2.09

1.6

1.3

27.59

29.15

u/l

0.16

587

therapeutic use

2.15

2.09

1.5

1.4

19.77

31.60

u/l

0.95

Giant cell arteritis

2.15

2.08

1.4

1.3

31.25

36.41

u/l

—

LeFortI or BSSO operation

349

1.51

2.08

1.4

19.68

23.21

u/l

0.46

296

Appendicitis, broad definition

718

5851

1.11

2.07

1.3

27.77

25.52

u/l

1.05

593

4816

Carcinoma in situ, bladder

2.72

2.07

1.4

1.3

22.75

24.38

u/l

—

IBD (strict) with PSC

0.00

2.07

0.0

1.5

—

18.02

—

HSIL lesion of the cervix uteri, vagina or vulva

345

2974

1.17

2.06

1.4

21.48

24.42

u/l

1.04

260

2462

Viral haemorrhagic fevers, not elsewhere classified/unspecified

333

1.51

2.06

1.4

27.58

25.55

u/l

0.17

269

Carcinoma in situ of cervix uteri, exocervix

2.12

2.06

1.2

1.5

13.75

23.36

u/l

0.94

Persons with potential health hazards related to communicable diseases

370

4226

0.87

2.06

1.4

20.40

20.79

u/l

0.09

337

3491

Anogenital herpesviral [herpes simplex] infection

635

1.37

2.05

1.4

18.76

20.81

u/l

0.27

548

Amblyopia ex anopsia

207

1.66

2.05

1.2

1.4

17.05

18.28

u/l

0.10

176

Coeliac disease

102

772

1.33

2.05

1.3

1.4

25.69

26.23

u/l

0.05

642

Benign neoplasm of meninges

399

1.46

2.04

1.6

1.4

34.02

37.01

u/l

0.26

322

Atrial septal defect, secundum type

154

1.77

2.03

1.4

24.97

20.11

u/l

0.28

131

Chronic pancreatitis

334

1.50

2.03

1.3

27.88

26.60

u/l

0.09

270

Desensitization to allergens

526

1.40

2.02

1.5

1.3

18.19

18.90

u/l

0.07

451

Parkinson's disease, excluding more controls

159

1.72

2.02

1.2

34.17

35.56

u/l

0.08

140

MS-disease / Multiple Sclerosis

697

1.34

2.02

1.2

1.4

27.87

24.03

u/l

0.55

589

Type 2 diabetes, wide definition

522

2953

1.13

2.01

1.4

1.3

23.75

34.53

u/l

11.51

405

2398

Injury of nerves at wrist and hand level

170

1.72

2.01

1.2

1.3

24.45

20.50

u/l

0.24

138

Psoriasis vulgaris

128

1002

1.28

2.00

1.4

23.25

27.58

u/l

1.00

108

822

Rash and other nonspecific skin eruption

501

1.40

2.00

1.5

1.3

26.17

29.15

u/l

0.36

415

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

893

5611

1.10

2.00

1.4

1.3

26.35

26.36

u/l

0.01

746

4611

Malignant neoplasm of tonsil

3.36

1.97

1.3

32.10

47.04

u/l

—

Dislocation, sprain and strain of joints and ligaments of head

273

1.55

1.96

1.4

32.55

22.02

u/l

0.81

233

Infective dermatitis

520

1.39

1.96

1.4

26.22

27.37

u/l

0.11

432

LSIL lesion of the vulva

298

1.53

1.95

1.4

37.18

29.88

u/l

0.70

246

Antepartum haemorrhage, not elsewhere classified

164

1330

1.24

1.95

1.4

24.11

24.78

u/l

0.09

139

1103

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

462

1.42

1.95

1.4

20.88

21.10

u/l

0.02

396

Anxious personality disorder

142

1.79

1.95

1.8

1.4

23.13

18.42

u/l

0.24

119

Other neurotic disorders

149

1.75

1.95

1.7

1.3

28.45

24.91

u/l

0.20

125

All dysplastic lesions of the vulva

405

1.45

1.93

1.4

37.38

30.63

u/l

0.74

329

Asthma/COPD (KELA code 203)

918

5754

1.09

1.92

1.3

23.80

25.17

u/l

0.69

758

4763

Leiomyoma of uterus

775

3980

1.11

1.92

1.3

1.4

31.43

33.01

u/l

0.62

645

3234

Other infectious diseases

282

1.53

1.92

1.3

27.01

24.80

u/l

0.15

229

Hallux rigidus

480

1.40

1.91

1.3

45.71

38.47

u/l

0.72

402

Certain conditions originating in the perinatal period

615

1.33

1.90

1.6

1.4

11.33

12.58

u/l

0.23

541

Dislocation, sprain and strain of joints and ligaments of thorax

173

1.69

1.90

1.2

1.4

18.74

21.66

u/l

0.27

142

Unspecific neurodegenerative disorder

375

0.64

1.90

1.3

40.90

34.65

u/l

0.36

308

Asthma mixed form (mode)

235

1.58

1.90

1.2

1.3

20.51

22.79

u/l

0.20

203

Condition for Implicit Sepsis (Organ dysfunction codes)

757

4731

1.10

1.90

1.3

1.4

25.13

26.72

u/l

0.65

608

3907

Defect, injury or illness of lumbar spine

2.98

1.89

1.4

1.6

19.40

26.27

u/l

—

Bilateral sagittal split ramus osteotomy operation

292

1.52

1.89

1.4

20.40

24.02

u/l

0.39

249

Pneumonia due to other infectious organisms, not elsewhere classified

121

1.83

1.89

1.5

1.4

32.71

25.09

u/l

0.41

Malignant neoplasm of oropharynx

3.21

1.88

1.3

32.10

47.04

u/l

—

Subacute thyroiditis

189

1.65

1.88

1.8

1.3

20.77

26.63

u/l

0.48

158

Mixed connective tissue disease

407

1.43

1.88

1.5

1.4

15.96

28.98

u/l

3.41

337

Heart failure and antihypertensive medication

104

519

1.31

1.87

1.3

1.4

28.57

34.84

u/l

1.02

424

Emotional disorders starting during childhood or adolescence

404

1.43

1.87

1.5

1.4

5.69

9.63

u/l

3.90

356

Colitis, primary sclerosing, strict definition

0.00

1.86

0.0

1.5

—

20.94

—

Mental retardation, wide definition

196

1.63

1.86

1.6

1.4

13.55

20.13

u/l

1.00

169

Bacterial, viral and other infectious agents

441

1.41

1.86

1.3

1.4

25.73

21.41

u/l

0.44

362

Injuries to the hip and thigh

249

1907

1.18

1.86

1.5

1.3

26.56

26.74

u/l

0.02

193

1575

Other heart diseases, wide

962

5396

1.09

1.86

1.4

1.3

27.18

25.93

u/l

0.55

793

4444

Combinations of oral blood glucose lowering drugs

110

854

1.29

1.85

1.3

25.52

32.52

u/l

1.70

685

Stroke, including SAH

194

1697

0.83

1.85

1.3

35.20

32.02

u/l

0.58

150

1388

Amputation

182

1.65

1.84

1.4

1.3

37.86

26.04

u/l

0.67

149

Asthma mixed form (mode), excluding more controls

237

1.57

1.84

1.2

1.3

20.51

22.74

u/l

0.20

205

Nontoxic diffuse goitre

137

1.77

1.84

1.4

1.3

28.83

30.36

u/l

0.08

111

Contusion of other and unspecified parts of foot

351

1.46

1.83

1.6

1.4

12.82

19.65

u/l

2.00

301

Other disorders starting during childhood or adolescence

364

1.45

1.83

1.4

9.24

10.77

u/l

0.32

326

Malignant neoplasm of larynx, including Hilmo

4.19

1.82

1.6

1.3

9.20

19.37

u/l

—

Other arthritis (FG)

240

2032

1.18

1.81

1.4

1.3

29.28

28.40

u/l

0.15

197

1676

Varicella [chickenpox]

246

1.55

1.81

1.6

1.4

14.39

16.87

u/l

0.27

204

Maternal care for other conditions predominantly related to pregnancy

364

3123

1.15

1.81

1.3

22.04

25.60

u/l

1.49

297

2555

Other infective otitis externa

295

1.50

1.80

1.4

27.34

25.82

u/l

0.11

243

Haemangioma, any site

478

1.39

1.80

1.3

1.4

31.52

28.39

u/l

0.24

389

Contact with sharp glass

247

1.55

1.79

1.3

1.4

31.01

17.06

u/l

2.04

210

Congenital malformations of the musculoskeletal system, not elsewhere classified

177

1.67

1.79

1.3

1.4

26.82

18.89

u/l

0.64

152

Haemangioma and lymphangioma, any site

504

1.38

1.79

1.3

1.4

30.67

28.37

u/l

0.18

411

Sarcoidosis

650

1.33

1.78

1.4

1.3

30.16

30.44

u/l

0.02

519

All dysplastic lesions of the vagina

216

1.59

1.78

1.4

26.85

28.79

u/l

0.12

180

Aortic valve malfunction, age under 60 years

403

1.42

1.78

1.3

1.4

30.51

27.13

u/l

0.34

330

Fall on and from stairs and steps

187

1551

1.21

1.78

1.3

21.97

26.69

u/l

1.14

140

1277

Chronic suppurative otitis media

312

1.48

1.78

1.3

1.4

18.50

20.43

u/l

0.18

264

Cerebrovascular diseases

286

2336

0.86

1.77

1.3

32.51

32.09

u/l

0.07

222

1899

Anterior Iridocyclitis

147

1191

1.24

1.76

1.4

1.3

28.01

27.22

u/l

0.11

127

980

Malignant neoplasm of digestive organs

107

656

1.29

1.76

1.3

34.02

33.63

u/l

0.04

472

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

3.37

1.75

1.3

36.50

33.66

u/l

—

Explicit bacterial Sepsis

346

1.45

1.75

1.4

1.3

22.81

23.36

u/l

0.05

291

Autoimmune hyperthyroidism

473

1.38

1.74

1.4

1.3

29.21

26.70

u/l

0.22

392

Psoriasis

203

1701

1.20

1.74

1.3

1.4

25.44

28.60

u/l

0.82

167

1396

Adhesive capsulitis of shoulder

100

775

1.29

1.74

1.3

1.4

29.99

34.85

u/l

0.82

630

Certain disorders involving the immune mechanism

132

1059

1.25

1.73

1.5

1.3

29.58

28.07

u/l

0.19

116

861

Symptoms and signs involving emotional state

194

1.61

1.73

1.5

1.4

24.93

19.09

u/l

0.39

169

Ulcerative colitis (strict) with PSC

0.00

1.72

0.0

1.5

—

17.03

—

Chronic tubulo-interstitial nephritis

163

1.67

1.71

1.5

1.4

44.40

30.60

u/l

1.15

132

Thyrotoxicosis with toxic multinodular goitre

202

1.59

1.71

1.3

1.4

48.54

33.46

u/l

1.08

166

Benign neoplasm of eye and adnexa

398

1.41

1.71

1.3

1.4

36.65

30.74

u/l

0.53

329

Corneal ulcer

145

1178

1.23

1.71

1.5

1.4

29.35

24.52

u/l

0.88

122

978

Oesophageal varices

1.89

1.71

1.3

1.4

20.65

30.19

u/l

0.60

Benign neoplasm: Skin of ear and external auricular canal

118

1.79

1.70

1.7

1.4

17.82

29.12

u/l

1.31

Deep bite that required surgery

104

1.86

1.69

1.3

1.4

20.85

23.63

u/l

0.16

Pervasive developmental disorders excl. Autism + Asperger

2.14

1.68

1.5

3.94

12.68

u/l

2.69

Urolithiasis

158

1299

1.22

1.66

1.4

1.3

25.23

26.17

u/l

0.15

123

1069

Other blood glucose lowering drugs, excl. Insulins

392

1.41

1.65

1.3

1.4

23.80

37.52

u/l

2.40

324

Crohn disease (strict definition, all UC cases excluded)

318

1.46

1.65

1.3

1.4

18.06

19.90

u/l

0.20

269

Other bacterial agents as the cause of diseases classified to other chapters

2.28

1.65

1.4

1.6

31.51

24.40

u/l

0.17

Insulin, fast-acting

236

2013

1.17

1.64

1.3

1.4

20.24

23.18

u/l

0.84

185

1660

L04AD Calcineurin inhibitors

529

1.35

1.64

1.4

27.75

24.61

u/l

0.31

433

Other inflammatory liver diseases

285

1.48

1.64

1.2

1.3

27.08

27.11

u/l

0.00

233

COPD, hospital admissions 3, with asthma pneumonia sepsis

421

1.36

1.64

1.3

25.98

32.09

u/l

0.90

340

Delivery, wide proxy

317

1461

1.15

1.64

1.4

20.58

21.85

u/l

0.30

273

1201

Other arrhythmias

567

3860

1.11

1.64

1.4

1.3

27.82

28.49

u/l

0.17

458

3154

Other congenital malformations of the digestive system

227

1.54

1.63

1.4

26.35

17.90

u/l

0.87

192

Type 1 diabetes, strict definition, subgroup 1

605

0.69

1.63

1.2

1.4

15.81

17.82

u/l

0.20

520

LSIL lesion of the vagina

128

1.75

1.62

1.1

1.4

24.67

26.17

u/l

0.07

104

Demyelinating diseases of the central nervous system

104

820

1.28

1.62

1.3

1.4

27.00

24.91

u/l

0.28

689

Malignant neoplasm of base of tongue, including Hilmo

3.61

1.62

1.8

1.2

16.94

32.96

u/l

—

Statin medication

803

4138

1.09

1.62

1.4

1.3

28.84

27.17

u/l

0.71

646

3404

Fall on same level

1153

5852

1.08

1.62

1.4

1.3

26.10

24.27

u/l

1.03

910

4894

Poisoning by narcotics and psychodysleptics [hallucinogens]

1.89

1.62

2.0

1.4

33.33

12.90

u/l

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

143

1.69

1.61

1.2

1.4

33.61

27.46

u/l

0.39

118

Follicular cysts of skin and subcutaneous tissue

124

998

1.25

1.61

1.4

1.3

25.41

27.98

u/l

0.45

105

821

Alzheimer disease

241

0.58

1.61

1.3

55.72

37.73

u/l

0.70

193

Personal history of risk-factors, not elsewhere classified

1.97

1.60

1.5

1.4

3.36

13.08

u/l

—

Fracture of lower leg, including ankle

413

3636

1.13

1.60

1.4

1.3

29.17

28.63

u/l

0.12

342

2973

Heterophoria

558

1.33

1.60

1.5

1.4

28.90

22.17

u/l

0.71

469

Strabismus

237

2025

1.17

1.60

1.4

22.00

24.65

u/l

0.64

191

1673

Other disorders of bladder

328

1.44

1.60

1.3

26.11

25.71

u/l

0.02

272

Insulin, combination of fast acting with intermediate-acting or long-acting

364

2934

1.13

1.60

1.3

21.26

25.33

u/l

1.89

287

2408

Disorders of vitreous body

260

2165

1.16

1.59

1.4

1.3

36.55

36.64

u/l

0.01

196

1746

Pneumonia, organism unspecified

787

5061

1.09

1.59

1.3

1.4

25.26

26.19

u/l

0.36

646

4169

Schizotypal disorder

152

1.66

1.58

1.4

21.14

21.73

u/l

0.03

126

Disorders of lipoprotein metabolism and other lipidaemias

431

2993

0.89

1.57

1.3

30.46

34.02

u/l

1.30

338

2439

Left bundle-branch block

175

1.61

1.57

1.4

1.3

26.99

34.35

u/l

0.66

141

Hemiplegia

231

1.52

1.57

2.1

1.3

27.69

25.39

u/l

0.13

187

Manic episode

160

1.64

1.56

1.4

26.24

19.81

u/l

0.40

135

malignant neoplasm of female genital organs

539

1.33

1.56

1.4

1.3

46.96

35.15

u/l

1.91

402

Ankylosing spondylitis, ICD10

517

1.34

1.56

1.3

1.4

21.98

26.57

u/l

0.70

425

Urethral stricture

1.89

1.55

1.4

18.89

19.52

u/l

0.04

Caught, crushed, jammed or pinched in or between objects

265

1.48

1.54

1.2

1.4

22.80

19.40

u/l

0.24

223

Intentional self-harm by sharp object

193

1.57

1.52

1.5

1.4

13.86

14.14

u/l

0.02

165

Hydronephrosis

416

1.37

1.52

1.4

37.37

26.10

u/l

1.30

348

Malignant neoplasm of eye and adnexa, including Hilmo

2.61

1.52

1.4

1.2

20.04

37.27

u/l

—

Calculus of kidney and ureter

150

1241

1.21

1.51

1.4

1.3

24.54

26.15

u/l

0.27

117

1018

Type 1 diabetes, strict definition

630

0.71

1.51

1.2

1.3

17.18

18.31

u/l

0.10

542

Other and unspecified injuries of shoulder and upper arm

154

1.64

1.50

1.6

1.4

22.24

20.75

u/l

0.10

128

Other and unspecified disorders of vitreous body

206

1731

1.18

1.49

1.3

38.88

39.08

u/l

0.03

153

1395

Injuries involving multiple body regions

202

1.55

1.49

1.4

25.77

20.11

u/l

0.48

175

Postmenopausal osteoporosis with pathological fracture

101

1.79

1.49

1.7

1.3

70.98

49.12

u/l

0.74

Diabetic maculopathy, excluding more controls

401

1.38

1.48

1.4

16.25

22.76

u/l

0.70

334

Infectious mononucleosis

102

813

1.26

1.48

1.3

1.4

15.48

16.34

u/l

0.12

705

Unspecified acute lower respiratory infection

750

1.27

1.48

1.5

1.4

23.04

21.93

u/l

0.13

624

Hyperplasia of prostate

302

1.34

1.47

1.4

1.3

9.14

11.78

u/l

1.56

252

Foreign body entering into or through eye or natural orifice

351

1.40

1.47

1.2

1.4

22.05

19.79

u/l

0.20

288

Fracture of foot, except ankle

215

1843

1.17

1.47

1.3

1.4

27.75

24.77

u/l

0.58

172

1525

Other and unspecified injuries of lower leg

506

1.33

1.46

1.3

1.4

30.05

23.40

u/l

0.78

431

Lyme disease

213

1826

1.17

1.45

1.3

1.4

30.78

30.73

u/l

0.01

171

1489

Other symptoms and signs involving general sensations and perceptions

140

1.65

1.45

1.6

1.4

19.88

20.16

u/l

0.02

120

Other or unspecified ileus, impaction or obstruction

558

1.31

1.45

1.3

34.39

30.14

u/l

0.51

461

Contact with and exposure to communicable diseases

331

3717

0.88

1.44

1.4

20.52

20.01

u/l

0.12

303

3078

Labour and delivery complicated by fetal stress [distress]

481

2843

1.11

1.43

1.3

1.4

16.98

23.18

u/l

6.40

425

2320

Alcohol-induced chronic pancreatitis

164

1.59

1.43

1.5

1.4

24.66

23.55

u/l

0.08

124

Purpura and other haemorrhagic conditions

630

1.29

1.43

1.4

29.11

24.49

u/l

0.54

525

Other spirochaetal diseases

219

1885

1.16

1.42

1.3

1.4

31.10

30.69

u/l

0.06

175

1539

Parkinson's disease, strict definition, excluding more controls

141

1.62

1.42

1.2

1.3

36.11

36.94

u/l

0.04

123

Cluster headache, strict, including avohilmo

371

1.38

1.42

1.3

1.4

26.48

23.21

u/l

0.31

311

Senile cataract

198

1422

0.85

1.42

1.3

37.22

37.79

u/l

0.07

155

1137

Visual field defects

320

1.41

1.42

1.8

1.4

22.36

26.90

u/l

0.44

262

Gout, idiopatic and unspecified

456

1.34

1.41

1.2

1.3

22.56

25.40

u/l

0.23

372

Abscess of anal and rectal regions

405

1.36

1.41

1.3

1.4

29.22

23.45

u/l

0.52

337

Other hearing loss

773

1.25

1.41

1.4

1.3

25.65

31.28

u/l

0.89

628

Type 1 diabetes, definitions combined

713

0.74

1.41

1.3

1.4

21.40

18.91

u/l

0.25

606

Iridocyclitis

159

1334

1.19

1.41

1.4

26.96

26.86

u/l

0.01

138

1096

Obstructive hydrocephalus

2.19

1.40

3.1

1.4

7.22

26.74

u/l

—

Valvular heart disease excluding rheumatic fever

204

1258

1.17

1.40

1.4

1.3

33.38

29.48

u/l

0.81

165

1033

Malignant neoplasm of rectum

157

1.60

1.40

1.5

1.3

49.69

34.36

u/l

0.83

106

Acute appendicitis

673

5783

1.09

1.40

1.3

27.62

25.53

u/l

0.89

555

4755

Secondary hypertension

292

1.43

1.40

1.5

1.4

17.41

24.11

u/l

0.88

242

Colon adenocarcinoma

165

1.58

1.39

1.3

26.61

37.39

u/l

0.91

112

Respiratory insufficiency

118

1.69

1.39

1.4

1.3

13.02

30.02

u/l

3.27

Other Crohn's disease

458

1.34

1.39

1.3

1.4

22.78

22.53

u/l

0.02

390

Acute pancreatitis (for exclusion)

774

1.26

1.39

1.6

1.3

21.67

27.87

u/l

1.45

627

Bursitis of shoulder

1.78

1.39

1.3

1.4

26.50

31.95

u/l

—

Barrett oesophagus

111

1.72

1.39

1.2

1.4

27.46

34.50

u/l

0.42

Type 1 diabetes, strict (exclude DM2)

711

0.74

1.39

1.3

1.4

21.40

18.80

u/l

0.26

604

Gout, unspecified

355

1.38

1.39

1.3

23.27

24.60

u/l

0.08

288

Colorectal adenocarcinoma

312

1.41

1.38

1.4

1.3

38.21

35.89

u/l

0.15

212

Failed attempted abortion

191

1.55

1.38

1.8

1.4

21.63

23.43

u/l

0.12

161

Impacted maxillary molar

599

1.29

1.38

1.4

1.3

13.18

11.73

u/l

0.25

527

Congenital deformities of hip

127

1.67

1.37

1.3

1.5

30.47

17.30

u/l

0.68

109

Type 1 diabetes

189

1612

1.17

1.37

1.4

18.63

22.41

u/l

1.10

149

1335

Abnormal findings on antenatal screening of mother

146

1223

1.20

1.35

1.5

1.4

17.31

17.46

u/l

0.02

128

1023

Spirochaetal infections, other/unspecified

214

1848

1.16

1.35

1.3

1.4

31.21

30.63

u/l

0.08

172

1506

Pure hypercholesterolaemia

328

2411

0.89

1.35

1.3

31.33

34.53

u/l

0.88

262

1958

Maternal care for known or suspected disproportion

741

0.75

1.35

1.3

1.4

31.48

28.60

u/l

0.31

612

Pedal cyclist injured in transport accident

171

1451

1.18

1.35

1.4

18.21

23.99

u/l

2.02

138

1205

Vitamin B12 deficiency anaemia

273

1.43

1.34

1.5

1.4

29.45

31.58

u/l

0.14

225

Other spirochaetal diseases

214

1849

1.16

1.34

1.4

30.78

30.62

u/l

0.02

171

1505

Use of dimethyl fumarate

1.78

1.33

1.5

1.4

22.05

21.22

u/l

0.04

Congenital deformities of feet

249

1.46

1.33

1.4

16.05

21.12

u/l

0.64

213

Acute pancreatitis

779

1.25

1.33

1.6

1.3

21.67

28.02

u/l

1.51

636

Non-rheumatic valve diseases

202

1250

1.17

1.33

1.4

1.3

33.56

29.45

u/l

0.87

164

1026

Other viral diseases

297

2619

1.13

1.33

1.4

21.29

22.18

u/l

0.20

243

2192

Lung diseases due to external agents

324

1.39

1.33

1.2

1.4

30.30

25.67

u/l

0.32

268

Colorectal cancer

434

1.33

1.4

1.3

39.63

33.79

u/l

0.51

303

Open wound of abdomen, lower back and pelvis

152

1.59

1.32

1.7

1.4

21.55

17.67

u/l

0.32

130

Insulin, fast-acting or short human

236

2056

1.15

1.31

1.3

1.4

20.24

23.21

u/l

0.85

185

1696

Open wound of forearm

437

1.33

1.31

1.6

1.4

16.45

18.85

u/l

0.30

367

Abnormalities of gait and mobility

334

1.38

1.30

1.5

1.3

28.47

26.93

u/l

0.12

272

Benign neoplasm: Liver

177

1.54

1.30

1.4

27.12

26.50

u/l

0.03

149

Excessive earwax

304

2631

1.13

1.30

1.4

27.31

27.77

u/l

0.09

244

2171

Other heart diseases

527

3137

1.10

1.29

1.4

1.3

27.00

27.99

u/l

0.28

433

2587

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

141

1184

1.20

1.29

1.4

21.88

27.91

u/l

1.73

121

976

Cluster headache, wide,, including avohilmo

378

1.36

1.29

1.3

1.4

26.48

23.91

u/l

0.23

318

Diabetic maculopathy

663

0.75

1.29

1.4

16.87

16.37

u/l

0.04

559

Other congenital malformations of the digestive system

200

1.50

1.29

1.4

23.68

17.62

u/l

0.51

171

Other and unspecified injuries of wrist and hand

218

1.48

1.28

1.6

1.4

22.28

20.27

u/l

0.13

185

Nonischemic cardiomyopathy

259

1.43

1.28

1.4

29.07

27.11

u/l

0.13

211

Benign neoplasm of breast

104

847

1.23

1.28

1.3

1.4

28.12

31.07

u/l

0.39

698

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

941

5720

1.07

1.28

1.4

26.01

25.59

u/l

0.14

785

4718

Congenital malformations of the musculoskeletal system, not elsewhere classified

146

1.60

1.28

1.4

29.26

19.74

u/l

0.63

126

Any dementia

387

0.72

1.28

1.2

1.3

44.43

35.30

u/l

0.53

319

Diverticular disease of intestine

424

2443

1.11

1.27

1.5

1.3

33.56

35.92

u/l

0.75

332

1977

Other specified/unspecified inflammatory spondylopathies

345

1.37

1.27

1.4

23.91

26.12

u/l

0.20

289

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

1.84

1.26

1.2

1.5

7.68

16.92

u/l

2.23

Mandibular prognathia AND surgery (LeFortI or BSSO)

2.28

1.26

2.3

1.5

10.53

21.57

u/l

—

Insulin medication

364

2748

1.12

1.25

1.3

21.26

26.61

u/l

2.91

287

2261

Obstructed labour due to malposition and malpresentation of fetus

377

3168

1.11

1.25

1.4

25.74

27.82

u/l

0.59

324

2557

Disorders of vitreous body and globe

263

2226

1.14

1.25

1.4

1.3

36.23

36.28

u/l

0.01

199

1797

Other and unspecified injuries of head

286

1.40

1.25

1.3

1.4

16.54

24.07

u/l

1.16

235

Use of glatiramer acetate

171

1.54

1.25

1.5

1.4

28.68

23.09

u/l

0.36

141

Other orthopaedic follow-up care

261

1.42

1.25

1.6

1.3

27.44

26.57

u/l

0.05

211

Vitreous haemorrhage

338

1.36

1.23

1.4

29.43

26.81

u/l

0.17

280

Ulcer of oesophagus

147

1.57

1.23

1.3

1.4

35.80

27.95

u/l

0.37

117

Antenatal screening

381

1924

1.12

1.23

1.4

22.81

29.78

u/l

4.08

336

1520

Other necrotizing vasculopathies

212

1.47

1.22

1.8

1.3

30.82

28.56

u/l

0.12

170

Paroxysmal tachycardia

188

1356

1.16

1.22

1.4

24.16

28.21

u/l

1.03

153

1114

Reactive arthropathies

451

1.31

1.22

1.4

1.3

29.65

28.13

u/l

0.11

374

Other keratitis

744

1.24

1.22

1.4

22.56

23.67

u/l

0.12

621

Malignant neoplasm of vulva

2.66

1.22

1.2

1.3

58.04

32.08

u/l

—

Bicipital tendinitis

172

1.52

1.20

1.4

27.86

34.86

u/l

0.52

144

Gout

466

1.29

1.20

1.3

22.54

27.85

u/l

0.54

390

Contact with heat and hot substances

255

1.42

1.20

1.3

1.4

24.98

21.10

u/l

0.29

212

Exposure to unspecified factor

813

6266

0.93

1.19

1.4

1.3

24.03

24.85

u/l

0.30

657

5196

Malignant neoplasm of colon, including Hilmo

340

1.35

1.18

1.3

28.24

33.64

u/l

0.51

237

Renal failure

145

1086

1.18

1.17

1.4

1.3

30.64

27.23

u/l

0.46

118

876

Diseases of spleen

1.95

1.17

1.6

1.4

24.76

26.34

u/l

0.05

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

265

1.41

1.17

1.5

1.3

10.08

14.18

u/l

0.72

224

Primary open-angle glaucoma, strict

486

0.72

1.17

1.2

1.3

34.82

37.50

u/l

0.14

389

Artificial joint re-operation

141

1.57

1.17

1.2

1.3

52.83

39.64

u/l

0.73

112

Respiratory conditions due to other external agents

2.01

1.17

1.2

1.5

39.49

33.90

u/l

—

Benign neoplasm: Liver/bile ducts

182

1.50

1.16

1.4

27.12

26.12

u/l

0.05

152

Other/unspecified enthesopathies of lower limb, excluding foot

420

1.31

1.16

1.6

1.4

25.38

28.71

u/l

0.37

346

Infections of genitourinary tract in pregnancy

104

859

1.22

1.15

1.4

24.10

22.54

u/l

0.18

712

Other and unspecified disease of Bartholin gland

142

1.56

1.15

1.3

1.4

19.19

27.52

u/l

0.38

121

STROKE

306

2323

0.89

1.14

1.4

34.04

33.38

u/l

0.12

244

1883

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

535

3103

1.09

1.14

1.4

1.3

31.32

29.26

u/l

0.68

441

2554

Other specified/unspecified arthritis

196

1708

1.15

1.14

1.4

1.3

30.27

28.75

u/l

0.24

161

1413

Divergent concomitant strabismus

536

1.27

1.14

1.5

1.4

20.77

26.46

u/l

0.89

438

Abnormal spermatozoa

150

1.54

1.14

1.4

21.40

12.81

u/l

0.45

122

Other/unspecified rheumatoid arthritis

439

1.30

1.13

1.2

1.3

40.82

33.93

u/l

0.61

358

Disorder of the sleep-wake schedule

103

1.67

1.13

1.7

1.5

11.17

19.25

u/l

0.68

Cramp and spasm

250

1.41

1.13

1.6

1.4

18.50

21.58

u/l

0.32

207

Thiazolidinediones

233

1.42

1.12

1.3

1.4

26.37

35.80

u/l

0.86

191

Gout, FINNGEN

535

1.27

1.12

1.3

1.4

22.54

26.34

u/l

0.36

434

Inflammatory bowel disease

268

2387

1.12

1.4

23.65

24.45

u/l

0.17

222

1967

Other necrotizing vasculopathies (FG)

159

1.51

1.12

2.0

1.4

34.61

26.35

u/l

0.46

128

119

999

1.19

1.11

1.5

1.4

23.86

25.29

u/l

0.20

102

813

Multiple delivery

110

918

1.20

1.11

1.3

1.4

31.76

30.07

u/l

0.19

732

Other disorders of cornea

397

1.31

1.11

1.4

37.26

29.49

u/l

0.92

323

Polyarthropathies

505

3588

0.92

1.11

1.3

27.74

26.07

u/l

0.51

410

2977

Influenza and pneumonia

998

5971

1.06

1.11

1.3

1.4

25.14

24.98

u/l

0.05

827

4937

Allergic purpura

176

1.49

1.11

1.7

1.4

21.39

22.38

u/l

0.06

147

Malignant neoplasm of tonsil, including Hilmo

2.27

1.10

1.3

32.10

40.07

u/l

—

Coronary atherosclerosis

197

1427

0.87

1.10

1.3

32.39

34.55

u/l

0.40

160

1150

Varicose veins

352

2934

0.90

1.09

1.3

38.27

36.51

u/l

0.39

287

2365

Perioral dermatitis

177

1.48

1.09

1.6

1.3

21.48

23.09

u/l

0.09

143

Symptoms and signs involving speech and voice

240

2130

1.13

1.08

1.4

32.20

30.82

u/l

0.22

186

1749

Previous suicide attempt

1.78

1.08

1.6

1.5

3.79

15.75

u/l

—

Other strabismus

202

1767

1.14

1.08

1.5

1.3

22.43

24.25

u/l

0.33

162

1457

Congenital malformations of heart and great arteries

724

1.22

1.07

1.5

1.4

23.05

20.95

u/l

0.27

614

Other benign neoplasms of connective and other soft tissue

514

1.27

1.07

1.3

1.4

26.15

28.17

u/l

0.19

427

Heart failure and coronary heart disease

596

0.80

1.07

1.4

1.3

31.07

29.51

u/l

0.14

478

Bacterial meningitis

153

1.51

1.06

1.1

1.4

22.24

24.83

u/l

0.18

130

COPD-related respiratory insufficiency

194

1.45

1.06

1.2

1.3

20.17

29.85

u/l

0.98

159

Sequelae of injuries of lower limb

524

1.26

1.06

1.5

1.4

25.05

26.53

u/l

0.13

431

Stroke, excluding SAH

173

1452

0.87

1.06

1.4

1.3

33.54

31.64

u/l

0.28

133

1186

Malignant neoplasm of oropharynx, including Hilmo

2.13

1.05

1.3

32.10

40.07

u/l

—

Fracture of femur

515

1.25

1.05

1.5

1.3

41.33

29.56

u/l

1.24

421

Neovascular glaucoma

122

0.49

1.05

1.7

1.5

17.38

24.67

u/l

—

101

Glaucoma secondary to other eye disorders

124

0.48

1.05

1.7

1.5

17.38

26.19

u/l

—

104

Meningitis

263

1.38

1.03

1.4

20.89

24.57

u/l

0.40

212

Carcinoma in situ of cervix uteri

142

1221

1.17

1.03

1.3

1.4

20.21

20.65

u/l

0.06

109

1023

Pneumocystosis

1.93

1.02

1.3

1.4

40.27

30.16

u/l

—

Placenta praevia

645

1.23

1.02

1.4

24.86

23.00

u/l

0.18

539

Long labour

391

3059

1.10

1.02

1.4

23.25

26.39

u/l

1.18

335

2477

Chondrocostal junction syndrome [Tietze]

213

1.42

1.02

1.4

1.3

18.47

23.18

u/l

0.51

178

Gonarthrosis,primary

582

3324

1.08

1.02

1.4

1.3

35.42

35.93

u/l

0.12

454

2686

ILD medications: azathioprine

116

982

1.18

1.01

1.3

1.4

25.71

23.68

u/l

0.27

811

Bronchitis, not specified as acute or chronic

351

1.31

1.00

1.2

1.3

16.27

24.03

u/l

1.37

291

Suggestive for eosinophilic asthma

360

1.31

1.00

1.4

1.3

23.76

26.96

u/l

0.26

293

Voice disturbances

206

1822

1.13

1.00

1.4

32.91

31.17

u/l

0.26

162

1491

Personal history of certain other diseases

164

1.48

1.00

1.5

1.4

12.00

12.82

u/l

0.07

142

Other demyelinating diseases of the central nervous system

335

1.32

0.99

1.1

1.4

25.72

22.75

u/l

0.30

278

Disorders of iron metabolism

1.82

0.99

1.4

40.26

27.16

u/l

0.43

Pedal cyclist injured in collision with pedestrian or animal

0.00

0.98

0.0

1.6

—

21.82

—

Cerebral aneurysm, nonruptured

406

1.28

0.97

1.4

30.90

33.16

u/l

0.19

329

Intermittent heterotropia

406

1.28

0.97

1.6

1.4

23.05

17.24

u/l

0.56

350

Synovial cyst of popliteal space [Baker]

258

1.36

0.96

1.4

38.28

35.70

u/l

0.16

215

Heart failure and bmi 25plus

642

0.82

0.96

1.3

32.92

28.55

u/l

0.48

503

Vascular disorders of the intestines

108

1.58

0.96

1.4

1.3

41.10

30.57

u/l

0.46

Contact with nonpowered hand tool

157

1.47

0.96

1.3

1.4

16.44

19.10

u/l

0.21

127

Glomerular disorders in diseases classified elsewhere

398

1.28

0.96

1.4

29.71

22.38

u/l

0.62

328

Major anomalies of jaw size

174

1.45

0.95

1.5

1.4

31.19

23.77

u/l

0.44

146

Coagulation defects, purpura and other haemorrhagic conditions

140

1211

1.16

0.95

1.5

1.4

23.91

24.69

u/l

0.10

113

1011

Other disorders of prostate

0.00

0.95

0.0

1.1

—

14.32

—

Acute appendicitis, no complications

558

5173

1.07

0.94

1.4

26.74

25.31

u/l

0.47

457

4253

Congenital malformations of ovaries, fallopian tubes and broad ligaments

688

1.21

0.94

1.4

29.93

24.01

u/l

0.88

577

Urethritis and urethral syndrome

117

1.55

0.94

1.3

1.4

33.95

25.10

u/l

0.45

Complications predominantly related to the puerperium

355

3250

1.09

0.94

1.3

1.4

23.89

24.90

u/l

0.25

284

2682

Alzheimer’s disease, strict definition

203

0.65

0.93

1.3

47.33

39.88

u/l

0.28

159

Molar incisor enamel hypoplasia, with caries

2.23

0.93

3.2

1.4

11.78

5.50

u/l

—

Ischaemic heart disease, wide definition

309

2108

0.91

0.93

1.3

33.75

35.67

u/l

0.45

256

1689

Other and unspecified disorders of white blood cells

175

1.44

0.93

1.5

1.4

33.94

23.23

u/l

0.70

145

Chronic nephritic syndrome

145

0.55

0.93

1.1

1.4

33.76

25.84

u/l

—

118

Fibrosis and cirrhosis of liver

243

1.36

0.92

1.2

1.3

35.31

30.54

u/l

0.22

196

Reactive arthropathies, FINNGEN

374

1.29

0.92

1.4

28.74

23.63

u/l

0.38

303

Communicating hydrocephalus

1.83

0.92

1.8

1.4

30.35

29.92

u/l

—

Complications of the puerperium, not elsewhere classified

576

0.78

0.92

1.4

19.70

23.89

u/l

0.52

492

Alcohol withdrawal state with delirium

167

1.44

0.92

1.4

1.3

24.26

24.88

u/l

0.02

127

Type 1 diabetes, wide definition, subgroup 1

160

1401

1.14

0.91

1.3

1.4

18.12

22.17

u/l

1.09

127

1163

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

331

1.31

0.91

1.3

1.4

27.81

29.03

u/l

0.08

262

Diffuse large B-cell lymphoma, including Hilmo

1.67

0.91

1.2

31.52

30.19

u/l

0.05

Diffuse large B-cell lymphoma, helper endpoint

1.67

0.91

1.2

31.52

30.19

u/l

0.05

Diffuse large B-cell lymphoma

1.67

0.91

1.2

31.52

30.19

u/l

0.05

Mandibular prognathia

1.61

0.91

1.9

1.4

8.89

18.76

u/l

1.79

Other diseases of the respiratory system

527

1.23

0.90

1.3

1.4

23.37

28.98

u/l

0.73

429

Other respiratory disorders and diseases

527

1.23

0.90

1.3

1.4

23.37

28.98

u/l

0.73

429

Melanocytic naevi of other and unspecified parts of face

358

1.29

0.90

1.5

1.4

19.02

25.94

u/l

0.99

299

Other specified transport accidents

2.10

0.90

1.2

1.6

14.88

22.79

u/l

—

Chronic kidney disease

686

1.20

0.90

1.3

1.4

36.84

26.96

u/l

1.14

557

Peptic ulcer

2.08

0.89

1.8

1.3

31.77

19.99

u/l

—

Optic neuritis

350

1.29

0.89

1.3

1.4

24.88

23.43

u/l

0.13

298

Other specified/unspecified deforming dorsopathies

127

1.51

0.89

1.3

1.4

27.39

30.54

u/l

0.17

108

Coronary artery bypass grafting

320

0.74

0.89

1.2

1.3

28.80

23.14

u/l

0.40

254

Other obstructed labour

748

1.20

0.88

1.3

1.4

29.20

29.97

u/l

0.07

612

Paralytic ileus and intestinal obstruction

106

903

1.17

0.88

1.3

32.10

30.51

u/l

0.20

742

All chronic kidney diseases

296

2201

1.10

0.88

1.4

28.34

25.41

u/l

0.68

250

1815

Glaucoma

194

1873

0.89

0.88

1.4

1.3

33.87

34.03

u/l

0.02

152

1523

Fracture at wrist and hand level

235

2112

1.11

0.87

1.4

21.68

24.28

u/l

0.64

186

1742

Childhood asthma (age<16), excluding more controls

151

1042

1.14

0.86

1.2

1.4

12.83

14.47

u/l

0.37

126

912

Crushed, pushed or stepped on by crowd or human stampede

468

1.24

0.86

1.5

1.4

18.64

16.98

u/l

0.17

403

Non-Hodgkin lymphoma, all

1.82

0.86

1.6

1.4

30.68

36.45

u/l

—

Disorders of orbit

221

1.36

0.85

1.4

30.40

28.55

u/l

0.09

182

Actinic keratosis

575

1.21

0.85

1.4

1.3

47.09

35.89

u/l

1.61

465

Cardiodefibrillation

691

0.81

0.85

1.1

1.3

25.63

28.34

u/l

0.23

555

Childhood asthma (age<16)

151

1044

1.14

0.85

1.2

1.4

12.83

14.59

u/l

0.40

126

916

Distal bite

263

1.33

0.85

1.3

1.5

25.94

15.80

u/l

0.91

230

Dementia

478

0.81

0.85

1.3

35.85

33.83

u/l

0.14

395

Otosclerosis

282

1.32

0.85

1.2

1.4

30.64

31.43

u/l

0.07

234

Benign neoplasm: Spinal meninges

1.95

0.84

1.3

1.5

42.10

42.93

u/l

—

Iron deficiency

248

1.34

0.84

1.3

1.4

8.83

17.27

u/l

3.78

219

Respiratory and cardiovascular disorders specific to the perinatal period

101

0.53

0.84

1.2

1.5

5.45

9.98

u/l

—

Granulomatous disorders of skin and subcutaneous tissue

154

1.44

0.84

1.4

24.08

22.83

u/l

0.07

130

Phlebitis and thrombophlebitis (not including DVT)

146

1282

1.14

0.83

1.4

1.3

26.96

29.35

u/l

0.40

121

1044

DVT of lower extremities

743

1.19

0.83

1.4

1.3

25.37

30.39

u/l

0.84

594

COPD, hospital admissions 1, only main diagnosis

619

1.19

0.83

1.2

1.3

28.87

31.06

u/l

0.25

492

Specific development disorders of speech and language

281

1.31

0.83

1.5

1.4

11.66

12.41

u/l

0.08

249

Other viral diseases

408

3752

1.08

0.83

1.4

20.73

22.93

u/l

0.81

334

3108

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

125

976

0.87

0.83

1.4

1.3

39.95

36.13

u/l

0.58

106

714

Other congenital malformations of face and neck

197

1.38

0.82

1.3

1.4

22.34

20.57

u/l

0.10

164

Other specified/unspecified bacterial intestinal infections

266

1.32

0.82

1.2

1.4

26.94

26.45

u/l

0.03

216

Localized adiposity

1.90

0.82

1.7

1.5

10.18

35.96

u/l

—

Primary open-angle glaucoma

581

0.80

0.82

1.3

37.84

35.78

u/l

0.12

472

Short stature, not elsewhere classified

1.59

0.82

1.8

1.2

11.17

9.42

u/l

0.16

Benign neoplasm: Kidney

105

1.53

0.81

1.3

1.4

18.91

32.33

u/l

0.96

Prurigo nodularis

1.61

0.81

1.2

1.4

30.19

29.04

u/l

—

Lesion of plantar nerve

232

1.34

0.81

1.4

33.45

41.49

u/l

0.55

192

Perichondritis of external ear

1.71

0.81

1.5

1.4

20.23

25.66

u/l

—

Fracture of lumbar spine and pelvis

680

1.19

0.81

1.4

30.67

27.05

u/l

0.31

569

Primary coxarthrosis, bilateral

672

1.19

0.80

1.2

1.3

43.08

36.69

u/l

0.70

538

Diabetic nephropathy, excluding more controls

611

0.82

0.80

1.3

1.4

21.26

18.50

u/l

0.25

500

Peripheral arterial reconstruction

232

1.34

0.80

1.4

1.3

33.50

28.24

u/l

0.32

190

Injury of eye and orbit

774

1.18

0.80

1.4

26.83

22.32

u/l

0.62

655

Viral warts

186

1665

1.12

0.80

1.4

20.48

22.73

u/l

0.49

150

1376

Benign neoplasm: Lower jaw bone

0.00

0.80

0.0

1.3

—

25.13

—

Adult respiratory distress syndrome

1.83

0.79

1.5

29.82

30.34

u/l

—

Benign neoplasm: Adrenal gland

268

1.31

0.79

1.3

1.4

25.62

33.31

u/l

0.74

219

Viral warts

638

1.19

0.78

1.6

1.4

17.37

21.91

u/l

0.72

538

Atrial septal defect

189

1.37

0.78

1.5

1.4

21.16

20.18

u/l

0.05

160

Dermatographic urticaria

556

1.21

0.78

1.6

1.4

19.21

24.55

u/l

0.76

479

Syphilis

1.56

0.78

1.5

1.3

29.07

24.00

u/l

—

Syphilis

1.56

0.78

1.5

1.3

29.08

24.00

u/l

—

Other/unspecified disorders of vestibular function

148

1.42

0.78

1.3

1.4

31.84

26.01

u/l

0.33

120

Other general symptoms and signs

319

1.28

0.77

1.5

1.3

28.24

22.40

u/l

0.42

265

Progressive vascular leukoencephalopathy

0.00

0.77

0.0

1.4

—

28.35

—

Carbimazole or st.post thyroidectomy, condition for graves disease

194

1745

1.11

0.77

1.3

1.4

29.49

29.67

u/l

0.03

160

1423

Intestinal stricture

134

1178

1.14

0.77

1.4

32.61

30.89

u/l

0.24

115

957

Non-ischemic cardiomyopathy

602

1.18

0.77

1.3

30.34

31.00

u/l

0.06

484

Blepharospasm

1.78

0.76

1.0

1.4

24.48

33.31

u/l

—

Other disorders of white blood cells

226

1.33

0.76

1.5

1.3

33.89

24.27

u/l

0.61

185

Ischaemic Stroke, excluding all haemorrhages

155

1298

0.89

0.76

1.4

1.3

31.85

31.76

u/l

0.01

120

1058

Congenital malformations of the urinary system

297

1.28

0.75

1.4

17.30

21.60

u/l

0.37

251

Congenital malformations of the circulatory system

101

846

1.16

0.75

1.4

21.55

22.19

u/l

0.08

714

Dementia in other diseases classified elsewhere

1.54

0.75

1.2

1.4

29.46

30.65

u/l

—

Exposure to other and unspecified animate mechanical forces

220

0.68

0.75

1.2

1.4

20.90

20.48

u/l

—

186

Molar incisor enamel hypoplasia

227

1.32

0.74

1.6

1.4

24.75

10.88

u/l

1.20

198

Type 1 diabetes, wide definition

164

1463

1.12

0.74

1.3

1.4

18.49

22.14

u/l

0.93

130

1213

Dislocation, sprain and strain of joints and ligaments of elbow

414

1.24

0.74

1.5

1.4

20.84

22.32

u/l

0.11

351

Maxillary prognathism

1.87

0.74

1.6

1.5

6.66

22.52

u/l

—

Villonodular synovitis (pigmented)

1.86

0.74

1.1

1.3

31.83

30.28

u/l

—

Ulcerative proctitis

406

1.24

0.73

1.2

1.4

22.81

22.57

u/l

0.02

340

Herpesviral [herpes simplex] infections

260

2382

1.09

0.73

1.3

25.20

25.97

u/l

0.14

209

1963

Adverse effects, not elsewhere classified

190

1714

1.11

0.73

1.4

23.05

24.55

u/l

0.26

161

1418

Ptosis of eyelid

343

1.26

0.73

1.4

1.3

19.38

32.90

u/l

2.73

283

Toxic effect of ethanol

237

1.31

0.72

1.5

1.4

18.27

17.06

u/l

0.10

202

Peripheral artery operations in Hilmo

228

1.32

0.72

1.4

40.13

26.25

u/l

0.91

185

Glaucoma suspect

159

1421

1.12

0.72

1.4

1.3

34.24

33.60

u/l

0.08

125

1154

Other congenital malformations of skin

577

0.81

0.71

1.3

1.4

21.57

24.29

u/l

0.24

490

Any dementia, excluding more controls

338

0.79

0.71

1.2

1.3

44.43

34.54

u/l

0.58

281

Otitis media, unspecified

100

799

1.15

0.71

1.5

1.4

11.28

16.26

u/l

2.15

697

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

115

977

1.14

0.70

1.4

20.51

21.41

u/l

0.12

821

Sleep disorders, other/unspecified

256

1.30

0.70

1.6

1.3

32.00

21.23

u/l

0.82

219

Acute tubulo-interstitial nephritis

499

4047

1.06

0.70

1.4

25.35

25.61

u/l

0.06

412

3324

Azathioprine

116

1019

1.14

0.70

1.3

1.4

25.71

23.44

u/l

0.31

839

Mental and behavioural disorders due to use of other stimulants, including caffeine

195

1.34

0.70

1.3

1.4

15.71

14.20

u/l

0.12

168

Contact with other sharp object(s)

436

1.22

0.69

1.5

1.4

15.19

19.47

u/l

0.55

369

Dislocation, sprain and strain of joints and ligaments of knee

584

5086

1.06

0.69

1.3

1.4

22.42

25.29

u/l

1.61

479

4200

Complications of genitourinary prosthetic devices, implants and grafts

118

1.45

0.69

1.1

1.4

28.71

26.30

u/l

0.10

101

Disorders of lens

297

2009

0.92

0.69

1.4

1.3

35.17

36.29

u/l

0.19

234

1606

Burns and corrosions confined to eye and internal organs

161

1.37

0.68

1.7

1.3

20.39

23.08

u/l

0.16

136

Aphakia

1.86

0.68

1.0

1.6

14.38

19.05

u/l

—

Primary gonarthrosis, bilateral

206

1603

1.10

0.68

1.4

1.3

36.02

38.55

u/l

0.46

165

1293

Malignant neoplasm of colon

257

1.29

0.68

1.3

32.71

34.85

u/l

0.12

182

Hypertensive Heart Disease

334

1.22

0.68

1.4

1.3

34.83

31.05

u/l

0.28

275

Other renal tubulo-interstitial diseases

170

1.36

0.68

1.2

1.4

25.94

25.66

u/l

0.01

135

Dementia, including avohilmo

523

0.84

0.67

1.3

33.86

33.71

u/l

0.01

432

Striae atrophicae

0.53

0.67

1.2

1.5

9.26

22.32

u/l

—

Endocrine disorders, other/unspecified

0.55

0.67

1.4

13.56

26.33

u/l

—

Congenital deformities of feet

162

1.37

0.66

1.5

1.4

21.31

19.78

u/l

0.09

141

Traumatic subdural haemorrhage

180

1.33

0.66

1.5

1.3

15.72

30.55

u/l

2.63

155

Kyphosis

1.79

0.66

1.8

1.5

28.10

27.76

u/l

—

Skin changes due to chronic exposure to nonionizing radiation

650

1.16

0.66

1.4

1.3

44.43

35.36

u/l

1.27

522

Pedestrian injured in transport accident

312

1.25

0.66

1.2

1.3

17.45

23.71

u/l

0.71

255

Multiple gestation

157

1413

1.12

0.66

1.3

1.4

30.51

27.72

u/l

0.43

136

1156

Pilonidal cyst

558

1.19

0.66

1.3

1.4

18.24

19.48

u/l

0.15

470

Discitis, unspecified

1.79

0.66

1.2

1.5

51.82

25.56

u/l

—

100

800

1.15

0.66

1.3

45.58

34.36

u/l

1.99

645

Other acute skin changes due to ultraviolet radiation

128

1.41

0.65

1.2

1.4

42.76

26.34

u/l

0.75

103

Abnormal blood-pressure reading, without diagnosis

206

1.32

0.65

1.3

1.4

25.77

26.28

u/l

0.02

170

Twin gestation

152

1367

1.12

0.65

1.3

1.4

29.85

27.73

u/l

0.30

132

1122

Secondary polycythaemia

1.58

0.65

1.1

1.4

11.16

26.14

u/l

1.68

Viral pneumonia

541

1.18

0.64

1.2

1.4

26.55

23.71

u/l

0.29

453

Hereditary ataxia

1.73

0.64

1.0

1.5

49.18

25.02

u/l

—

Malignant neoplasm of prostate

138

1.30

0.64

1.6

1.2

9.44

12.06

u/l

0.48

Myelodysplastic syndrome, including Hilmo

1.73

0.64

1.0

1.2

30.88

25.67

u/l

—

Inguinal hernia

252

1828

0.92

0.63

1.4

23.05

22.16

u/l

0.18

203

1536

Atrial fibrillation and flutter

144

1041

0.90

0.63

1.3

31.66

35.31

u/l

0.56

119

829

Hydrocephalus

181

1.33

0.63

2.2

1.3

20.09

27.44

u/l

0.68

150

Allergic conjunctivitis

565

5799

0.95

0.62

1.4

1.3

23.18

26.39

u/l

1.68

459

4793

Other disorders of the musculoskeletal system and connective tissue

636

1.17

0.62

1.5

1.3

33.29

30.83

u/l

0.25

512

Bronchiectasis

173

1.33

0.61

1.3

25.09

35.99

u/l

0.53

143

Other and unspecified disorders of psychological development

1.61

0.61

1.3

1.5

6.73

11.89

u/l

—

Idiopathic gout

147

1.36

0.61

1.2

1.3

14.48

24.42

u/l

0.80

117

Focal brain injury

147

1.36

0.61

1.5

1.4

11.41

24.77

u/l

2.05

124

Injury of muscle and tendon at hip and thigh level

508

1.18

0.61

1.5

1.4

24.72

28.35

u/l

0.38

409

Anomalies of pupillary function

139

1.38

0.61

1.4

17.90

21.78

u/l

0.27

120

Synovial hypertrophy, not elsewhere classified

1.58

0.61

1.1

1.4

20.46

24.44

u/l

—

Eustachian salpingitis and obstruction

722

1.15

0.60

1.3

1.4

17.54

21.43

u/l

0.75

610

Tibial collateral bursitis [Pellegrini-Stieda]

1.58

0.60

1.1

1.5

51.45

34.22

u/l

—

Calcaneal spur

1.58

0.60

1.1

1.4

15.84

32.73

u/l

—

Delivery

360

1775

1.07

0.60

1.4

22.24

24.75

u/l

0.75

311

1466

Endovascular or surgical operations to intracerebral aneurysms

218

1.29

0.60

1.5

1.4

30.62

33.42

u/l

0.18

179

Atrophic disorders of skin

100

882

1.14

0.60

1.4

1.3

26.57

31.18

u/l

0.87

716

Budesonide

109

967

1.13

0.60

1.3

1.4

24.96

25.11

u/l

0.02

799

Malignant neoplasm of rectum, including Hilmo

218

1.29

0.59

1.5

1.3

45.46

34.29

u/l

0.62

145

Whooping cough

1.46

0.59

1.6

1.5

27.74

17.46

u/l

—

severe traumatic brain injury, does not include concussion

583

1.17

0.59

1.5

1.4

11.56

25.32

u/l

7.76

476

230

1.27

0.59

1.2

1.3

41.50

40.33

u/l

0.07

183

Superficial injuries involving multiple body regions

157

1.34

0.59

1.4

26.06

18.75

u/l

0.48

134

Foreign body in ear

114

1.41

0.59

1.1

1.4

8.59

19.05

u/l

—

Mental disorders, not otherwise specified

682

0.85

0.59

1.3

1.4

30.01

22.61

u/l

0.72

582

Benign neoplasm: Skin of trunk

210

1.29

0.59

1.4

26.50

25.83

u/l

0.03

173

Sub-endpoint used in defining T1D endpoints

192

1729

1.09

0.59

1.4

18.76

21.74

u/l

0.80

152

1432

Use of anticholinesterases

298

0.79

0.58

1.4

1.3

32.05

37.21

u/l

0.35

239

N06DA Anticholinesterases

298

0.79

0.58

1.4

1.3

32.05

37.21

u/l

0.35

239

Congenital malformations of eye, ear, face and neck

455

1.19

0.58

1.3

1.4

17.88

18.73

u/l

0.08

390

Seropositive rheumatoid arthritis, wide

123

1372

0.90

0.58

1.4

1.3

30.82

32.17

u/l

0.16

1125

Mental and behavioural disorders due to cannabinoids

175

1.32

0.58

1.3

1.4

10.02

11.95

u/l

0.24

149

All kidney diseases

843

6003

0.96

0.58

1.4

1.3

26.57

25.10

u/l

0.63

696

4963

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

802

4627

1.04

0.58

1.4

1.3

23.80

30.09

u/l

7.33

637

3815

Other diseases of pericardium

123

1.39

0.58

1.8

1.3

36.90

26.93

u/l

0.55

Seropositive rheumatoid arthritis, strict definition

809

0.86

0.57

1.4

34.30

31.00

u/l

0.26

656

Other specified and unspecified disorders of conjunctiva

1.68

0.57

1.2

1.6

7.35

24.96

u/l

—

Speech disturbances, not elsewhere classified

292

1.24

0.56

1.5

1.3

22.98

25.77

u/l

0.17

238

Thoracic aortic aneurysm

301

1.23

0.56

1.2

1.4

32.24

23.34

u/l

0.71

247

Mixed conductive and sensorineural hearing loss

402

1.20

0.56

1.4

1.3

23.79

30.13

u/l

0.79

330

ILD, hospital admissions

341

0.79

0.55

1.2

1.4

27.93

31.35

u/l

0.30

276

Carcinoma in situ of skin of trunk

1.62

0.55

1.7

1.4

43.32

24.37

u/l

—

Acute peritonitis

203

1.28

0.55

1.3

1.4

31.73

24.06

u/l

0.38

169

Other/unspecified seropositive rheumatoid arthritis

122

1356

0.90

0.55

1.4

1.3

30.94

32.19

u/l

0.14

1114

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

541

5522

0.95

0.55

1.4

1.3

23.37

26.36

u/l

1.44

438

4566

Follicular lymphoma, hilmo

1.45

0.55

1.4

1.2

37.92

36.51

u/l

0.05

Major coronary heart disease event excluding revascularizations

169

1233

0.91

0.55

1.3

1.4

35.97

33.40

u/l

0.40

139

987

Pyoderma gangrenosum

1.59

0.54

2.2

1.4

20.58

23.45

u/l

—

Septal defects

332

1.21

0.54

1.6

1.4

18.19

19.66

u/l

0.13

285

Congenital malformations of cardiac septa

346

1.21

0.54

1.5

1.4

17.53

19.37

u/l

0.17

296

Mandibular retrognathia AND surgery (BSSO)

222

1.27

0.54

1.4

14.65

23.86

u/l

1.51

187

Sulfonylureas

453

1.16

0.54

1.3

22.73

34.72

u/l

2.74

363

Aortic aneurysm

405

1.19

0.53

1.2

1.4

28.22

22.45

u/l

0.53

326

L04AA Selective immunosuppressants

168

1538

1.09

0.53

1.3

1.4

31.20

27.35

u/l

0.75

140

1268

Myotonic disorders

1.55

0.53

1.3

1.4

29.48

25.15

u/l

—

Psoriatic arthropathies

516

1.16

0.53

1.2

1.4

23.52

31.93

u/l

1.60

432

Maternal care for known or suspected abnormality of pelvic organs

446

2878

1.06

0.53

1.4

22.22

26.77

u/l

2.38

381

2375

Generalized epilepsy

277

1.23

0.52

1.4

1.3

15.20

19.52

u/l

0.48

240

Rheumatoid arthritis, including avohilmo

208

2247

0.92

0.52

1.4

31.64

31.50

u/l

0.02

168

1829

Other and unspecified hydrocephalus

1.43

0.52

3.3

1.4

9.37

30.01

u/l

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

120

1050

1.11

0.52

1.4

20.35

21.83

u/l

0.22

100

879

Fracture of forearm

364

3531

0.94

0.52

1.3

1.4

28.12

28.74

u/l

0.13

283

2921

Other and/or unspecified nontoxic goitre

351

1.20

0.51

1.3

34.56

35.24

u/l

0.05

287

Meniscus derangement

374

2378

1.06

0.51

1.3

32.03

31.73

u/l

0.06

307

1959

Other cataract

190

1326

1.08

0.50

1.4

1.3

34.00

35.04

u/l

0.16

152

1069

Cerebrovascular diseases (FINNGEN)

203

1551

0.92

0.50

1.4

31.41

33.51

u/l

0.35

157

1251

Other malignant neoplasms of skin (=non-melanoma skin cancer)

112

853

0.90

0.50

1.4

1.3

40.67

36.82

u/l

0.55

621

Other degenerative diseases of the nervous system

124

837

1.11

0.50

1.3

29.52

29.09

u/l

0.04

699

Other diseases of intestine

472

1.17

0.50

1.3

27.82

30.95

u/l

0.25

390

Oral lichen planus

101

1.39

0.49

1.6

1.3

37.59

33.70

u/l

0.17

Myeloproliferative diseases

243

1.24

0.49

1.1

1.4

25.26

28.90

u/l

0.27

197

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

122

1343

0.91

0.48

1.4

1.3

30.94

32.25

u/l

0.15

1102

Defects in the complement system

1.50

0.48

1.4

29.74

21.87

u/l

—

Percutaneous Coronary Intervention

443

2580

1.05

0.48

1.4

1.3

32.67

35.81

u/l

1.10

361

2058

Single spontaneous delivery

353

1765

1.06

0.47

1.4

24.76

24.88

u/l

0.02

296

1456

Congenital malformations of the urinary system

281

1.21

0.47

1.4

18.89

20.14

u/l

0.08

237

Chondropathies

118

1071

1.10

0.47

1.3

23.11

23.87

u/l

0.10

881

Varus deformity, not elsewhere classified

1.47

0.47

1.6

1.5

35.10

25.37

u/l

—

Presence of cardiac and vascular implants and grafts

112

752

1.11

0.47

1.2

1.4

28.38

27.33

u/l

0.10

616

Other coagulation defects

504

1.15

0.46

1.6

1.4

17.41

23.43

u/l

0.87

425

Abnormal serum enzyme levels

794

1.12

0.46

1.4

27.89

22.05

u/l

0.80

654

Other puerperal infections

126

1150

1.10

0.46

1.3

1.4

16.03

18.32

u/l

0.44

975

Hard cardiovascular diseases

533

3322

0.96

0.46

1.4

1.3

32.67

34.17

u/l

0.45

431

2676

Interstitial lung disease endpoints

342

0.82

0.45

1.2

1.4

27.59

31.26

u/l

0.34

277

Interstitial lung disease

342

0.82

0.45

1.2

1.4

27.59

31.26

u/l

0.34

277

Degenerative macular diseases

264

1.21

0.45

1.4

1.3

25.90

33.91

u/l

0.57

215

Other congenital malformations

684

1.13

0.45

1.4

22.91

21.94

u/l

0.10

585

Peripheral artery disease

100

717

1.11

0.45

1.4

1.3

32.86

29.41

u/l

0.43

568

Poisoning by medicine, drug-induced

1.41

0.45

2.0

1.4

17.42

24.98

u/l

0.63

Other osteochondropathies

394

1.17

0.45

1.2

1.4

25.77

22.58

u/l

0.26

324

Contact with sharp object, undetermined intent

112

1.34

0.45

1.2

1.4

34.44

18.44

u/l

0.68

Other interstitial pulmonary diseases

341

0.82

0.44

1.2

1.4

27.59

31.05

u/l

0.32

276

Injuries to unspecified part of trunk, limb or body region

478

1.15

0.44

1.4

24.51

22.20

u/l

0.25

398

Other condition

875

1.11

0.44

1.4

19.77

24.07

u/l

0.73

730

Ankle and foot

1.38

0.44

1.3

1.5

46.26

23.63

u/l

—

Glomerular diseases

752

1.12

0.44

1.4

29.50

24.26

u/l

0.59

630

Open wound of lower leg

743

1.12

0.43

1.4

22.45

22.98

u/l

0.05

634

Congenital ovarian cysts

536

1.14

0.43

1.3

1.4

28.59

23.69

u/l

0.53

457

Hallux valgus (acquired)

245

1653

1.07

0.43

1.4

1.3

38.26

36.68

u/l

0.27

188

1360

Congenital hypothyroidism without goiter

1.63

0.43

1.8

1.5

7.62

20.47

u/l

—

Unspecified lump in breast

110

1206

0.91

0.42

1.2

1.4

33.89

32.73

u/l

0.13

994

Melanoma in situ of lower limb, including hip

1.57

0.42

1.6

1.5

51.16

43.30

u/l

—

Other benign neoplasm of uterus: Corpus uteri

1.57

0.42

1.0

1.7

38.08

37.43

u/l

—

Malignant neoplasm of endocrine gland

350

1.17

0.42

1.7

1.4

33.63

28.41

u/l

0.38

265

Other disorders of eyelid

196

1742

1.07

0.42

1.4

1.3

29.09

36.18

u/l

2.35

157

1419

Organic, including symptomatic, mental disorders

131

855

1.09

0.42

1.4

1.3

27.93

30.16

u/l

0.34

103

697

Intrahepatic Cholestasis of Pregnancy (ICP)

110

1004

1.10

0.42

1.4

25.14

24.08

u/l

0.12

839

Myocardial infarction

121

929

0.92

0.41

1.2

1.3

39.14

30.96

u/l

1.57

100

745

Nonspecific lymphadenitis

435

1.15

0.41

1.4

29.96

28.98

u/l

0.08

353

Coronary revascularization (ANGIO or CABG)

442

2585

1.05

0.41

1.4

1.3

32.68

35.78

u/l

1.07

360

2063

Other diseases of oesophagus

286

1.19

0.41

1.3

1.4

21.74

28.19

u/l

0.42

235

Nonhereditary hypogammaglobulinemia

1.36

0.41

1.4

1.5

35.40

24.54

u/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

113

1034

1.10

0.41

1.4

27.05

25.06

u/l

0.25

864

Faecal incontinence

342

1.17

0.40

1.4

28.81

36.09

u/l

0.48

277

Gonarthrosis, primary, with knee surgery

211

1574

1.07

0.40

1.3

38.77

39.36

u/l

0.08

159

1257

Impetigo

296

1.19

0.40

1.5

1.4

15.86

19.68

u/l

0.40

246

Hypoplasia of dental enamel

1.47

0.40

2.2

1.5

12.08

6.24

u/l

—

Neurofibromatosis, type 1

1.44

0.39

1.0

1.3

7.66

22.90

u/l

—

Diseases caused by chlamydiae

169

1.25

0.39

1.6

1.4

31.76

28.08

u/l

0.18

142

Benign neoplasm: Skin, unspecified

187

1.23

0.39

1.4

28.01

27.41

u/l

0.03

150

Other salmonella infections

160

1.25

0.38

1.1

1.3

54.72

26.58

u/l

1.57

130

Parkinson's disease

242

1.20

0.38

1.2

1.3

34.17

32.95

u/l

0.07

196

Ulcerative colitis

186

1742

1.07

0.38

1.3

1.4

25.36

24.29

u/l

0.19

154

1447

Rheumatic valve diseases

1.39

0.38

1.6

32.08

31.04

u/l

—

Other specified and unspecified strabismus

1.35

0.38

1.4

1.5

15.92

20.07

u/l

—

Maternal care for cervical incompetence

280

1.18

0.37

1.5

1.4

22.00

21.89

u/l

0.01

237

Varicose veins of other sites

197

1.22

0.37

1.4

1.3

33.34

24.12

u/l

0.43

160

Other hammer toe(s) (acquired)

483

1.13

0.37

1.3

1.4

40.04

43.32

u/l

0.30

402

Cleft lip, lip and palate or palate

115

0.69

0.37

1.1

1.5

12.87

17.73

u/l

—

Other superficial mycoses

125

1.29

0.37

1.2

1.4

13.11

22.11

u/l

—

104

Herpesviral [herpes simplex] infections

791

1.10

0.37

1.4

22.55

26.23

u/l

0.64

657

Pedal cyclist injured in noncollision transport accidents

696

1.11

0.36

1.5

1.4

17.09

23.72

u/l

1.12

578

Other viral diseases, not elsewhere classified

153

1423

1.07

0.36

1.5

1.4

22.63

22.86

u/l

0.03

126

1178

Use of levodopa decarboxylase inhibitor

207

1.21

0.36

1.2

1.3

27.30

32.77

u/l

0.50

169

Congenital malformations of pulmonary and tricuspid valves

1.44

0.36

2.0

1.5

12.40

15.00

u/l

—

Diabetic retinopathy, strict definition

888

0.91

0.35

1.3

1.4

21.04

18.75

u/l

0.25

738

Congenital malformations of eyelid, lacrimal apparatus and orbit

1.44

0.35

1.3

1.5

22.80

14.50

u/l

—

Protozoal diseases

1.32

0.35

1.3

41.47

29.09

u/l

0.66

Rheumatoid arthritis

174

1663

0.94

0.35

1.4

1.3

32.10

32.38

u/l

0.03

137

1369

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

119

1285

0.93

0.35

1.3

1.4

25.89

23.63

u/l

0.34

101

1060

Benign neoplasm: Other and unspecified parts of small intestine

1.40

0.35

1.7

1.5

6.27

38.63

u/l

—

Other disorders of kidney and ureter

423

1.14

0.35

1.4

20.78

29.08

u/l

1.10

346

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

106

1149

0.92

0.34

1.3

25.89

22.68

u/l

0.49

953

Other diseases caused by chlamydiae

172

1.23

0.34

1.6

1.4

31.76

27.78

u/l

0.20

144

Other appendicitis

499

1.12

0.34

1.4

28.04

26.94

u/l

0.10

421

Malignant neoplasm of thyroid gland

320

1.16

0.34

1.7

1.4

32.41

28.37

u/l

0.25

241

Melanocytic naevi of eyelid, including canthus

1.34

0.34

1.0

1.4

37.42

30.29

u/l

—

Glucosamine medication

111

958

0.92

0.34

1.3

39.95

41.13

u/l

0.13

778

Ulcerative colitis (strict definition, all Crohn cases excluded)

1002

0.92

0.34

1.3

1.4

24.35

22.81

u/l

0.18

837

Coxarthrosis, primary, with hip surgery

139

1213

1.07

0.33

1.2

1.3

38.22

38.16

u/l

0.01

110

979

Benign neoplasm of bone and articular cartilage

529

1.12

0.33

1.5

1.4

28.06

25.54

u/l

0.21

440

Helminthiases

0.69

0.33

1.3

1.5

22.77

22.91

u/l

—

Congenital malformations of eyelid, lacrimal apparatus and orbit

1.31

0.33

1.3

1.5

22.80

13.63

u/l

—

Secondary thrombocytopenia

1.31

0.33

1.3

1.5

67.47

29.27

u/l

—

Renal tubulo-interstitial diseases

680

5216

0.97

0.33

1.4

27.04

25.36

u/l

0.63

563

4289

Single delivery by forceps and vacuum extractor

248

1420

1.05

0.32

1.3

1.4

19.91

22.28

u/l

0.70

215

1168

Myocardial infarction, strict

106

816

0.92

0.32

1.2

1.3

38.79

29.86

u/l

1.68

649

Coxarthrosis, primary

216

1733

1.06

0.32

1.3

36.63

37.90

u/l

0.19

169

1389

313

1.14

0.32

1.3

36.99

40.11

u/l

0.23

255

Malignant neoplasm of thyroid gland, including Hilmo

379

1.14

0.32

1.6

1.4

30.77

28.37

u/l

0.15

290

Cardiomyopathy

476

0.88

0.32

1.4

1.3

22.64

27.08

u/l

0.48

383

ILD, hospital admissions 1, main diag only

295

0.85

0.32

1.2

1.4

25.27

31.25

u/l

0.59

238

Diseases of arteries, arterioles and capillaries

253

1961

0.95

0.31

1.3

29.83

29.68

u/l

0.02

212

1601

Scissor bite

163

1.22

0.31

1.3

1.5

30.88

13.84

u/l

0.89

141

Poor fetal growth

211

2003

1.06

0.31

1.3

1.4

17.52

20.92

u/l

1.16

179

1668

Sequelae of cerebrovascular disease

101

805

1.08

0.31

1.4

1.3

37.61

31.33

u/l

0.90

643

D07AA Corticosteroids, weak (group I)

137

1281

1.07

0.31

1.4

1.3

21.09

21.17

u/l

0.01

122

1080

Hypertensive heart and/or renal disease

382

1.11

0.31

1.3

33.60

31.07

u/l

0.19

314

Heart failure, strict

134

1010

0.94

0.31

1.3

31.09

30.24

u/l

0.10

108

819

Other salmonella infections

212

1.18

0.30

1.1

1.3

46.45

24.46

u/l

1.31

175

Aneurysms, operations, SAH

667

1.10

0.30

1.3

35.00

33.41

u/l

0.14

540

Tic and related disorders

1.28

0.30

1.0

1.3

26.96

12.88

u/l

—

Other congenital malformations of female genitalia

106

0.75

0.29

3.0

1.4

11.43

16.05

u/l

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

854

5680

1.03

0.29

1.3

1.4

25.30

25.74

u/l

0.16

704

4688

All-cause Heart Failure

132

993

0.94

0.29

1.3

31.59

30.23

u/l

0.17

106

805

Sequelae of injuries of upper limb

478

1.11

0.28

1.3

1.4

28.88

27.23

u/l

0.12

394

Parkinson's disease, including avohilmo

260

1.15

0.28

1.2

1.3

34.17

33.99

u/l

0.01

212

Other fall from one level to another

141

1328

1.06

0.28

1.4

1.3

18.97

19.68

u/l

0.11

118

1119

Gout, strict definition

280

1.14

0.27

1.1

1.4

19.97

24.43

u/l

0.34

227

Emergency coronary revascularization (for ACS)

449

2641

1.03

0.27

1.4

1.3

32.76

35.66

u/l

0.99

366

2104

Alzheimer disease, excluding more controls

128

0.82

0.27

1.3

51.55

38.62

u/l

—

118

Benign neoplasm of major salivary glands

357

1.12

0.26

1.2

1.4

18.72

29.73

u/l

1.72

290

Tic disorders

0.70

0.26

1.0

1.4

18.30

16.64

u/l

—

Other and unspecified haemorrhagic conditions

0.68

0.26

1.6

1.5

9.30

24.46

u/l

—

Use of ropinirole

1.30

0.26

1.2

1.4

43.68

35.58

u/l

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

107

1003

1.07

0.26

1.6

1.4

30.81

28.43

u/l

0.27

827

Bullous disorders

197

1.17

0.25

1.6

1.3

29.61

26.96

u/l

0.12

160

Other respiratory diseases principally affecting the interstitium

425

0.89

0.25

1.2

1.4

34.68

30.82

u/l

0.30

348

Fall on same level involving ice and snow

413

4003

1.03

0.25

1.4

1.3

25.50

28.37

u/l

1.01

339

3271

Ulcerative colitis (strict definition, require KELA)

111

1181

0.94

0.25

1.3

25.38

22.94

u/l

0.36

980

L04AX Other immunosuppressants

446

4328

1.03

0.25

1.3

1.4

27.93

28.03

u/l

0.02

371

3540

Adjustment and management of implanted device

361

0.89

0.24

1.5

1.3

27.68

27.58

u/l

0.00

285

Diseases of arteries, arterioles and capillaries (FINNGEN)

660

0.93

0.24

1.3

1.4

31.89

32.75

u/l

0.08

536

Transient ischemic attack

186

1437

1.05

0.24

1.4

1.3

33.72

33.17

u/l

0.08

148

1162

Bleeding

476

3291

1.03

0.23

1.4

26.29

29.26

u/l

1.21

388

2694

Sacrococcygeal disorders, not elsewhere classified

199

1.16

0.23

1.1

1.4

18.57

27.08

u/l

0.77

165

Osteomalacia

1.32

0.23

1.4

1.5

56.58

19.31

u/l

—

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

1.32

0.23

1.0

1.2

56.74

38.22

u/l

—

Childhood allergy (age < 16)

158

1240

1.05

0.23

1.3

1.4

7.21

7.69

u/l

0.22

133

1091

Ectropion of eyelid

1.32

0.23

1.4

1.3

19.24

21.88

u/l

—

Nontraumatic intracranial haemmorrhage

526

0.91

0.23

1.1

1.4

43.55

32.54

u/l

1.19

422

Sensorineural hearing loss

395

2601

1.03

0.23

1.3

30.97

33.30

u/l

0.64

318

2101

Other viral diseases, not elsewhere classified

257

2465

1.04

0.22

1.4

21.05

23.62

u/l

0.74

212

2054

Benign neoplasm: Parotid gland

295

1.12

0.22

1.2

1.4

20.07

28.89

u/l

1.08

240

Injury of muscle and tendon at lower leg level

690

1.07

0.22

1.3

1.4

23.69

24.66

u/l

0.10

571

Transient global amnesia

210

1.14

0.21

1.3

25.52

41.59

u/l

1.09

167

Other metabolic disorders

112

1060

1.06

0.21

1.6

1.4

29.94

28.49

u/l

0.15

878

Congenital absence of the vagina

0.00

0.21

0.0

1.5

—

17.72

—

Hypersensitivity angiitis

0.00

0.21

0.0

1.7

—

25.39

—

Surgical ablation of atrial fibrillation

0.00

0.21

0.0

1.4

—

18.36

—

Accidental poisoning by and exposure to pesticides

0.00

0.21

0.0

1.9

—

22.84

—

Other benign neoplasm of uterus: Cervix uteri

1.17

0.21

2.0

1.6

19.72

32.70

u/l

—

Benign neoplasm: salivary glands, exclude unknown (D119)

325

1.11

0.21

1.2

1.4

19.46

29.98

u/l

1.46

263

Injury of muscle and tendon at forearm level

1.25

0.20

1.4

10.71

22.47

u/l

—

Other/unspecified enthesopathies, not elsewhere classified

364

1.10

0.20

1.3

1.4

28.71

33.49

u/l

0.34

305

Insulin, fast-acting (human)

107

1014

1.06

0.20

1.3

1.4

18.03

20.88

u/l

0.46

852

Normal-pressure hydrocephalus

1.25

0.20

1.7

1.3

18.95

34.12

u/l

—

Basal cell carcinoma, including avohilmo

124

898

0.95

0.20

1.4

1.3

38.04

36.89

u/l

0.13

105

657

Hyperprolactinaemia, drug-induced

1.21

0.20

2.0

1.5

18.75

33.11

u/l

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

1.23

0.19

1.4

1.5

21.86

23.09

u/l

0.05

Chronic hepatitis NAS

1.16

0.19

1.3

1.6

24.28

27.68

u/l

—

Colectomy operation

520

1.08

0.19

1.3

1.4

32.97

29.55

u/l

0.29

427

Other disorders of ear

675

4504

0.98

0.18

1.3

1.4

29.49

29.46

u/l

0.01

549

3678

Disorders in reading

109

1.20

0.18

1.5

1.4

14.45

12.41

u/l

0.10

Tooth eruption problems

141

1435

0.96

0.18

1.3

1.4

12.15

13.65

u/l

0.45

127

1249

Benign mammary dysplasia

807

0.94

0.18

1.4

1.3

31.13

34.08

u/l

0.30

650

Other retinal disorders

270

2168

0.97

0.18

1.4

1.3

27.01

28.73

u/l

0.33

208

1783

Abscess of Bartholin gland

261

1.11

0.18

1.6

1.4

15.85

22.57

u/l

0.95

224

Accidental poisoning by and exposure to alcohol

100

1.20

0.18

1.6

1.5

28.64

14.88

u/l

0.98

Arthropathic psoriasis

609

1.07

0.18

1.2

1.4

24.63

29.74

u/l

0.80

495

Pneumonias (Asthma/COPD co-morbidities)

883

5831

1.02

0.18

1.3

1.4

25.20

25.56

u/l

0.12

726

4814

Other congenital malformations

103

1081

0.95

0.17

1.4

20.94

22.73

u/l

0.24

911

Psoriatic arthropathies, ICD10

561

1.07

0.17

1.2

1.4

23.52

29.36

u/l

0.95

456

Periodontal disease, other/unspecified

119

1.18

0.17

1.5

1.4

30.38

27.01

u/l

0.14

104

Other (seronegative) rheumatoid arthritis, wide

912

1.05

0.17

1.3

36.40

31.46

u/l

0.60

741

Second line medication for Crohn's disease

462

4519

1.02

0.17

1.3

1.4

27.57

27.45

u/l

0.02

384

3706

Seropositive rheumatoid arthritis

123

1280

0.96

0.17

1.4

1.3

30.82

32.77

u/l

0.24

1059

Psoriatic and enteropathic arthropathies

659

1.06

0.17

1.2

1.3

23.08

27.84

u/l

0.81

536

Myocardial infarction, without ST-elevation

680

1.06

0.17

1.3

39.13

29.80

u/l

1.33

544

Iridocyclitis in diseases classified elsewhere

1.22

0.17

1.2

1.4

20.25

24.12

u/l

—

Delirium, not induced by alcohol and other psychoactive substances

214

1.12

0.17

1.5

1.3

19.06

28.48

u/l

1.40

174

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

795

5007

1.02

0.17

1.4

1.3

30.31

28.37

u/l

0.83

644

4100

Caries in Clefts patients

0.71

0.17

1.0

1.5

17.82

16.34

u/l

—

Ischemic heart diseases

486

2979

0.98

0.16

1.4

32.37

35.16

u/l

1.01

396

2395

Overexertion and strenuous or repetitive movements

536

0.93

0.16

1.4

21.38

25.20

u/l

0.45

445

Disorders of eyelid in diseases classified elsewhere

177

1.13

0.16

1.2

1.4

37.74

24.37

u/l

0.86

144

IBD patients in KELA-register

184

1780

1.03

0.16

1.4

23.69

22.85

u/l

0.14

156

1482

Pre-eclampsia or poor fetal growth

452

4413

1.02

0.16

1.3

1.4

21.42

25.26

u/l

2.11

380

3635

Hernia

733

4832

1.02

0.16

1.4

1.3

28.43

27.99

u/l

0.13

592

3965

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

1.11

0.16

2.3

1.4

10.53

18.82

u/l

—

Ulcerative colitis, NAS

100

955

1.05

0.16

1.3

24.69

23.60

u/l

0.14

796

Metabolic disorders

756

4684

0.98

0.15

1.4

1.3

28.97

29.27

u/l

0.08

610

3843

Gestational [pregnancy-induced] hypertension

374

3813

0.98

0.15

1.3

1.4

20.75

24.92

u/l

2.09

321

3126

Exclusion endpoint for supernumerary teeth

1.13

0.15

1.2

1.5

11.34

15.86

u/l

—

Injuries to the shoulder and upper arm

570

4512

1.02

0.15

1.3

1.4

25.21

27.41

u/l

0.83

456

3716

Other disorders of veins

302

2932

1.02

0.15

1.4

30.04

33.14

u/l

0.84

233

2370

Melanocytic naevi of lower limb, including hip

265

1.10

0.14

1.9

1.4

34.06

24.58

u/l

0.57

218

Other obstetric conditions, not elsewhere classified

638

4123

0.98

0.14

1.4

16.21

22.38

u/l

7.49

553

3417

Parkinson's disease, strict definition

217

1.11

0.14

1.2

1.3

36.11

31.95

u/l

0.27

175

Other psoriatic arthropathies

547

1.06

0.14

1.2

1.4

22.60

29.60

u/l

1.20

445

Systemic atrophies primarily affecting the central nervous system

112

1.16

0.14

1.1

1.4

28.05

29.88

u/l

0.07

Retinal detachments and breaks

133

1283

1.04

0.14

1.4

1.3

40.39

33.00

u/l

1.26

100

1035

Intracerebral haemorrhage

233

0.90

0.14

1.1

1.3

47.17

28.09

u/l

1.20

186

Ulcerative enterocolitis

199

1.11

0.13

1.1

1.4

21.31

21.36

u/l

0.00

163

Other diseases of biliary tract

228

1.10

0.13

1.4

1.3

26.84

31.49

u/l

0.30

187

Dysplastic lesion of unknown severity of the cervix uteri

107

0.84

0.13

1.0

1.5

17.28

24.20

u/l

—

Coxarthrosis

237

1526

1.03

0.13

1.3

33.64

36.70

u/l

0.64

186

1246

Fracture of shoulder and upper arm

162

1667

0.97

0.13

1.3

1.4

24.92

27.00

u/l

0.31

126

1381

Unspecified abortion

540

1.06

0.13

1.5

1.4

33.93

36.72

u/l

0.26

436

Blepharochalasis

113

1090

1.04

0.12

1.4

1.3

33.00

39.19

u/l

1.13

885

Diabetes, insulin treatment (Kela reimbursement)

811

4837

1.01

0.12

1.4

1.3

23.86

29.76

u/l

6.63

645

3982

Acute renal failure

531

1.05

0.12

1.5

1.4

27.75

28.18

u/l

0.03

439

Pacemaker

585

0.95

0.12

1.4

1.3

30.44

29.32

u/l

0.07

478

Mandibular retrognathia

520

1.06

0.12

1.5

1.4

21.92

21.67

u/l

0.02

443

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

110

1063

1.04

0.12

1.4

25.14

23.22

u/l

0.25

885

Embedded teeth, including avohilmo

876

1.04

0.11

1.3

1.4

14.20

15.68

u/l

0.28

765

Cyst of Bartholin Gland

337

1.07

0.11

1.4

35.15

26.98

u/l

0.53

290

Inflammatory bowel disease, strict (require KELA)

184

1795

1.03

0.11

1.4

23.69

22.85

u/l

0.15

156

1487

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

204

1.08

0.11

1.2

1.4

35.81

37.72

u/l

0.11

179

Reimbursement for rheumatic diseases

428

4197

1.02

0.11

1.3

28.31

29.08

u/l

0.18

350

3432

Calcific aortic valvular stenosis, operated

422

1.06

0.11

1.3

27.19

29.87

u/l

0.24

344

Calcific aortic valvular stenosis

422

1.06

0.11

1.3

27.19

29.87

u/l

0.24

344

All pneumoniae

887

5864

1.01

0.10

1.3

1.4

25.64

25.43

u/l

0.07

730

4841

Atherosclerosis, excluding cerebral and coronary sclerosis

594

0.96

0.10

1.4

1.3

28.65

30.30

u/l

0.17

474

Bacterial pneumonia, not elsewhere classified

179

1614

0.98

0.10

1.4

23.94

26.56

u/l

0.58

154

1338

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

113

1096

1.03

0.10

1.4

27.05

24.11

u/l

0.41

912

Other superficial mycoses

810

0.96

0.10

1.3

1.4

14.96

20.88

u/l

1.32

690

Personal history of other diseases and conditions

118

1209

0.97

0.10

1.3

1.4

21.34

20.58

u/l

0.10

102

1020

Right ventricular outflow tract obstruction

1.11

0.10

2.2

1.5

6.20

13.60

u/l

—

Birth trauma

1.09

0.09

1.4

1.5

3.84

16.19

u/l

—

Injuries to the elbow and forearm

550

4776

1.01

0.09

1.3

1.4

25.38

26.50

u/l

0.34

424

3955

Retinal detachment with retinal break

381

0.94

0.09

1.3

1.4

35.55

30.73

u/l

0.30

313

Oesophagitis

174

1.09

0.09

1.4

38.06

25.85

u/l

0.77

140

Premature separation of placenta [abruptio placentae]

299

0.93

0.09

1.7

1.4

34.06

27.29

u/l

0.48

254

Dermatopolymyositis (FG)

1.04

0.09

1.4

31.30

28.77

u/l

—

Acute appendicitis, with complications

115

1119

1.03

0.09

1.3

31.72

28.82

u/l

0.41

919

Impacted maxillary canine

1.11

0.09

1.2

1.6

9.88

9.62

u/l

—

Retinal haemorrhage

1.11

0.09

1.7

1.5

7.92

33.38

u/l

—

Ulcer of lower limb, not elsewhere classified

331

1.06

0.08

1.5

1.4

28.12

27.87

u/l

0.02

271

Motorcycle rider injured in other and unspecified transport accidents

302

1.06

0.08

1.4

10.36

15.51

u/l

0.92

254

Complications specific to multiple gestation

0.81

0.08

1.2

1.5

6.96

24.52

u/l

—

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

0.83

0.08

1.4

6.34

15.22

u/l

—

Tubulo-interstitial nephritis, not specified as acute or chronic

328

0.94

0.08

1.3

1.4

28.59

26.42

u/l

0.14

270

Bacterial pneumoniae

192

1724

0.98

0.08

1.3

1.4

22.99

26.22

u/l

0.84

166

1430

Diabetic nephropathy

624

0.96

0.08

1.3

1.4

21.26

18.45

u/l

0.26

509

Benign neoplasm: Pancreas

1.05

0.08

2.3

1.3

46.89

33.63

u/l

—

Pre-eclampsia

249

2528

0.98

0.07

1.3

1.4

23.62

28.77

u/l

1.91

207

2060

Other immunodeficiencies

1.08

0.07

1.5

1.4

32.15

23.16

u/l

—

Other and unspecified injuries of abdomen, lower back and pelvis

1.08

0.07

1.5

10.49

19.61

u/l

—

Bacterial pneumonia (organism specified)

209

1926

0.98

0.07

1.3

1.4

23.53

26.38

u/l

0.74

180

1591

Tic and related disorders

0.87

0.07

1.0

1.5

26.96

15.85

u/l

—

Total colectomy operation

204

0.93

0.07

1.3

1.4

22.81

22.27

u/l

0.03

170

Total colectomy

204

0.93

0.07

1.3

1.4

22.81

22.27

u/l

0.03

170

Acute lymphadenitis

377

0.95

0.07

1.6

1.4

28.33

19.97

u/l

0.57

319

Crowding of teeth, including avohilmo

684

1.03

0.07

1.4

9.90

14.25

u/l

1.77

602

0.88

0.06

1.7

1.5

6.01

7.42

u/l

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

203

0.93

0.06

1.4

12.72

19.73

u/l

0.60

173

Infections of breast associated with childbirth

444

1.04

0.06

1.4

18.98

21.24

u/l

0.19

379

Degeneration of macula and posterior pole

105

818

1.02

0.06

1.4

1.3

34.20

34.69

u/l

0.04

667

Other embolism and thrombosis

557

0.97

0.05

1.4

1.3

21.94

30.07

u/l

0.95

455

Calcific aortic valvular stenosis, diagnosis (helper)

421

1.04

0.05

1.3

27.79

29.93

u/l

0.18

343

Operations 2 for CAVS

421

1.04

0.05

1.3

27.79

29.93

u/l

0.18

343

Diabetic neuropathy

393

1.04

0.05

1.3

1.4

19.68

22.69

u/l

0.24

328

AV-block

329

1.04

0.05

1.5

1.3

23.26

26.93

u/l

0.25

269

Artificial opening status

151

0.93

0.05

1.3

1.4

39.07

26.35

u/l

0.47

123

Atrial fibrillation and flutter with reimbursement

527

0.98

0.05

1.4

32.92

36.77

u/l

0.39

429

Sequelae of infectious and parasitic diseases

384

0.96

0.05

1.5

1.4

27.11

25.28

u/l

0.14

311

Basal cell carcinoma

113

796

0.98

0.05

1.4

1.3

40.00

37.49

u/l

0.32

579

Adalimumab

743

1.02

0.05

1.2

1.4

23.67

23.97

u/l

0.03

625

Calcific aortic valvular stenosis, including rheumatic fever

422

1.03

0.05

1.3

27.79

30.06

u/l

0.19

344

Tumor necrosis factor alpha inhibitors

131

1290

1.02

0.04

1.3

1.4

23.07

23.80

u/l

0.11

116

1068

Sequelae of other and unspecified infectious and parasitic diseases

363

0.96

0.04

1.4

28.43

25.26

u/l

0.26

295

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

631

4029

0.99

0.04

1.4

1.3

15.48

21.94

u/l

9.01

545

3338

Angina pectoris

172

1160

0.99

0.04

1.3

33.53

34.56

u/l

0.14

134

930

Complications following abortion and ectopic and molar pregnancy

200

1.05

0.03

1.3

48.38

36.53

u/l

0.53

169

Myopia

116

1176

0.99

0.03

1.4

27.16

22.14

u/l

0.66

980

Myeloproliferative diseases (CML excluded)

220

1.05

0.03

1.2

1.4

30.22

29.51

u/l

0.04

178

Viral conjunctivitis

270

0.96

0.03

1.3

1.4

20.68

22.61

u/l

0.13

222

Pyogenic granuloma

1.09

0.03

1.3

1.4

31.62

23.10

u/l

—

Open wound of ankle and foot

509

1.02

0.03

1.3

1.4

23.28

20.28

u/l

0.30

433

Unspecified privation

529

1.02

0.03

1.4

13.90

24.14

u/l

3.26

439

Pre-eclampsia or eclampsia

264

2623

1.01

0.02

1.3

1.4

24.47

29.04

u/l

1.63

220

2136

Sulfasalazine

202

2035

0.99

0.02

1.4

27.91

27.83

u/l

0.01

169

1662

Generalized epilepsy, strict definition

148

0.95

0.02

1.5

1.4

6.84

19.27

u/l

—

127

Seronegative rheumatoid arthritis

520

0.98

0.02

1.3

36.98

31.74

u/l

0.40

421

Heart failure,strict

133

930

1.01

0.02

1.3

31.11

30.01

u/l

0.13

107

754

Arthropod-borne viral fevers and viral haemorrhagic fevers

939

0.99

0.01

1.3

1.4

26.11

25.50

u/l

0.07

774

Dialysis, with operation codes

392

1.02

0.01

1.5

1.4

32.45

24.13

u/l

0.62

319

5-aminosalicylic acid

160

1590

1.01

0.01

1.4

25.15

24.00

u/l

0.18

138

1309

Retinal vascular disorders

227

0.97

0.01

1.4

1.3

42.71

32.93

u/l

0.61

183

Biological medication for rheuma

142

1411

1.01

0.01

1.3

1.4

23.66

23.95

u/l

0.04

126

1162

Unspecified fall

299

2936

1.00

0.01

1.4

26.21

25.28

u/l

0.18

235

2414

Supervision of normal pregnancy

333

1896

1.00

0.01

1.4

24.49

29.85

u/l

2.33

284

1495

Dilated cardiomyopathy

254

1.02

0.00

1.5

1.3

19.39

23.52

u/l

0.35

207

Major coronary heart disease event

459

2765

1.00

0.00

1.4

1.3

32.97

35.46

u/l

0.81

376

2215

Conductive and sensorineural hearing loss

448

3026

1.00

0.00

1.3

31.51

32.46

u/l

0.22

361

2450

Viral haemorrhagic fevers, not elsewhere classified/unspecified

812

1.00

0.00

1.3

1.4

24.84

24.57

u/l

0.03

672

Retinal breaks without detachment

674

0.99

0.00

1.6

1.4

42.95

33.57

u/l

1.02

540

Subarachnoid haemorrhage

310

1.00

0.00

1.2

1.4

43.40

32.13

u/l

0.93

248

Nephropathy related operations

388

1.01

0.00

1.6

1.4

28.51

23.61

u/l

0.34

313

Cardiomyopathies, Primary/intrinsic

285

0.98

0.00

1.5

1.3

18.91

25.44

u/l

0.66

232

Cardiomyopathy (excluding other)

304

0.99

0.00

1.5

1.3

17.95

25.24

u/l

0.86

248

Retinal vascular occlusion

223

0.99

0.00

1.4

1.3

42.71

32.99

u/l

0.61

179

Methotrexate

828

1.00

0.00

1.4

1.3

31.38

29.72

u/l

0.17

673

Coxarthrosis [arthrosis of hip](FG)

243

1710

1.00

0.00

1.3

34.18

36.14

u/l

0.36

191

1379

Valvular operations

284

0.99

0.00

1.2

1.3

22.85

23.81

u/l

0.06

232

Benign neoplasm: Long bones of lower limb

205

1.02

0.00

1.3

1.4

27.14

21.35

u/l

0.23

175

Unstable angina pectoris

640

1.00

0.00

1.3

30.10

30.91

u/l

0.07

504

Pemphigus foliaceus

0.00

0.0

1.3

—

46.15

—

Sequelae of poliomyelitis

0.00

0.0

1.7

—

23.11

—

Hookworm diseases

0.00

0.0

1.8

—

13.80

—

Alpha thalassaemia

0.00

0.0

2.3

—

20.03

—

Toxic effect of pesticides

0.00

0.0

2.0

—

28.27

—

Acne keloid

0.00

0.0

1.7

—

15.85

—

Photocontact dermatitis [berloque dermatitis]

0.00

0.0

1.8

—

37.35

—

Forearm

0.00

0.0

1.0

—

31.36

—

Subclinical iodine-deficiency hypothyroidism

0.00

0.0

1.7

—

31.95

—

Other changes in lacrimal passages

0.00

0.0

1.7

—

26.04

—

Intrauterine hypoxia

0.00

0.0

1.0

—

27.44

—

Accident to watercraft causing other injury

0.00

-0.00

0.0

1.6

—

15.46

—

Disorders of hypoglossal nerve

0.00

-0.00

0.0

1.6

—

26.87

—

Other disorders originating in the perinatal period

0.86

-0.00

1.2

1.5

36.88

21.69

u/l

—

Dermatopolymyositis

0.93

-0.00

1.4

1.5

31.30

28.71

u/l

—

Other disorders following mastoidectomy

0.00

-0.00

0.0

1.0

—

23.78

—

Drug-induced myopathy

0.00

-0.00

0.0

1.1

—

31.04

—

Myasthenia gravis

0.94

-0.00

1.7

1.4

19.32

27.38

u/l

—

Profound mental retardation

0.00

-0.00

0.0

1.2

—

38.80

—

Arthropathy in hypersensitivity reactions classified elsewhere

0.00

-0.00

0.0

1.8

—

29.12

—

Malignant neoplasms of independent (primary) multiple sites

0.00

-0.00

0.0

1.4

—

36.68

—

Migraine with aura, drug-induced

1.01

-0.00

1.6

1.4

22.20

28.95

u/l

—

Calcinosis cutis

0.00

-0.00

0.0

1.0

—

28.74

—

Acute epiglottitis

0.89

-0.00

1.3

1.4

12.55

21.58

u/l

—

Pemphigus vulgaris

0.00

-0.00

0.0

2.0

—

44.26

—

Ulcerative rectosigmoiditis

540

1.00

-0.00

1.3

1.4

27.39

24.74

u/l

0.22

443

Iodine-deficiency-related goitre

0.00

-0.00

0.0

1.2

—

32.32

—

Combined immunodeficiencies

1.02

-0.00

2.0

1.5

35.36

29.44

u/l

—

Genetic anomalies of leukocytes

0.00

-0.00

0.0

1.9

—

43.36

—

Folliculitis decalvans

0.00

-0.00

0.0

1.7

—

50.28

—

Diffuse (eosinophilic) fasciitis

0.00

-0.00

0.0

2.0

—

32.16

—

Benign neoplasm: Scrotum

0.00

-0.00

0.0

1.0

—

17.96

—

Benign neoplasm: Vertebral column

0.00

-0.00

0.0

1.7

—

38.02

—

Juvenile dermatomyositis

0.00

-0.00

0.0

1.8

—

21.74

—

Other secondary gonarthrosis

170

1.00

-0.00

1.1

1.3

36.34

32.22

u/l

—

134

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

0.00

-0.00

0.0

2.0

—

4.94

—

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

0.00

-0.00

0.0

1.6

—

45.28

—

Disorders of muscle tone of newborn

0.00

-0.00

0.0

1.3

—

6.67

—

Other/unspecified crystal arthropathies

0.00

-0.00

0.0

1.4

—

38.58

—

Intracranial laceration and haemorrhage due to birth injury

0.00

-0.00

0.0

1.2

—

47.50

—

Other birth injuries

0.00

-0.00

0.0

1.0

—

18.64

—

Use of trihexyphenidyl

0.00

-0.00

0.0

1.5

—

43.62

—

Other congenital malformations of spinal cord

0.00

-0.00

0.0

1.5

—

33.77

—

Hirsprung

0.00

-0.00

0.0

1.4

—

5.48

—

Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis

0.00

-0.00

0.0

1.1

—

24.20

—

Hereditary corneal dystrophies

1.01

-0.00

1.7

1.4

43.18

30.89

u/l

—

Hereditary factor IX deficiency

0.00

-0.00

0.0

1.6

—

26.78

—

Maze procedure for atrial fibrillation

0.00

-0.00

0.0

2.0

—

31.96

—

Malignant neoplasm of floor of mouth, including Hilmo

0.00

-0.00

0.0

1.4

—

29.34

—

Mucocutaneous lymph node syndrome [Kawasaki]

0.00

-0.00

0.0

1.7

—

12.70

—

Congenital malformation of biliary tract

0.00

-0.00

0.0

1.2

—

25.32

—

Foreign body in genitourinary tract

0.90

-0.00

1.6

1.5

24.73

21.20

u/l

—

Loose body in joint

0.98

-0.00

1.1

1.4

33.65

22.19

u/l

—

Cleft palate

0.93

-0.00

1.1

1.5

14.40

17.25

u/l

—

Contact with lifting and transmission devices, not elsewhere classified

0.95

-0.00

1.2

1.5

21.56

24.30

u/l

—

Secondary lactase deficiency

0.00

-0.00

0.0

1.4

—

11.42

—

Other parasitologically confirmed or unspecified malaria

0.00

-0.00

0.0

2.0

—

12.50

—

Other parasitologically confirmed or unspecified malaria

0.00

-0.00

0.0

2.2

—

13.50

—

Other acute disseminated demyelination

0.98

-0.00

1.3

1.5

20.02

23.67

u/l

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Follitropin [Units/volume] in Serum or Plasma by Immunoassay

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS